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ABSTRACT 
Although muhisite toxicity of bilirubin towards metabolism of cells is well known, 
mechanism of bilirubin entry from plasma to cells is still an enigma. Several 
studies have been performed to unravel the pathway (s) through which bilirubin 
enters into the cells using red blood cells as a model. But there is no clear evidence 
about the nature of membrane receptors for bilirubin. However, participation of 
membrane proteins as receptors has been excluded in an earlier study, but it is 
suggested that membrane proteins may function as an effective barrier to the 
binding of bilirubin. Further, it is proposed that negatively charged phosphate 
groups of phospholipids on the membrane surface may prevent a large amount of 
bilirubin from binding to the membrane. Since the membrane make-up of 
erythrocytes varies from species to species, I have studied the binding of bilirubin 
to erythrocytes as well as erythrocyte membranes from four different species 
namely, human {Homo sapiens), goat {Cepra hircus), buffalo {Bos indicus) and 
sheep {Ovis aries) under different conditions. 
Binding of bilirubin to erythrocytes of various mammalian species in the presence 
of their respective serum albumins was studied at pH 8.0, ionic strength 0.41 and 
at 37°C. In human, buffalo, goat and sheep, the amount of erythrocyte-boimd 
bilirubin increased with the increase in both the bilirubin/ albumin molar ratio 
(B/A) and the total bilirubin concentration. In all species, the binding patterns 
were qualitatively similar. However, at any given B/A above 1:1, goat erythrocytes 
bound the highest amount of bilirubin, followed by buffalo and human 
erythrocytes; sheep erythrocytes bound the lowest amount of bilirubin. Increase in 
erythrocyte-bound bilirubin per unit increase in bilirubin concentration at a 
constant B/A as obtained from the values of the slope of the plot between 
erythrocyte-bound bilirubin and total bilirubin in the incubate, was found to be 
highest for goat erythrocytes, followed by buffalo, human and sheep erythrocytes. 
( i ) 
At a given bilirubin concentration, percentage fractional binding of bilirubin 
between any two B/As was found to be highest between 1.5 and 2.0, suggesting 
that a greater amount of bilirubin was transferred from plasma to cells between 
B/As 1.5 and 2.0. Percentage fractional binding of bilirubin was highest in goat 
erythrocytes, followed by buffalo, human and sheep erythrocytes. These 
differences in the amount of erythrocyte-bound bilirubin were not due to the effect 
of various plasma albumins. These results suggest that erythrocytes of different 
mammalian species differ significantly in their bilirubin-binding characteristics. 
When bilirubin binding to erythrocytes was studied in the absence of albumin, 
curves between bilirubin bound to erythrocytes and bilirubin in the incubate 
followed Michaelian saturation kinetics. The dissociation constants of the 
bilirubin-receptor complex and saturable binding sites were calculated using 
double reciprocal plots. Goat erythrocytes had the highest dissociation constant 
(265.7 ^mol/1) and highest saturation (125.9 jiM), whereas sheep erythrocytes had 
the lowest dissociation constant (115.6 ^mol/1) and lowest saturation (62.5 i^M). 
Buffalo and human erythrocytes bound bilirubin in a similar fashion and the values 
of interaction parameters were midway between those obtained with goat and 
sheep erythrocytes. Differences in the affinity and number of saturable binding 
sites can be attributed to the different make-up of the erythrocyte membranes of 
these species. 
Human erythrocytes, preincubated with different concentrations of calcium 
chloride (0.17 - 1.67 mM) showed hemolysis after addition of bilirubin (72fjM). 
Hemolysis was observed only when cells were incubated first with calcium 
followed by bilirubin and not vice versa. This hemolysis was found to be 
dependent upon several factors such as concentration of bilirubin, time of 
incubation of erythrocytes with calcium and time of incubation of bilirubin 
with the calcium-loaded erythrocytes. Inclusion of EDTA in the incubation 
medium reduced the percentage hemolysis to a significant extent. Involvement 
( i i ) 
of activated oxygen species in hemolytic process seems to be unlikely as 
inclusion of sodium azide and catalase did not prevent hemolysis. A compa-
rison of other bivalent cations such as Ba"^ ', Mg^ *, Mn ' and Cu'* with 
Ca * for their ability to hemolyse cells in presence of bilirubin shows that 
Ba" and Mg"^^ are ineffective, whereas both Mn*'and Cu^'induce hemolysis 
both in the absence as well as in the presence of bilirubin. However, their 
mechanism of hemolysis is different from that of calcium-induced hemolysis. 
Formation of calcium-induced hydrophobic a^regates of phospholipid molecules 
in erythrocyte membrane may open the new binding sites for bilirubin on these 
membranes which may perturb the membrane conformation. 
Erythrocytes from human, buffalo, sheep and goat preincubated with different 
concentrations of calcium chloride (16.7-1830 |a,M) showed significantly different 
rates of hemolysis (up to 62 %) after addition of bilirubin (72 (xM). Goat 
erythrocytes displayed marked resistance to hemolysis with only 11% hemolysis 
observed at the highest calcium concentration. Similar trend in hemolysis was also 
observed when the concentration of CaCl2 was fixed (330 |j.M) and bilirubin 
concentration varied (0 - 72 |xM). (Ca^*-Mg*')-ATPase levels were found 
significantly lower in goat and sheep erythrocyte membranes compared to human 
and buffalo erythrocyte membranes. This was correlated well with the observed 
hemolysis in various mammalian erythrocytes. 
As Mg -loaded erythrocytes from human, buffalo, sheep and goat failed to show 
any hemolysis in the presence of bilirubin, the effect of Mg'' on tlie interaction of 
bilirubin with human, buffalo, sheep and goat erythrocytes was studied. Different 
erythrocytes preincubated with different concentrations of MgCb (0- 3.33 mM) 
followed by further incubation with bilirubin (72JAM), showed increased level of 
bilirubin binding as compared to untreated erythrocytes. This increase was directiy 
proportional to the concentration of MgCb in the incubate. However, a 
( i i i ) 
comparison of the percentage increase in the erythrocyte-bound bihrubin at 
various MgCl2 concentrations showed significant variation among erythrocytes of 
different mammalian species. Maximum percentage increase in the bound bilirubin 
was noticed in human er>1hrocytes, followed by buffalo and sheep erythrocytes 
while goat erythrocytes showed the lowest. Increase in bilirubin binding observed 
with these erythrocytes in the presence of MgCla can be attributed to the 
differential binding of Mg' * to these erythrocytes, thereby masking the negatively 
charged polar head groups of phospholipids. 
Three different methods were compared for their possible use in the extraction of 
membrane-bound bilirubin (EMB) from erythrocyte membranes. Use of 2.5% 
albumin, pH 7.4 for elution of EMB resulted in only 34% of the total EMB which 
was estimated after the solubilization of bilirubin loaded erythrocyte membranes 
(BLEMs) with 1% SDS. On the other hand, incubation of BLEMs with 38 mM 
sodium carbonate solution containing 5 mM EDTA, pH 11.0 yielded 77% of the 
total EMB. Application of Fog's reaction directly on the BLEMs resulted in the 
estimation of 75% of the total EMB. These results suggest that either of the 
above methods i.e. use of albumin or high pH, or direct Fog's reaction can not 
estimate the total EMB correctly. Increase in ionic strength from 0.15 to 0.45 did 
not release any EMB from erythrocyte membranes. Therefore, the best method for 
the estimation of total EMB is the solubilization of membrane with 1% SDS 
followed by Fog's reaction method. 
Studies on the interaction of bilirubin with erythrocyte membranes showed that in 
all mammalian species, concentration of EMB increased with the increase in 
bilirubin concentration in the incubate (8.5 - 68.3^iM). However, quantitative 
differences were noticed among different mammalian species. Binding was 
maximum in himian erythrocyte membranes, followed by sheep and buffalo 
erythrocyte membranes and lowest binding was observed in goat erythrocyte 
membranes. These differences can not be ascribed to the differences in either 
( i v ) 
protein or phospholipid content of the membrane as no correlation was found 
between the amount of EMB and membrane protein or phospholipid content. 
However, statistical analysis of bilirubin binding data using reported membrane 
phospholipid composition of human, buffalo, sheep and goat erythrocyte mem-
branes revealed a strong positive correlation (r = 0.98; P> 0.0001) between the 
EMB and the sum of choline phospholipids [phosphatidylcholine (PC) + sphin-
gomyelin (Sph)] and with the ratio of total choline phospholipids to the sum of 
phosphatidylserine (PS), phosphatidylinositol (PI) and phosphatidylethanolamine 
(PE). Further, a comparison of the amount of bilirubin bound to erythrocytes with 
that of bound to equivalent membranes at 68.3[iM bilirubin concentration in the 
incubate under similar conditions, showed that membranes bound much higher 
bilirubin than intact erythrocytes. The percentage increase in the amount of 
bilirubin bound to membranes from that bound to erythrocytes was found to be 
different for different mammalian species being highest in human and lowest in 
goat erythrocyte membranes. Thus, it appears that large number of bilirubin 
binding sites were exposed in membranes compared to intact erythrocytes as both 
the membrane surfaces are available for bilirubin binding in membranes compared 
to the availability of only outer surface in intact erythrocytes. The unequal binding 
of bilirubin to these membranes may be due to the variation of lipid distribution in 
both the outer and inner layers of the membrane from species to species. 
Human erythrocyte membranes preincubated with varying concentrations (0 -3.2 
mM) of different metal ions (Ca"^ *, Sr^ ,^ Mg""^  and Ba^ ) showed increased level of 
bilirubin binding. This increase in bilirubin binding was found to be dependent 
upon metal ion concentration. However, the increase was found to be highest with 
Ca"^ ^ followed by Sr^ *^  and Mg"^ ^ and lowest with Ba"^ .^ Further Ca*'-loaded 
membranes showed a marked increase in the bound bilirubin up to 1.2 mM beyond 
which it sloped off whereas binding increased continuously in Sr' \ Mg*^ ^ and 
Ba"^-loaded membranes up to 3.2 mM metal ion concentration. Thus, it appears 
(v) 
that human erythrocyte membranes have different binding characteristics for 
different metal ions. Increased binding of bilirubin to erythrocyte membranes in 
the presence of metal ions can be viewed as the shielding effect of metal ions on 
tiie negatively charged lipid bilayer. However, strength of this effect varied from 
ion to ion being maximum for Ca*', followed by Sr^  * and Mg^  * and minimum for 
Effect of Ca ' (being most effective among all the four metal ions used) on the 
bilirubin binding to erythrocyte membranes of different mammalian species was 
also studied. Erythrocyte membranes of different mammalian species preincubated 
with fixed concentrations of CaCl2 (0.5, 1.0 and 1.5 mM) showed increased level 
of bilirubin binding at increasing bilirubin concentrations (8.5 -68.3 jiM) as 
compared to untreated membranes. This increase in the amount of bilirubin bound 
to these membranes was found to be dependent on both calcium and bilirubin 
concentrations. However, a different pattern of bilirubin binding was observed in 
Ca -treated membranes compared to the untreated membranes. Order of bilirubin 
binding in Ca* -treated membranes was : human > goat > buffalo > sheep against 
human > sheep > buffalo > goat observed with untreated membranes. Higher 
bilirubin binding to calcium-loaded goat erythrocyte membranes cdmpared to 
sheep and buffalo erythrocyte membranes can be due to high PS content (having 
very high affinity for Ca*') present in goat erythrocyte membranes. Increase in 
membrane-bound bilirubin produced by calcium binding to membranes, when 
plotted against bilirubin concentration showed a downward curvature in human 
and goat erythrocyte membranes which became more pronounced at higher Ca*^ * 
concentrations. This was probably due to saturable binding of Ca' ' in goat and 
human erythrocyte membranes. 
Treatment of erythrocyte membranes of different mammalian species with 
phospholipase C for different time periods resulted in the release of membrane 
phosphorus, the amount of which increased with increasing time of enzyme 
( v i ) 
incubation. The amount of phosphorus released was found to be highest in human 
erythrocyte membranes followed by buffalo and sheep erythrocyte membranes and 
lowest in goat erythrocyte membranes. However, the percentage of the phosphorus 
released from human, buffalo and sheep erythrocyte membranes was nearly same. 
On the other hand, goat erythrocyte membranes showed lowest percentage of 
phosphorus released. Phospholipase C-treated erythrocyte membranes of different 
mammalian species showed increased level of bilirubin binding as compared to 
untreated membranes at all the bilirubin concentrations used. However, 
quantitative differences in the amount of EMB were noticed among different 
erythrocyte membranes. These differences became more pronounced when 
enzyme treatment prolonged for 30 minutes. The order of bilirubin binding to 
these membranes was : human > buffalo > sheep > goat. Statistical analysis 
showed a positive correlation (r = 0.95) between the amount of EMB and ratio of 
total sum of PC, PE and Sph content to that of PS content. Since phospholipase C 
from C. welchii removes membrane phosphorus predominantly from PC, PE and 
Sph only, increased binding of bilirubin to treated membranes can be attributed to 
the removal of polar head groups from PC, PE and Sph of these membranes. In 
other words, exposure of non-polar fatty acid diacylglycerols and sphingosine was 
responsible for increased binding of bilirubin to these membranes. 
Trypsin treatment of erythrocyte membranes of different mammalian species 
resulted in the loss of membrane glycopeptides and the amount of released 
carbohydrate increased with the increase in time of incubation of enzyme with 
membranes. However, the percentage of carbohydrate released from these 
membranes was nearly equal in all the species. Increased binding of bilirubin to 
erythrocyte membranes was found after trypsin treatment in all the mammalian 
species. However, they were different from each other in terms of EMB at higher 
bilirubin concentrations. The order of bilirubin binding to these membranes was : 
human > sheep > buffalo > goat. No correlation was found between the amount of 
( v i i ) 
EMB after trypsin treatment and the amount of carbohydrate released from these 
membranes. Further, treatment of erythrocyte membranes with trypsin for a longer 
time period (up to 3 hours) did not result in any significant change in the amount 
of EMB as compared to one hour treatment, although the amount of released 
carbohydrate increased. The increase in bilirubin binding to trypsin-treated 
erythrocyte membranes seems to be due to the degradation of membrane proteins 
by trypsin and the release of phosphate from the phospholipids associated with 
these proteins. The highest increase in bilirubin binding to human erythrocyte 
membranes after trypsin treatment compared to otiher species may be ascribed to 
either differential degradation of membrane proteins due to differential location of 
trypsin cleavable sites or due to differential protection of protein hydrolysis by 
trypsin provided by phospholipids. 
Neuraminidase treatment of erythrocyte membranes resulted in increased binding 
of bilirubin as compared to untreated membranes in all the mammalian species. 
However, the percentage increase in bilirubin binding was similar (-14%) in all 
the species. Furthermore, the pattern of bilirubin binding to these membranes was 
similar (human > sheep > buffalo > goat) to the one obtained with untreated 
membranes. A slight increase in bilirubin binding to neuraminidase-treated 
membranes can be ascribed to the loss of negatively charged sialic acid residues 
from these membranes which may repel the negatively charged bilirubin 
monoanion. 
( v i i i ) 
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ABSTRACT 
Although multisite toxicity of bilirubin towards metabolism of cells is well known, 
mechanism of bilirubin entry fi:om plasma to cells is still an enigma. Several 
studies have been performed to unravel the pathway (s) through which bilirubin 
enters into the cells using red blood cells as a model. But there is no clear evidence 
about the nature of membrane receptors for bilirubin. However, participation of 
membrane proteins as receptors has been excluded in an earlier study, but it is 
suggested that membrane proteins may function as an effective barrier to the 
binding of bilirubin. Further, it is proposed that negatively charged phosphate 
groups of phospholipids on the membrane surface may prevent a large amount of 
bilirubin from binding to the membrane. Since the membrane make-up of 
erythrocytes varies from species to species, I have studied the binding of bilirubin 
to erythrocytes as well as erythrocyte membranes from four different species 
namely, human (Homo sapiens), goat (Cepra hircus), buffalo {Bos indicus) and 
sheep {Ovis aries) under different conditions. 
Binding of bilirubin to erythrocytes of various mammalian species in the presence 
of their respective serum albumins was studied at pH 8.0, ionic strength 0.41 and 
at 37^C. In human, buffalo, goat and sheep, the amount of erythrocyte-bound 
bilirubin increased with the increase in botii the bilirubin/ albumin molar ratio 
(B/A) and the total bilirubin concentration. In all species, the binding patterns 
were qualitatively similar. However, at any given B/A above 1:1, goat erythrocytes 
bound the highest amount of bilirubin, followed by buffalo and human 
erythrocytes; sheep erythrocytes bound the lowest amount of bilirubin. Increase in 
erythrocyte-bound bilirubin per unit increase in bilirubin concentration at a 
constant B/A as obtained from the values of the slope of the plot between 
erythrocyte-bound bilirubin and total bilirubin in the incubate, was found to be 
highest for goat erythrocytes, followed by buffalo, himian and sheep erythrocytes. 
( i ) 
At a given bilirubin concentration, percentage fractional binding of bilirubin 
between any two B/As was found to be highest between 1.5 and 2.0, suggesting 
that a greater amount of bilirubin was transferred from plasma to cells between 
B/As 1.5 and 2.0. Percentage fractional binding of bilirubin was highest in goat 
erythrocytes, followed by buffalo, human and sheep erythrocytes. These 
differences in the amount of erythrocyte-bound bilirubin were not due to the effect 
of various plasma albumins. These results suggest that erythrocytes of different 
mammalian species differ significantly in their bilirubin-binding characteristics. 
When bilirubin binding to erythrocytes was studied in the absence of albumin, 
curves between bilirubin bound to erythrocytes and bilirubin in the incubate 
followed Michaelian saturation kinetics. The dissociation constants of the 
bilirubin-receptor complex and saturable binding sites were calculated using 
double reciprocal plots. Goat erythrocytes had the highest dissociation constant 
(265.7 ^mol/l) and highest saturation (125.9 ^M), whereas sheep erythrocytes had 
the lowest dissociation constant (115.6 iamol/1) and lowest saturation (62.5 ^M). 
Buffalo and human erythrocytes bound bilirubin in a similar fashion and the values 
of interaction parameters were midway between those obtained with goat and 
sheep erythrocytes. Differences in the affinity and number of saturable binding 
sites can be attributed to the different make-up of the erythrocyte membranes of 
these species. 
Human erythrocytes, preincubated with different concentrations of calcium 
chloride (0.17 - 1.67 mM) showed hemolysis after addition of bilirubin (72)^ M). 
Hemolysis was observed only when cells were incubated first with calcium 
followed by bilirubin and not vice versa. This hemolysis was found to be 
dependent upon several factors such as concentration of bilirubin, time of 
incubation of erythrocytes with calcium and time of incubation of bilirubin 
with the calcium-loaded erythrocytes. Inclusion of EDTA in the incubation 
medium reduced the percentage hemolysis to a significant extent. Involvement 
( i i ) 
of activated oxygen species in hemolytic process seems to be imlikely as 
inclusion of sodium azide and catalase did not prevent hemolysis. A compa-
rison of other bivalent cations such as Ba\ Mg' , Mn'' and Cu'" with 
Ca"^ ^ for their ability to hemolyse cells in presence of bilirubin shows that 
Ba'' and Mg*' are ineffective, whereas both Mn^ "^  and Cu*^  induce hemolysis 
both in the absence as well as in the presence of bilirubin. However, their 
mechanism of hemolysis is different from that of calcium-induced hemolysis. 
Formation of calcium-induced hydrophobic aggregates of phospholipid molecules 
in erythrocyte membrane may open the new binding sites for bilirubin on these 
membranes which may perturb the membrane conformation. 
Erythrocytes from human, buffalo, sheep and goat preincubated with different 
concentrations of calcium chloride (16.7-1830 [j,M) showed significantly different 
rates of hemolysis (up to 62 %) after addition of bilirubin (72 jaM). Goat 
erythrocytes displayed marked resistance to hemolysis with only 11% hemolysis 
observed at the highest calcium concentration. Similar trend in hemolysis was also 
observed when the concentration of CaCl2 was fixed (330 (xM) and bilirubin 
concentration varied (0 - 72 i^M). (Ca '^-Mg^*)-ATPase levels were found 
significantly lower in goat and sheep erythrocyte membranes compared to human 
and buffalo erythrocyte membranes. This was correlated well with the observed 
hemolysis in various mammalian erythrocytes. 
As Mg'-loaded erythrocytes from human, buffalo, sheep and goat failed to show 
any hemolysis in the presence of bilirubin, the effect of Mg* * on the interaction of 
bilirubin with human, buffalo, sheep and goat erythrocytes was studied. Different 
erythrocytes preincubated with different concentrations of MgCla (0- 3.33 mM) 
followed by further incubation with bilirubin (72nM), showed increased level of 
bilirubin binding as compared to untreated erythrocytes. This increase was directly 
proportional to the concentration of MgCla in the incubate. However, a 
( i i i ) 
comparison of the percentage increase in the erythrocyte-bound bilirubin at 
various MgCla concentrations showed significant variation among erythrocytes of 
different mammalian species. Maximum percentage increase in the bound bilirubin 
was noticed in human erythrocytes, followed by buffalo and sheep erythrocytes 
while goat erythrocytes showed the lowest. Increase in bilirubin binding observed 
with these erythrocytes in the presence of MgCl2 can be attributed to the 
differential binding of Mg* * to these erythrocytes, thereby masking the negatively 
charged polar head groups of phospholipids. 
Three different methods were compared for their possible use in the extraction of 
membrane-bound bilirubin (EMB) from erythrocyte membranes. Use of 2.5% 
albumin, pH 7.4 for elution of EMB resulted in only 34% of the total EMB which 
was estimated after the solubilization of bilirubin loaded erythrocyte membranes 
(BLEMs) with 1% SDS. On the other hand, incubation of BLEMs with 38 mM 
sodium carbonate solution containing 5 mM EDTA, pH 11.0 yielded 77% of the 
total EMB. Application of Fog's reaction directly on the BLEMs resulted in the 
estimation of 75% of the total EMB. These results suggest that either of the 
above methods i.e. use of albumin or high pH, or direct Fog's reaction can not 
estimate the total EMB correctly. Increase in ionic strength from 0.15 to 0.45 did 
not release any EMB from erythrocyte membranes. Therefore, the best method for 
Ae estimation of total EMB is the solubilization of membrane with 1% SDS 
followed by Fog's reaction method. 
Studies on the interaction of bilirubin with erythrocyte membranes showed that in 
all mammalian species, concentration of EMB increased with the increase in 
bilirubin concentration in the incubate (8.5 - 68.3}iM). However, quantitative 
differences were noticed among different mammalian species. Binding was 
maximum in human erythrocyte membranes, followed by sheep and buffalo 
erythrocyte membranes and lowest binding was observed in goat erythrocyte 
membranes. These differences can not be ascribed to the differences in either 
( i v ) 
protein or phospholipid content of the membrane as no correlation was found 
between the amount of EMB and membrane protein or phospholipid content. 
However, statistical analysis of bilirubin binding data using reported membrane 
phospholipid composition of human, buffalo, sheep and goat erythrocyte mem-
branes revealed a strong positive correlation (r = 0.98; P> 0.0001) between the 
EMB and the sum of choline phospholipids [phosphatidylcholine (PC) + sphin-
gomyelin (Sph)] and with the ratio of total choline phospholipids to the simi of 
phosphatidylserine (PS), phosphatidylinositol (PI) and phosphatidylethanolamine 
(PE). Further, a comparison of the amount of bilirubin bound to erythrocytes with 
that of bound to equivalent membranes at 68.3jxM bilirubin concentration in the 
incubate under similar conditions, showed that membranes bound much higher 
bilirubin than intact erythrocytes. The percentage increase in the amount of 
bilirubin bound to membranes from that bound to erythrocytes was found to be 
different for different mammalian species being highest in human and lowest in 
goat erythrocyte membranes. Thus, it appears that large number of bilirubin 
binding sites were exposed in membranes compared to intact erythrocytes as both 
tiie membrane surfaces are available for bilirubin binding in membranes compared 
to the availability of only outer surface in intact erythrocytes. The unequal binding 
of bilirubin to these membranes may be due to the variation of lipid distribution in 
both the outer and inner layers of the membrane from species to species. 
Human erythrocyte membranes preincubated with varying concentrations (0 -3.2 
mM) of different metal ions (Ca*\ Sr' *, Mg* * and Ba* *) showed increased level of 
bilirubin binding. This increase in bilirubin binding was found to be dependent 
upon metal ion concentration. However, the increase was found to be highest with 
Ca * followed by Sr^ ^ and Mg '^ and lowest with Ba' . Further Ca '^-loaded 
membranes showed a marked increase in the bound bilirubin up to 1.2 mM beyond 
which it sloped off whereas binding increased continuously in Sr", Mg'' and 
Ba'-loaded membranes up to 3.2 mM metal ion concentration. Thus, it appears 
( v ) 
that human erythrocyte membranes have different binding characteristics for 
different metal ions. Increased binding of bilirubin to erythrocyte membranes in 
the presence of metal ions can be viewed as the shielding effect of metal ions on 
the negatively charged lipid bilayer. However, strength of this effect varied from 
ion to ion being maximum for Ca^\ followed by Sr'' and Mg^ ^ and minimum for 
Ba^ 
Effect of Ca" (being most effective among all the four metal ions used) on the 
bilirubin binding to erythrocyte membranes of different mammalian species was 
also studied. Erythrocyte membranes of different mammalian species preincubated 
with fixed concentrations of CaCl2 (0.5, 1.0 and 1.5 mM) showed increased level 
of bilirubin binding at increasing bilirubin concentrations (8.5 -68.3 \xM) as 
compared to untreated membranes. This increase in the amount of bilirubin bound 
to these membranes was found to be dependent on both calcium and bilirubin 
concentrations. However, a different pattern of bilirubin binding was observed in 
Ca* -treated membranes compared to the untreated membranes. Order of bilirubin 
binding in Ca'^ -treated membranes was : human > goat > buffalo > sheep against 
human > sheep > buffalo > goat observed with untreated membranes. Higher 
bilirubin binding to calcium-loaded goat erythrocyte membranes compared to 
sheep and buffalo erythrocyte membranes can be due to high PS content (having 
very high affinity for Ca"^ )^ present in goat erythrocyte membranes. Increase in 
membrane-boimd bilirubin produced by calcium binding to membranes, when 
plotted against bilirubin concentration showed a downward curvature in human 
and goat erythrocyte membranes which became more pronounced at higher Ca'' 
concentrations. This was probably due to saturable binding of Ca"^ ^ in goat and 
human erythrocyte membranes. 
Treatment of erythrocyte membranes of different mammalian species with 
phospholipase C for different time periods resulted in the release of membrane 
phosphorus, the amount of which increased with increasing time of enzyme 
( v i ) 
incubation. The amount of phosphorus released was found to be highest in human 
erythrocyte membranes followed by buffalo and sheep erythrocyte membranes and 
lowest in goat erythrocyte membranes. However, the percentage of the phosphorus 
released from human, buffalo and sheep erythrocyte membranes was nearly same. 
On the other hand, goat erythrocyte membranes showed lowest percentage of 
phosphorus released. Phospholipase C-treated erythrocyte membranes of different 
mammalian species showed increased level of bilirubin binding as compared to 
untreated membranes at all the bilirubin concentrations used. However, 
quantitative differences in the amount of EMB were noticed among different 
erythrocyte membranes. These differences became more pronounced when 
enzyme treatment prolonged for 30 minutes. The order of bilirubin binding to 
these membranes was : human > buffalo > sheep > goat. Statistical analysis 
showed a positive correlation (r = 0.95) between the amount of EMB and ratio of 
total sum of PC, PE and Sph content to that of PS content. Since phospholipase C 
from C. welchii removes membrane phosphorus predominantly from PC, PE and 
Sph only, increased binding of bilirubin to treated membranes can be attributed to 
the removal of polar head groups from PC, PE and Sph of these membranes. In 
other words, exposure of non-polar fatty acid diacylglycerols and sphingosine was 
responsible for increased binding of bilirubin to these membranes. 
Trypsin treatment of erythrocyte membranes of different mammalian species 
resulted in the loss of membrane glycopeptides and the amount of released 
carbohydrate increased with the increase in time of incubation of enzyme with 
membranes. However, the percentage of carbohydrate released from these 
membranes was nearly equal in all the species. Increased binding of bilirubin to 
erythrocyte membranes was found after trypsin treatment in all the mammalian 
species. However, they were different from each other in terms of EMB at higher 
bilirubin concentrations. The order of bilirubin binding to these membranes was : 
human > sheep > buffalo > goat. No correlation was found between the amount of 
( v i i ) 
EMB after trypsin treatment and the amount of carbohydrate released from these 
membranes. Further, treatment of erythrocyte membranes with trypsin for a longer 
time period (up to 3 hours) did not result in any significant change in the amount 
of EMB as compared to one hour treatment, although the amount of released 
carbohydrate increased. The increase in bilirubin binding to trypsin-treated 
erythrocyte membranes seems to be due to the degradation of membrane proteins 
by trypsin and the release of phosphate from the phospholipids associated with 
these proteins. The highest increase in bilirubin binding to human erythrocyte 
membranes after trypsin treatment compared to other species may be ascribed to 
either differential degradation of membrane proteins due to differential location of 
trypsin cleavable sites or due to differential protection of protein hydrolysis by 
trypsin provided by phospholipids. 
Neuraminidase treatment of erythrocyte membranes resulted in increased binding 
of bilirubin as compared to untreated membranes in all the mammalian species. 
However, the percentage increase in bilirubin binding was similar (-14%) in all 
the species. Furthermore, the pattern of bilirubin binding to these membranes was 
similar (human > sheep > buffalo > goat) to the one obtained with untreated 
membranes. A slight increase in bilirubin binding to neuraminidase-treated 
membranes can be ascribed to the loss of negatively charged sialic acid residues 
from these membranes which may repel the negatively charged bilirubin 
monoanion. 
( v i i i ) 
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INTRODUCTION 
Under physiological conditions, in human adult, 1-2 x 10* erythrocytes are 
destroyed per hour resulting in a turn over of approximately 6 gm of hemoglobin 
per day by a 70 kg human (Schmid and McDonough, 1978). Both the protein, 
globin and iron of hemoglobin are reutilized by the body, but the iron-free 
porphyrin portion of heme is catabolized mainly in the reticuloendothelial cells of 
the liver, spleen, and bone marrow producing a yellow pigment called bilirubin 
IX-a. Bilirubin IX-a can be isolated from gall stones and is the most commonly 
found natural linear tetrapyrrole. It is estimated that 1 gm of hemoglobin yields 35 
mg of bilirubin. Thus, about 250-350 mg of bilirubin is produced per day in human 
adults. 
Properties of bilirubin 
(i) Chemical properties : Bilirubin is described as a polar structure with several 
groups capable of forming hydrogen bonds, namely, two carboxyls, two pyrrol -
NH, two lactam-NH and two lactam carbonyls and several hydrophobic groups i.e. 
four methyls, two vinyls, two ethylenes, and one methylene (see Fig.l a and b). 
The protoporphyrin IX, the parent molecule, which occurs in Z-configuration 
mainly opens at the a-methin bridge during catabolism, leading to the formation of 
bilirubin IX-a (Z,Z). This is present either as dianion or intramolecularly 
hydrogen-bonded bilirubin acid as shown in Fig. 1 a. However, little amounts of 
protoporphyrin IX also undergo cleavage at the 15, y or 5 positions yielding about 
5% of bilirubin non-a isomers such as bilirubin IX-iJ, IX-y or IX-8 (Brown, 1976; 
Blanckaert et al, 1975, 1976; Blumenthal et al., \911; Heirwegh et ai, 1977). 
Upon illumination with blue light, bilirubin IX-a (Z,Z) undergoes cis-trans 
isomerization producing bilirubin IX-a (E,Z) or possibly bilirubin IX-a (E,E) 
a) 
CCXDH COOH COOH 
cv^ ^ 
Fig 1(a) Chemical structure of bilirubin 
(1) Protoporph>Tin IX (II) Bilirubin IX-a 
(111) Bilirubin IX-a (acid). (1\') Bilirubin IX-a (dianion) 
(\') Bilirubin IX-a (acid) intramolecularl> hydrogen bonded 
(D 
CH, 
H H I 
1 S>CH, H CH, „ ^ 
CH, H 
HOOC 
01) 
corf» 
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Fig l.(b) Photoisomers and non-a isomers of bilinibm. 
(I) The mother compound, bihrubin IX-a (Z.Z) 
(II)B.hrubml\-p (111) BihrubmlX-yanddV) Bilirubm IX-5. 
called photobilirubins (Lightner and Park, 1977, Pedersen et al, 1977) which can 
no longer form the pattern of intramolecular hydrogen bonds. 
(i) Solubility : Bilirubin IX-a (Z,Z) is nearly insoluble in water at pH values 
below 7 while non-a isomers and the photobilirubins (E,Z and E,E) are more 
soluble (Overbeek et al, 1955; Brodersen, 1979). Only a-isomers in (Z,Z) 
configuration, with undissociated carboxyl groups are capable of forming a 
complete pattern of intramolecular hydrogen bonds, saturating all affmities for 
water and are insoluble. In non-a isomers, the carboxyl groups are located 
differently, relative to the lactam groups and pyrrol nitrogen atoms and this is also 
the case in photoisomers where the outer rings have been turned, forming E-
configurations. All these have one or several hydrophilic moieties available for 
binding of water molecules and thus are water soluble even in acid solution. The 
solubility of bilirubin acid being too low in water, has been measured in several 
solvents (Brodersen, 1979). The solubility of bilirubin in apolar solvents, such as 
n-hexane is less than 1 jiM and generally increases with increasing solvent 
polarity, reaching to a value higher than 10 mM in dimethyl sulfoxide (Brodersen, 
1979). 
Several authors have stated that bilirubin is a lipophilic substance. This is mainly 
due to the work of Mustafa and King (1970) who demonstrated the binding of 
bilirubin to lipid-water interphases containing lipids of a polar nature. Another 
consideration of bilirubin lipophilicity is the insolubility of bilirubin acid in water 
due to intramolecular hydrogen bonding (Bonnett et al, 1976), wherby all 
hydrophilic groups in the molecule are saturated. This molecule is also insoluble in 
carbon hydrides and alcohols and has a low solubility in carbon tetrachloride, 
diethyl ether, acetone, ethyl acetate and triglycerides, while its solubility is high in 
formamide and dimethyl sulfoxide. A substance with these solubility characte-
ristics can hardly be considered as lipophilic (Brodersen, 1979). 
(iii) Spectroscopic properties : Light absorption spectrum of bilirubin IX-a (Z,Z) 
acid, dissolved in organic solvents shows two maxima, one weak band at about 
290 nm and another intense maximum at 450 to 460 nm (Hailmeyer, 1931), while 
spectrum of non-a isomers of bilirubin in dimethyl-formamide solution shows 
similar maximum although the main peak is located at shorter wavelength 390 to 
410 nm (Blanckaert et al, 1976). Bilirubin IX-a (Z,Z) acid dissolved in 
chloroform has light absorption maximum at 460 nm and a molar absorption 
coefficient close to 60,000 M* cm"' ( Brodersen, 1982). Dilute solutions of 
bilirubin disodium salt in alkaline aqueous media have light absorption maximum 
around 430 to 440 nm, depending upon buffer composition and temperature 
(Carey and Koretsky, 1979). A molar absorption coefficient of 4.7 to 5.2 x lO"* M* 
cm'' has been reported by several investigators (Carey and Koretsky, 1979; 
McDonagh, 1979; Blauer et al, 1972). The spectrum is constant with pH varying 
from 8 to 12. At low concentrations of bilirubin, from about 20 nM, which is the 
practical lower limit for spectroscopic recording, to an upper limit between 1.0 to 
10 ^M, the scattering to high values, indicating formation of large particles. The 
light absorption spectrum shows a shght, immediate loss of intensity followed by 
marked decrease of the peak at 440 nm and an increase of absorption at 500 nm 
with increasing time. 
Bilirubin catabolism in vivo 
In plasma, bilirubin is protein bound, specifically to albumin. Small amount of 
bilirubin is also conjugated with glucose (Blanckaert et al., 1974) and xylose 
(CompemoUe et al, 1971; Fevery et al, 1977). In the liver, albumin-bound 
bilirubin is removed from the albumin and taken up at the sinusoidal surface of the 
hepatocytes by a carrier-mediated saturable system. The smooth endoplasmic 
reticulum provides a specific set of enzymes which convert bilirubin into 
diglucuronide. This conversion can also take place in the kidney and the intestinal 
mucosa. Secretion of this conjugated bilirubin into the bile occurs against a large 
concentration gradient and is carried out by an active transport mechanism. As the 
conjugated bilirubin reaches the terminal ileum and the large intestine, the 
glucuronides are removed by specific bacterial enzymes and the pigment is 
subsequently reduced by the fecal flora to a group of colourless tetrapyrrolic 
compounds, called urobilinogens formed in the colon. They are oxidized to 
urobilins and finally excreted in the feces (Schmid and McDonough, 1978; 
Kitamura et al, 1990; Nishida et al, 1992). 
Bilirubin binding to serum albumin 
Serum albumin, a nonglycoprotein is known to bind a variety of substances 
differing in structure and chemical properties (Peters, 1970; 1975; 1980; 1985; 
Kragh-Hansen, 1981) and a large number of drugs (Brodersen and Ebbesen, 1983; 
Brodersen, 1985; Brodersen and Robertson, 1989; Evans et al., 1992; Fink et al., 
1987, 1988; Robertson et al., 1988, 1991; Karp, 1990; Onks et al., 1991; Vorum et 
al., 1994). Among the anionic ligands known to bind albumin, long chain fatty 
acids (Brown and Shockley, 1982; Brodersen et al., 1990) and bilirubin 
(Brodersen, 1979; Ho et al., 1985; Tayyab and Qasim, 1987; Roberson et al., 
1990) are physiologically important. Binding of bilirubin to serum albumin was 
first reported in 1949 (Martin, 1949). Earlier, it was suggested that one albumin 
molecule could bind two to three molecules of bilirubin (Martin, 1949; Odell, 
1959; Watson, 1962; Schmid et al., 1965). However, others (Ostrow and Schmid, 
1963; Kaufinann et al., 1969; Kucerova and Jirsa, 1969; Brodersen, 1979; 
Jacobsen and Brodersen, 1983) have described that albumin probably has two 
binding sites for bilirubin, one of which has a much higher affinity than the other. 
Jacobsen in 1969, using the peroxidase method, prepared the first binding isotherm 
for bilirubin-albumin and showed that one molecule of bilirubin is boimd with 
high affmity (Ka= 1.4 x 10* liters/mole) and that the isotherm fiirther corresponds 
to binding of two additional molecules of the pigment with lower affinity (Ka= 5 x 
10^  liters/mole) (Jacobsen, 1969). However, the binding of third molecule of 
bilirubin has not been demonstrated by most of the techniques. It has been shown 
that albumin binds bilirubin reversibly in plasma and even at bilirubin/albumin 
molar ratio of 1:1, a very small fraction of the total bilirubin remains as unbound 
fraction (Brodersen, 1979; Wennberg et al, 1979; Wennberg, 1988). The binding 
affinity of bilirubin to serum albumin has been reported to be independent of pH 
from 7.0 to 9.0 (Wennberg, 1971; Nelson et al, 1974; Jacobsen and Brodersen, 
1976; Wennberg and Rasmussen, 1978; Brodersen, 1979) However, albumin does 
not bind bilirubin above pH 12.0 because of unfolding of albumin and due to the 
insolubility of bilirubin at low pH, it is not possible to investigate whether it can 
be bound to serum albumin or not (Brodersen, 1979). Further, the affinity of 
bilirubin binding to albumin for primary binding site has been found to decrease 
with increasing temperature and ionic strength (Jacobsen, 1977). This suggests the 
role of electrostatic interactions in the binding process. 
Bilirubin toxicity and bilirubin encephalopathy 
Hervieux in 1847 first described yellow staining of the basal ganglia in association 
with neonatal jaundice (Hervieux, 1847) and the phenomenon was termed as 
kemicterus by Schmorl in 1904 (Schmorl, 1904). This term has since been used to 
describe both the acute, often fatal condition in the newborn with substantial 
elevation of serum bilirubin levels, seizures, opisthotonus, and bleeding tendency, 
as well as the neurologic sequelae in survivors, consisting of choreoathetosis, 
asymmetric spasticity, paresis of upward gaze and neurogenic hearing loss (Byers 
et al, 1955; Perlstein, 1960; Hyman et al, 1969; Keaster et al, 1969; Fenwick, 
1975). But now-a-days, the term kemicterus is replaced by another term bilirubin 
encephalopathy, so as to include all conditions in which bilirubin is known or 
thought to be the cause of brain toxicity (Hansen and Bratlid, 1986). Several 
studies have shown that bilirubin influences several enzymic system (Karp, 1979; 
Amit and Boneh, 1993). It inhibits the binding of cAMP to protein kinase 
(Constantopoulos and Matsaniotis, 1976). However, rat liver ATP-ase has been 
reported to be stimulated by bilirubin (Zetterstrom and Emster, 1956). 
Glycogenesis is inhibited in Morris hepatoma cells at concentrations of 170 i^M 
after 10 minutes of exposure (Thaler, 1971). In cultured human fibroblasts, 
bilirubin combined with phototherapy induced strand breakage in DNA 
(Rosenstein etal., 1983; Rosenstein and Ducore, 1984). 
Nature of bilirubin involved in bilirubin cell toxicity is still a controversy. It has 
been suggested that kemicterus and bilirubin toxicity are caused by the bilirubin-
albumin complex crossing a disrupted blood-brain barrier and that the level of free 
bilirubin or nature of bilirubin binding may not be important in the development 
of bilirubin encephalopathy (Levine et ai, 1982) . On the other hand, studies on 
the effects of bilirubin on respiration and viability in cell cultures have shown that 
toxicity increases when bilirubin is present in the incubate in molar concentrations 
which exceed that of albumin (Lie and Bratlid, 1970; Bratlid and Rugstad, 1972). 
Further, if albumin is present in an equimolar or higher ratio with bilirubin, 
toxicity is blocked (Rasmussen and Wennberg, 1972). Now, it is well recognized 
that free imconjugated bilirubin is the potential cytotoxic substance and its 
damaging effect on the cells of the central nervous system in newborns, suffering 
from a severe form of hyperbilirubinemia (kemicterus) is well known (Metze, 
1977; Odell, 1980; Brodersen and Stem, 1990). Even other cell types and tissues, 
e.g., platelets, heart, kidney, Langerhans islets of the pancreas, hver and teeth are 
reported to be damaged by free unconjugated bilimbin (Metze, 1977). 
Unconjugated bilimbin also induces platelet aggregation (Moiny et ai, 1990) and 
posseses a direct cytotoxic effect for human lymphocytes and granulocytes (Miler 
et ai, 1985). Now it is commonly accepted that toxicity of bilimbin depends on its 
passage across the plasma membrane and its association with membrane lipids 
(Mustafa and King, 1970; Hayward et ai, 1986; Noy et a/., 1992; Ali and Zakim, 
1993; Zucker et al, 1994). During the in vitro interaction between bilirubin and 
cells, bilirubin undergoes degradation due to both adsorption to the cells and 
action of cell enzymes (Knobloch and Miler, 1986). 
Binding of bilirubin to erythrocytes/ erythrocyte membranes 
Binding of bilirubin to erythrocytes was first reported by Watson (1962) who also 
demonstrated that presence of certain drugs such as sulfonamide and sodium 
salicylate greatly enhanced this binding. Later on, several other workers have also 
studied the binding of bilirubin to erythrocytes and erythrocyte ghosts in greater 
detail (Oski and Naiman, 1963; Cheung et al, 1966; Kaufinann et al, 1967; 
Bratlid, 1972 a and b; Bamhart and Clarenburg, 1973; Kapool, 1975; Thaler and 
Wennberg, 1977; Bouillerot et al, 1981; Sato and Kashiwamata, 1983; Sato et al, 
1987; Gulian et al, 1987; Hayer et al, 1989). The amount of erythrocyte-bound 
bilirubin is increased either on increasing the bilirubin concentration, while 
keeping the bilirubin/albumin molar ratio constant or by increasing the 
bilirubin/albumin molar ratio while keeping the bilirubin concentration constant 
(Bratlid, 1972 a). At any constant bilirubin/albumin molar ratio below 1:1, 
increase in bilirubin concentration leads to a smaller increase in erythrocyte-bound 
bilirubin. On the other hand, erythrocyte-bound bilirubin is increased around four 
fold on increasing bilirubin concentration at any bilirubin/albumin molar ratio 
above 1:1 (Kaufinann et al, 1967; Brathd, 1972 a; Bamhart and Clarenburg, 
1973). Bilirubin binding to erythrocytes takes place within 10 minutes and further 
increase in the incubation time does not result in any increase in erythrocyte-
bound bilirubin (Bamhart and Clarenburg, 1973; Sato and Kashiwamata, 1983). At 
a given albumin concentration, erythrocytes and albxmiin bind constant proportions 
of bilimbin, despite varying bilimbin concentrations (Bamhart and Clarenburg, 
1973). However, Wennberg and Rasmussen (1978) have reported that at 
10 
equilibrium, the cellular content of bilirubin is a function of the concentration of 
free bilirubin acid and not the total bilirubin concentration or bilirubin/albumin 
molar ratio. 
Effect of pH on the binding of bilirubin to erythrocytes and other cell types has 
been studied earlier by several workers and an increase in erythrocyte-bound 
bilirubin has been reported with decreasing pH ( Bratlid, 1972 b; Nelson et al, 
1974; Sato and Kashiwamata, 1983; Wennberg, 1988). In presence of albumin, 
decrease in pH from 7.4 to 6.8 results in an increase in erythrocyte-bound bilirubin 
at all the bilirubin/albumin molar ratios, including molar ratios below 1:1 (Bratlid, 
1972 b). In the absence of albumin, at higher bilirubin concentrations, there is an 
increase in erythrocyte-bound bilirubin on decreasing pH, although at lower 
bilirubin concentrations, decrease in pH does not affect the erythrocyte-bound 
bilirubin (Bratlid, 1972b). Thus, it appears that bilirubin binding to erythrocytes 
depends on both pH and bilirubia concentration (Bratlid, 1972 b). Most of the 
workers (Odell, 1970; Zamet and Chunga, 1971; Bratlid, 1972 b; Maisels, 1972) 
are of the view that increased cellular binding of bilirubin at lower pH may be due 
to either increased cellular affinity for bilirubin or increased dissociation of 
bilirubin from the secondary binding sites of albumin at low pH without any 
reduction in the affinity of the primary binding site. 
Although the cellular binding of bilirubin is a well known fact. But multisite 
toxicity of bilirubin towards the metabolism of Hving cells has not yet been 
completely elucidated. Also the nature of bilirubin binding to biological 
membranes and pathway(s) through which bilirubin enters into the cells is not 
fully understood. Increased toxicity of bilirubin at a bilirubin/ albumin molar ratio 
higher than 1: 1 (Lie and Bratiid, 1970; Bratiid and Rugstad, 1972) suggests that it 
is free unbound bilirubin which binds the cell membranes and not the albumin-
bound bilirubin. Most of the workers are of the view that bilirubin can diffuse 
freely through biological membranes as it has been found accumulated in the 
1 1 
intracellular compartments such as mitochondria (Odell, 1965; 1966; 1970; 
Weimberg, 1988). On the other hand, a facilitated mode of bilirubin binding 
accompanied by a release of phospholipids from the cell membranes, a process 
that favors the bilirubin penetration and aggregation within the membranes has 
been reported (Brito et ai, 1996). Brathd (1972a) has reported that stroma binds 
less bilirubin as compared to the whole cells, which means that some of the 
bilirubin might bound to other structures other than the stroma. Supporting this 
observation, Lamola et al. (1979) has also shown that bilirubin is not solely bound 
to the membranes but that its greater part is also present in the cytosol of 
erythrocytes. Contrary to this observation, lysed erythrocyte membranes have been 
shown to bind 14% more bilirubin than intact erythrocyte ghost (Karp et al, 
1985). Further, the same amount of bound bilirubin is reported in both red blood 
cells and erythrocyte ghosts having same phospholipid content (Hayer et al, 
1989). Thus, it appears that unlike other cells, erythrocytes have all the bilirubin 
bound to the specific binding sites present in the membrane. They have reported 
1 fi 
the binding saturation of 110 x 10' moles of bilirubin per red blood cell and 
dissociation constant of bilirubin/ receptor complex as 170 x 10'^  mol/ 1 (Hayer et 
al., 1989). Sato and Kashiwamata (1983) have reported the apparent dissociation 
constant (Kd) and maximum binding (B a^x) values for the saturable binding of 
bilirubin as 2.3 |xM and 0.93 n mol/ mg of membrane protein respectively. Further, 
the membranous binding of bilirubin has been supported by the observation that 
interaction of bilirubin with erythrocytes lead to a morphological alteration of 
erythrocytes, a phenomenon commonly observed only after the modification of 
membrane structure of erythrocytes (Brites et al, 1997). Loss of high affinity 
ouabain binding sites on the bilirubin-treated erythrocytes also suggests that 
bilirubin binding sites are located on the membrane itself (Corchs et al, 1994). 
However, characterization of the individual membrane components responsible for 
the binding of bilirubin as well as location of bilirubin binding sites on the 
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erythrocyte membrane have not been fully worked out. Leonard et al. (1989) has 
suggested that the extent of bilirubin binding to the membrane depends on the 
nature of the membrane. Since biomembranes have two important constituents, 
i.e., lipids and proteins, the bilirubin binding sites are supposed to be made up of 
lipids or proteins or both. However, involvement of erythrocyte membrane 
proteins as the bilirubin binding sites has been ruled out in an earlier study (Sato 
and Kashiwamata, 1983). They have reported an increase in the bilirubin binding 
capacity instead of a decrease after tryptic digestion and heat treatment of these 
membranes. Further, affinity labelling of the membrane proteins by bilirubin has 
not been successful in identifying any specific bilirubin binding protein (Sato and 
Kashiwamata, 1993). However, they have suggested that membrane proteins may 
function as an effective barrier to the binding of bilirubin. Contrary to this, 
incorporation of bacteriorhodopsin, an integral membrane protein which does not 
bind bilirubin into a bilayer of phosphatidylcholine enhances the bilirubin binding 
capacity of the membranes considerably compared to protein lacking model 
membranes (Leonard et al., 1989). It is suggested that membrane proteins exert 
some type of non-specific effect on the properties of the lipids in bilayer, 
especially on the apolar phase of the bilayer, which enhances the capacity of the 
bilayer to bind more bilirubin as compared to protein-free bilayer. 
The failure to identify any erythrocyte membrane protein as the bilirubin binding 
site suggests that membrane lipids are probably responsible for bilirubin binding. 
Vazquez et al. (1988) working with synaptosomal plasma membranes have 
reported that bilirubin binding sites are mainly concentrated on the outer layer of 
bilayer membranes. In another study, it has been suggested that bilirubin is capable 
of binding to both the outside and the inside of membranes (Karp et a/., 1985). 
Supporting this view, Sato et al. (1987) have reported no significant difference in 
the bilirubin binding capacity of inside-out and right-side out sealed membrane 
vesicles. According to them, bilirubin binding sites may be distributed on both 
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outer and inner surfaces of the membranes, or may exist in the membranes where 
bilirubin may be accessible from either side. 
The mechanism of bilirubin interaction with the lipid bilayer of erythrocyte 
membranes is still not clear. Nagaoka and Cowger (1978) have suggested that 
bilirubin is bound to the lipid bilayer through strong ionic interactions between a 
cationic head group of the lipid and anionic bilirubin. Binding constant has been 
reported highest for sphingomyelin as 3.7 x lO^M"' and diphosphatidylcholine with 
5% cholestrol as 2.6 x 10^  M"'. According to Cestaro et. a/. (1983), dianion form of 
bilirubin binds weakly to the polar heads of the phospholipids whereas acid 
bilirubin binds strongly and is hydrophobically inserted into the lipophilic region 
of the bilayer. This hydrophobically bound bilirubin is suggested to perturb the 
chemico-physical properties such as fluidity, phase transition etc. of the membrane 
(Cestaro et. al, 1983). Vazquez et al. (1988) have suggested three steps in the 
binding of bilirubin to synaptosomal plasma membrane vesicles isolated from rat 
brain i.e., (i) a rapid formation of an electrostatic complex between bilirubin and 
lipid polar head groups on the membrane surface, especially those from 
gangliosides and sphingomyelin (ii) a slow inclusion of the pigment into the 
hydrophobic core of the membrane and (iii) a membrane-induced aggregation of 
bilirubin acid. They have noticed a decrease in the bilirubin association constant 
after phospholipase C treatment of the membranes whereas phopholipase D 
treatment of membranes results in the increase in the bilirubin association constant 
with the membranes. They are of the opinion that the polar protruding ends of the 
lipids are involved in the initial interaction with bilirubin (Vazquez et. al., 1988). 
However, electrostatic interaction of bilirubin with polar head groups of lipid has 
been challenged in an earlier study involving human erythrocyte membranes (Sato 
et a/., 1987). They have found that phospholipse D treatment of erythrocyte 
membranes, which removes the polar head groups of phosphatidylcholine, 
phosphatidylethanolamine and phosphatidylserine to form phosphatidic acid, does 
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not result in any change in the bilirubin binding capacity of the membranes 
whereas phospholipase C treatment of these membranes greatly enhanced the 
bilirubin binding. It is suggested that the exposure of non-polar diacylglycerols at 
the surface of the membrane after the removal of polar head groups of 
phosphatidylcholine, phosphatidylethanolamine as well as phosphatidylserine of 
membrane, may potentiate a large amount of non-specific binding of bilirubin to 
the fatty acid moiety of diacylglycerols (Sato et al, 1987). Therefore, it is beUeved 
that the saturable bilirubin binding sites may probably be located at particular 
positions on the membranes which are not composed of polar head groups of 
phospholipids, rather the negatively charged phosphoric acid moiety of 
phosphoUpids prevents a large amount of bilirubin binding to the membranes. In 
an another study, interaction of bilirubin with membranes has been found to be 
independent of ionic strength and is proposed to be hydrophobic in nature 
(Kirschner-Zilber et a/., 1982). According to Leonard and his group (Leonard et 
al, 1989), bilirubin neither interacts with the polar region nor with the apolar 
regions of membranes but is localized within the membrane bilayer due to voids in 
the packing of bilayer. Zakim and Wong (1990) have reported that large amount 
of bilirubin can be intercalated tightly into the polymethylene chain region of the 
bilayer. On the other hand, views have been presented that bilirubin-membrane 
interaction may involve hydrogen bonding (Noy and Xu, 1990; Zucker et al., 
1992). Further, it has been suggested that a major portion of the bilirubin molecule 
is not localized within the hydrophobic domain of the membrane bilayer but rather 
associated at the membrane surface and the dissociation of the membrane-bound 
bilirubin depends upon the phospholipid composition of the membranes and the 
membrane size (Zucker et al, 1992; 1994). Recently, based on their results, Brites 
et al (1997) have su^ested that bilirubin monovalent anion is the species first 
involved in the interaction with the erythrocyte membrane, being the single ionized 
carboxyl group located in the aqueous medium, while the hydrophobic portion will 
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be buried in the bilayer, resembling a detergent. These views are in good 
agreement with the previous suggestion on the binding model of anilino-
naphthalene sulfonate (ANS) to the erythrocyte membrane (Podo, 1975). 
The influence of physico-chemical properties of the membranes such as overall 
charge on membrane surface, membrane fluidity, pH and temperature on the 
binding of bilirubin to the membranes are of great concern . Vazquez et. al. (1988) 
have suggested that the interaction of bilirubin with the membrane is modulated by 
the membrane fluidity in such a way that lower the fluidity, lesser is the binding of 
bilirubin to the membrane. Karp et al. (1985) have suggested that the change in 
shape and size of the erythrocyte membranes greatly influences the binding of 
bilirubin. They have reported that in the presence of chlorpromazine, a drug 
known to expand the erythrocyte membrane, bilirubin uptake is increased by the 
membranes as much as 45%. Sato and Kashiwamata (1983) have reported that 
saturable bilirubin binding to erythrocyte membranes has a pH optimum at around 
pH 7.1. A U-shaped thermal dependency of the total and saturable binding of 
bilirubin to erythrocyte membranes is reported with a minimum value near 37°C 
and a gradual increase below and above this temperature has been described (Sato 
and Kashiwamata, 1983). Contrary to this, Leonard et al. (1989) have reported no 
such thermal dependency of the binding of bilirubin to biological membranes over 
the temperature range of 10-40°C. Addition of calcium chloride to the assay 
medium has been found to increase the binding of bilirubin to the membrane (Sato 
et al, 1987 ; Vazquez et al, 1988). In view of the known binding of calcium to the 
sialic acid residues of the membrane (Moore et al, 1984), Vazquez et al. (1988) 
have suggested that negative charges present on the sialic acid residues exert an 
inhibitory effect on the binding of bilirubin to membranes but addition of calcium 
provides a favourable shielding of the negative charges of sialic acid residues 
thereby increasing the binding of bilirubin to membrane. However, Sato et al. 
(1987) have reported no significant change in the binding of bilirubin after 
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neuraminidase treatment of membranes suggesting negative charge of sialic acid 
play little role in the binding of bilirubin to the membrane. 
From the above review of the literature, it is clear that erythrocytes/ erythrocyte 
membranes have saturable binding sites for bilirubin. Despite extensive studies, 
the nature of these receptors has not been defined. Further, there is no report on 
whether erythrocytes/ erythrocyte membranes from different mammalian species 
bind same amount of bilirubin or not. Since protein and lipid make-up of 
erythrocyte membranes is different in different mammalian species (Lenard, 1970; 
Barenholz and Thompson, 1980), it would be interesting to carry out detailed 
studies on the binding of bilirubin to erythrocytes/ erythrocyte membranes of 
different mammalian species. This will be helpful in understanding the role of 
various membrane components in the binding of bilirubin to erj^hrocytes. With 
this idea in mind, I decided to undertake a detailed study on the binding of 
bilirubio to erythrocytes from different mammalian species, namely, human, 
buffalo, goat and sheep both in the absence as well as in the presence of their 
serum albumins respectively. This thesis describes a report on the comparative 
study on bilirubin binding to erythrocytes from different mammalian species imder 
different conditions i.e. (i) at different bilirubin/albumin molar ratios, (ii) at 
increasing bilirubin concentrations (keeping bilirubin/ albumin molar ratio 
constant while varying both bilirubin and albumin concentrations), (iii) in the 
absence of albumin and (iv) after incubating erythrocytes with different metal ions. 
It also includes the report on the comparative study on bilirubin binding to 
erythrocyte membranes prepared from human, buffalo, sheep and goat 
erythrocytes under different conditions such as (i) with the unmodified erythrocyte 
membranes (ii) after metal ions treatment (iii) after phospholipase C treatment (iv) 
after trypsin treatment and (v) after neuraminidase treatment. 
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EXPERIMENTAL 
Materials 
Proteins 
Bovine serum albumin, fraction V (Lot 100F0249), trypsin, type III from bovine 
pancreas (Lot 24H0070), catalase from bovine liver (Lot 12H7060), phospholipase 
C, type I from Clostridium welchii (Lot 10H6801) and neuraminidase, type V from 
Clostridium petfringens (Lot 31H82302) were purchased from Sigma Chemical 
Company, USA. Serum albumins were isolated from the plasma of different 
mammalian species, i.e., human, buffalo, goat and sheep by the method of Tayyab 
and Qasim (1990). 
Reagents used in protein determination 
Sodium carbonate, sodium potassium tartarate, lithium sulfate and liquid bromine 
(all GPR grade) were obtained from B.D.H., India. Copper sulfate, sodium 
tungstate and sodium molybdate (all LR grade) were purchased from S.D. Fine 
Chemicals., India. Qualigens Fine Chemicals, India was the source of 
ortiliophosphoric acid and hydrochloric acid. 
Reagents used in bilirubin determination 
Reagents used in bilirubin determination with their sources in parentheses were: 
bilirubin, caffeine anhydrous (LR), sulfanilic acid (LR), sodium benzoate (GR) 
and sodium nitrite (AR) (S.D. Fine Chemicals, India); sodium hydroxide (GPR), 
sodium potassium tartarate (GPR) (B.D.H., India) and sodium acetate (AR) 
(Qualigens Fine Chemicals, India). 
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Reagents used in polyacrylamide gel electrophoresis 
Bromophenol blue was obtained from B.D.H., England. Acrylamide (LR), N, N'-
methylenebisacrylamide (AR) and N, N, N', N'- tetramethylethylenediamine (LR) 
were purchased from Sisco Research Laboratories, India. B.D.H., India was the 
source of ammonium persulphate (GR), tris (hydroxymethyl) aminomethane (AR) 
and glycine (LR). Acetic acid glacial (AR), amido black lOB (LR), glycerol (LR), 
charcoal (GR) and methanol (GR) were purchased from S.D. Fine Chemicals., 
India. 
Reagents used in inorganic phosphorus determination 
L-Ascorbic acid (AR) was obtained from Sisco Research Laboratories, India. 
Ammonium molybdate (LR), perchloric acid (LR) and sodium dihydrogen 
orthophosphate (AR) were the products of Qualigens Fine Chemicals, India. 
Reagents used in sialic acid determination 
Thiobarbituric acid (GPR) was purchased from B.D.H., England. N-acetyl-
neuraminic acid, type IV-S (Lot 33H78141) was obtained from Sigma Chemical 
Company, USA. Sodium sulfate (LR) and ammonium periodate (AR) were the 
products of Qualigens Fine Chemicals, India. Sodium arsenite (GR) was purchased 
from Loba Chemie, India. 
Reagents used in carbohydrate determination 
Orcinol (extrapure) was supplied by Sisco Research Laboratories, India. Dextrose 
(LR), sucrose (LR) and sulfiiric acid (LR) were obtained from Qualigens Fine 
Chemicals, India. 
Miscellaneous 
Various chemicals/reagents used in this study with their sources in parentheses 
were : phenyhnethylsulfonyl fluoride (Lot 67H1645), ouabain (Lot 34H0459), 
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ethylene glycol bis-(P-aminoethyl ether) N, N, N', N'-tetraacetic acid (Lot 
55F5638) (Sigma Chemical Company, USA); ammonium sulfate (LR), ammonia 
solution, barium chloride (AR), calcium chloride (LR), hydrogen peroxide (LR), 
magnesium chloride (LR), manganous chloride (LR), sodium azide (AR), sodium 
chloride (AR), strontium chloride (LR) (Qualigens Fine Chemicals, India); cupric 
chloride (LR), potassium dichromate (AR), potassium hydrogen phthalate (LR), 
sodium tetraborate (AR), sodium dodecyl sulfate (LR), di-sodium hydrogen 
phosphate (LR) (S.D. Fine Chemicals, India); tri-sodium citrate (LR), 
ethylenediamine tetraacetic acid disodium salt (LR) (B.D.H., India) and adenosine 
triphosphate (AR) (Sisco Research Laboratories, India). 
Human blood in 1.32% sodium citrate and 1.47% dextrose was supplied by the 
Blood Bank of Jawaharlal Nehru Medical College, Aligarh Muslim University, 
Ahgarh. The blood of buffalo, goat and sheep was collected from the slaughter 
house in 1.32% sodium citrate at the time of slaughtering. 
Dialysis membranes of 1 inch diameter were obtained from Sigma Chemical 
Company, USA. Whatman filter papers No. 1 were purchased from Whatman Lab. 
Div., Kent, England. 
All glass distilled water was used throughout these studies. All the experiments 
were perfomed at 25°C unless otherwise stated. 
AR = Analytical Reagent; GR = Guaranteed Reagent; 
LR = Laboratory Reagent; GPR = General Purpose Reagent. 
20 
Methods 
pH measurements 
pH measurements were carried out on an INSTA digital pH meter, model DPH-
100 using DPH combined electrode. The pH meter was routinely calibrated with 
0.05 M potassium hydrogen phthalate buffer, pH 4.0, at 25°C, in the acidic pH 
range and with 0.01 M sodium tetraborate buffer, pH 9.2, at 25°C in the alkaline 
pH range. 
Optical measurements 
CECIL single beam spectrophotometer, model CE-202 was used for light 
absorption measurements in the ultraviolet as well as in the visible region using 
silica cells of 1 cm pathlength. Absorption measurements in the visible range were 
also made on AIMIL Photochem-8 colorimeter, using glass cuvettes of 1 cm 
pathlength. 
Determination of protein concentration 
Protein concentration was determined by the method of Lowry et al. (1951) using 
bovine serum albumin as the standard, hicreasing volimies of stock protein 
solution (0.4 mg/ ml) in the range of 0.1 - 1.0 ml were taken in series of tubes and 
the volume in each tube was made to 1.0 mJ, if required, with 0.07 M sodium 
phosphate buffer, pH 7.4 containing 0.08 M NaCl. Then 5.0 ml of freshly prepared 
copper reagent was added to all the tubes and mixed well. After 10 minutes of 
incubation at room temperature, 1.0 ml of diluted Folin-phenol reagent was added 
and the contents were mixed well. After 30 minutes, the color intensity was read at 
700 nm against a blank prepared in the same way except that, instead of protein 
solution, 1.0 ml of buffer was taken. The graph between absorbance at 700 nm and 
the amount of protein (mg) yielded the following straight line equation (Fig. 2): 
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Fig. 2. Standard curves for the determination of protein concentration by 
the method of Lowry era/. (1951) obtained with 0.07M sodium 
phosphate buffer, pH 7.4 containing 0.08M NaCl (•) and 10 mM 
Tris/HCl buffer, pH 7.4 containing 1% (w/v) SDS (A). 
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(Absorbance) 700 nm " -^^  (amount of protein, mg) + 0.08 (1) 
Use of protein solution (0.4 mg/ ml) prepared in lOmM Tris/HCl buffer, pH 7.4 
containing 1% SDS and employing the above protocol, the following straight line 
equation was obtained (Fig. 2). 
(Absorbance)7oo„„ =1.1 (amount of protein, mg) + 0.01 (2) 
For the determination of erythrocyte membrane proteins by the method of Lowry 
et al. (1951), membranes were subjected to solubilization in 1 % (w/v) SDS. To 
0.1 ml of erythrocyte membrane suspension in 50 mM Tris/HCl buffer, pH 7.4 
containing 100 mM NaCl, was added 0.9 ml of 1.1 % (w/v) SDS and incubated at 
60°C for 30 minutes. After complete solubilization of membranes, the above 
protocol was followed and protein concentration was determined by using 
equation (2). 
Isolation of serum albumin 
Serum albumin was isolated from the blood (human/ goat/ buffalo/ sheep) 
according to the method described by Tayyab and Qasim (1990). Blood was 
centrifuged at 3000 rpm for 20 minutes to obtain plasma which was brought to 
2.26 M in ammonium sulfate by adding requisite volume of 4 M ammonium 
sulfate solution, pH 7.0. The mixture was kept for 12 hours at room temperature 
and then centrifuged at 6000 rpm for 30 minutes. The supernatant, thus obtained, 
was carefully diluted with water and with frequent additions of 0.5 N H2SO4 such 
that the fmal concentration of ammonium sulfate was reduced to 1.9 M and the pH 
to 4.2. After incubating it for 12 hours at room temperature, the precipitate was 
collected by centrifiigation at 6000 rpm for 30 minutes. It was washed three times 
with 2.2 M ammonium sulfate solution, pH 4.2 and then dissolved in 0.07 M 
sodium phosphate buffer, pH 7.4 containing 0.08 NaCl. The protein preparation. 
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thus obtained, was extensively dialyzed against 6 liters of 0.07 M sodium 
phosphate buffer, pH 7.4 containing 0.08 M NaCl and stored at 4°C. 
Polyacrylamide gel electrophoresis 
Electrophoresis of different serum albumins was carried out in 7% (w/v) 
polyacrylamide gels using 0.02 M tris/glycine buffer, pH 8.2 following the method 
of Davis (1964). About 50 |a,g of each protein was applied in 50 [i\ of sample 
buffer and a current of 2-4 mA/ tube (7 x 0.5 cm) was passed for nearly 2 hours. 
The gels were stained for one hour in 1% (w/v) amido black solution prepared in 
7% (v/v) acetic acid and destained with 7% (v/v) acetic acid at 37°C. 
Determination of bilirubin concentration 
Concentration of bilirubin was determined by the modified Jendrassik and Grof 
method (1938) [Fog's method (1958)] as alkaline azobilirubin. The method 
involved the use of three reagents, namely, 1, II and HI which were prepared in the 
following manner: 
(i) Preparation of reagent I: Twenty grams of caffeine anhydrous, 30 gm of 
sodium benzoate and 50 gm of sodium acetate were dissolved in 400 ml of water 
and the mixture was warmed up to 50°C with continuous stirring until a clear 
transparent solution was obtained. 
(ii) Preparation of reagent II: Working solution of reagent II was prepared 
fresh just before the experiment by adding 3 drops of reagent lib (containing 500 
mg of sodium nitrite in 100 ml of water) in 5 ml of reagent Ila, prepared by 
dissolving 0.5 gm of sulfanilic acid in 1.5 ml of concentrated hydrochloric acid 
followed by dilution with 100 ml of water. 
(in) Preparation of reagent III: It was prepared by dissolving 30 gm of sodium 
hydroxide and 105 gm of sodium potassium tartarate in 300 ml of water. 
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Preparation of stock bilirubin solution: It was prepared by dissolving few 
crystals of bilirubin in 1 N NaOH containing 5 mM EDTA and diluting it witii 
0.06 M sodium phosphate buffer, pH 8.0. Bilirubin concentration was determined 
spectrophotometrically using a molar extinction coefficient of 47,500 at 440 nm 
(Jacobsen and Wermberg, 1974). 
Procedure: Increasing volumes (0.1 to 1.0 ml) of stock bilirubin solution (116 
HM) were added to different tubes and the final volume was made to 1.0 ml, if 
required, with water or buffer. It was followed by the addition of 2.0 ml of reagent 
I and 0.5 ml of reagent II with gentle mixing. After 10 minutes of incubation at 
room temperature, 1.5 ml of reagent III was added to all the tubes and the contents 
were mixed well. Absorbance of the solution was read at 600 imi against buffer. 
For each bilirubin concentration, reagent II blank and bilirubin blank were 
prepared in the same way as described above except that water/ buffer was used 
instead of reagent II and bilirubin in these blanks respectively. Absorbance of 
diazotized bilirubin solution was determined by subtracting the absorbance values 
of reagent II blank and bilirubin blank from the absorbance of bilirubin solution. 
Data were plotted as absorbance at 600 nm versus bilirubin concentration, which 
yielded the following straight line equation (Fig. 3). 
(Absorbance)6oo„^= 0.0125 (bilirubin concentration, ^M) + 0.02 (3) 
Presence of either serum albumin or 1% (w/v) SDS in the bilirubin stock solution 
and the use of 38 mM sodium carbonate solution containing 5 mM EDTA, pH 
11.0 instead of 0.06 M sodium phosphate buffer, pH 8.0 did not affect the value of 
slope of the standard curve. In the SDS containing samples, turbidity caused by 
SDS was removed by centrifugation at 15000 rpm for 20 minutes. 
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Fig. 3. Standard curve for the determination of bilirubin concentration by 
Fog's method (1958). 
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Determination of inorganic phosphorus 
Inorganic phosphorus was determined by the method of Fiske and Subbarow 
(1925). Different volumes of stock solution, prepared by dissolving 30 mg of 
disodium hydrogen orthophosphate in 100 ml of water (equivalent to 52.2 |ig of 
inorganic phosphorus per ml of this solution), were taken in the range of 0.1 - 1.0 
ml in different tubes and the volume in each tube was adjusted to 5.0 ml with 
water. Then 0.2 ml of 5% (w/v) ammonium molybdate was added to all the tubes 
and mixed well. It was followed by the addition of 0.2 ml of 0.1% (w/v) ascorbic 
acid. The contents were mixed well and the tubes were incubated at 80°C for 30 
minutes, then cooled under tap water and the absorbance was read at 700 nm 
against an appropriate blank. Data were plotted as absorbance at 700 nm versus 
amount of inorganic phosphorus, which yielded the following straight line 
equation (Fig. 4): 
(Absorbance)7oo nm ~ 0.032 (inorganic phosphorus, ng) (4) 
For the determination of total inorganic phosphorus of erythrocyte membranes, 
initially the organic matter was destroyed by heating the membranes (0.2 ml 
suspension in 50 mM Tris/HCl buffer, pH 7.4 containing 100 mM NaCl) at 180°C 
for 2 hours with 1.0 ml of 70 % (v/v) perchloric acid and then after adjusting the 
volume to 1.0 ml with water, the inorganic phosphorus was determined in the same 
way as described above using equation (4). 
Determination of carbohydrate content 
Orcinol method was employed for the determination of carbohydrate concentration 
using glucose as the standard (Svennerholm, 1956). To 1.0 ml of solution 
containing 0.5 to 20 ^g of glucose was added 200 i^l of orcinol reagent [prepared 
by dissolving 150 mg orcinol in 10 ml of 30% (v/v) sulfiiric acid] and 2.5 ml of 
60% (v/v) sulfuric acid. The contents were rapidly mixed and heated at 80°C for 
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Fig 4 Standard curve for the determination of inorganic phosphorus content 
by the method of Fiske and Subbarow (1925) 
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20 minutes. The tubes were then cooled and left for 45 minutes in the dark. The 
absorbance was read at 470 nm against a blank prepared in the same way but 
substituting water for sugar solution. The data, thus obtained, were plotted as 
absorbance at 470 nm versus the amount of glucose (^ ig) which yielded the 
following straight line equation (Fig. 5): 
(Absorbance)47o nm = 0004 (amount of glucose, |ig) + 0.01 (5) 
The carbohydrate content of erythrocyte membranes was determined in the same 
way by subjecting the erythrocyte membranes directly to the orcinol reaction. 
Determination of sialic acid 
The sialic acid content was determined using thiobarbituric acid assay as 
recommended by Warren (1959) using N-acetyhieuraminic acid as the standard. 
The method involved the use of following reagents : (a) 0.2 M sodium meta 
periodate in 9 M orthophosphoric acid; (b) 10 % (w/v) sodium arsenite in a 
solution of 0.5 M sodium sulfate and 0.1 N sulfiiric acid and (c ) 0.6% (w/v) 
thiobarbituric acid in a solution of 0.5 M sodium sulfate. Solutions were stored at 
room temperature and were used within one month. 
Procedure: To a sample containing 1-64 nmole of N-acetylneuraminic acid in 0.2 
ml of water, was added 0.1 ml of periodate solution. The tubes were shaken and 
allowed to stand at room temperature for 20 minutes. After the addition of 1.0 ml 
of arsenite solution, the tubes were shaken well until a yellow color first formed, 
disappeared. Then, 3.0 ml of thiobarbituric acid reagent was added and the tubes 
were heated at 100"C for 15 minutes by keeping them in vigorously boiling water 
bath. The tubes were then cooled for 5 minutes under tap water and the entire 
solution was added to an equal volume of cyclohexanone. The tubes were shaken 
well and centrifiiged at 3000 rpm for 5 minutes. The upper pink layer was 
aspirated with Pasteur pipette and the absorbance was read at 550 nm against the 
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Fig 5 Standard curxe for the determination of carbohydrate content by 
Orcinol method (Svennerhobn. 1956), 
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blank prepared in the same way but without N-acetyhieuraminic acid. The data 
were plotted as absorbance at 550 nm versus fomoles of N-acetylneuraminic acid 
(Fig. 6), which yielded the following straight line equation: 
(Absorbance)55onm = 13.3 (N-acetybieuraminic acid, fimoles) (6) 
For the determination of sialic acid content of erythrocyte membranes, sialic acid 
was liberated from the membranes by mild acid hydrolysis in 0.1 N sulfuric acid at 
80°C for 1 hour. Then, the solution was cooled to room temperature, centrifiiged at 
10,000 rpm for 20 minutes and sialic acid content was determined in the same way 
as described above. 
Interaction of bilirubin with erythrocytes 
For studying the interaction of bilirubin with erythrocytes, erythrocyte suspension 
of 50% hematocrit value was used, which was prepared as follows : 
(i) Preparation of 50% hematocrit value of erythrocytes: Erythrocytes were 
isolated by centrifugation of collected blood at 2000 rpm for 20 minutes. After 
removing the upper huffy coat through gentle decantation, the cells were washed 
three times with 0.07 M sodium phosphate buffer, pH 7.4, containing 0.08 M 
NaCl by centrifugation at 2000 rpm for 20 minutes. Alternatively, 50 mM 
Tris/HCl buffer, pH 7.4 containing 100 mM NaCl was also used for washing 
erythrocytes wherever studies were made in the presence of metal ions. The final 
packed cell volume was diluted with the same buffer in a ratio of 1 : 1 to get 50 % 
hematocrit value of erythrocytes. 
(a) Preparation of bilirubin solution: Fresh bilirubin solution was prepared by 
dissolving a few crystals of bilirubin in a known volume of 38 mM sodium 
carbonate solution containing 5 mM EDTA, pH 11.0. For the studies, involving 
the use of metal ions, 38 mM sodium carbonate solution containing 0.15M NaCl, 
pH 11.0 (adjusted with O.IN HCl) was used to dissolve bilirubin crystals. The 
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the method of Warren (1959). 
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bilirubin solution was protected from light to avoid photodegradation and 
experiments with bilirubin were performed in yellow light. The concentration of 
bilirubin was determined by Fog's method (1958) as described earlier. Bilirubin 
solution was used within one hour. 
(Hi) Procedure: Binding of bilirubin to erythrocytes was studied at pH 8.0, 
ionic strength 0.41 and at 37°C according to the method of Bratlid (1972a). To 1.0 
ml of albumin solution in 0.07 M sodium phosphate buffer, pH 7.4, containing 
0.08 M NaCl, 1.0 ml of bilirubin solution was added and the volume was 
increased to 5.0 ml with the same buffer. Then, 1.0 ml of erythrocyte suspension 
of 50% hematocrit value was added and the tubes were incubated for 30 minutes at 
37°C after gentle shaking. After incubation, they were centriftiged at 2000 rpm for 
20 minutes and the supernatant was removed by gentle decantation. The 
erythrocytes were washed three times with 0.07 M sodium phosphate buffer, pH 
7.4, containing 0.08 M NaCl so that the last supernatant was devoid of yellow 
color. The last supernatant was carefiilly removed by aspiration and 2.5 ml of 
2.5% albumin solution was added to these tubes. The erythrocyte-bound bilirubin 
was eluted by incubation for 30 minutes at 37°C after shaking the tubes gently. 
The tubes were centriftiged at 2000 rpm for 20 minutes and the supernatant was 
carefiilly removed by aspiration. Bilirubin concentration in the eluate was 
determined by the method of Fog (1958) as described above. 
Bilirubin binding to erythrocytes in the absence of albumin but in the presence of 
metal ions was studied in the same manner as described above except that albumin 
solution was replaced with metal salt solution with which erythrocytes were fwst 
incubated for 30 minutes and 50 mM Tris/HCl buffer, pH 7.4, containing 100 mM 
NaCl was used instead of 0.07 M sodium phosphate buffer, pH 7.4, containing 
0.08 M NaCl. 
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Bilirubin binding experiments were performed at different bilirubin/ albumin 
molar ratios (B/As) obtained by varying the albumin concentration in the range of 
(a) 14 to 84 fxM, (b) 28 to 165 ^M and (c ) 42 to 250 ^M, while keeping the 
bilirubin concentration constant; i.e., (a) 41.8 i^M, (b) 83.7 i^M and (c ) 125.5 jiM, 
respectively. In another set of experiments, the bilirubin concentration was varied 
from (a) 6.5 - 38.8 \M, (b) 13.8 -78.3 i^M and (c ) 20.0 - 116.7 )iM, while the 
albumin concentration was kept constant; i.e., (a) 13.2 jj,M, (b) 26.3 |iM and (c ) 
39.5 [xM, respectively to obtain different B/As. In another set of experiments, both 
the bilirubin and albumin concentrations were varied to obtain a constant B/A. 
Experiments without albumin were also conducted. In these experiments, albumin 
solution was replaced with the same buffer and the bilirubin concentration was 
varied from 7.5 to 147 |iM . 
Interaction of bilirubin with erythrocyte membranes 
For studying the interaction of bilirubin with erythrocyte membrane, membranes 
prepared from erythrocyte suspension of 50% hematocrit value were used. 
(i) Preparation of erythrocyte membranes: Erythrocyte membranes were 
prepared following the metiliod of Palfrey and Waseem (1985). Hemolysis of 
erythrocytes was carried out using cold 10 mM Tris/HCl buffer, pH 7.4 containing 
O.OlmM EDTA and O.OlmM PMSF. To 1.0 ml aliquots of the washed erythrocyte 
suspension of 50% hematocrit value in 50 mM Tris/HCl buffer, pH 7.4 containing 
lOOmM NaCl, taken into 16.0 ml polypropylene tubes, was added 9.0 ml of the 
lysis buffer. The contents were mixed by gentle swirling and then centrifuged at 
15,000 rpm at 4'^ C for 30 minutes. The dark red supernatant was removed carefully 
by gentle aspiration and the erythrocyte membrane pellet was resuspended by 
swirling in 5.0 ml of the same lysis buffer and then centrifuged again at 15,000 
rpm at 4°C for 20 minutes. The membranes were washed five to six times with the 
same buffer: the supernatant after the last wash was colorless. After final washing. 
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the erythrocyte membrane pellet was resuspended in 50mM Tris/HCl buffer, pH 
7.4 containing 100 mM NaCl such that the total volume of membrane suspension 
was 1.0 ml in each tube. This suspension was stored at lO^C and used as such 
within two days for subsequent studies. 
(ii) Determination of phospholipid content of erythrocyte membranes: 
Phospholipids were extracted from the erythrocyte membranes in the same way as 
described by Folch et al. (1957). To 1.0 ml of erythrocyte membrane suspension, 
taken in 16.0 ml centriftige tubes, was added 4.0 ml of chloroform/ methanol 
mixture (2 :1, v/v). The contents were mixed well by shaking the tubes for 10 
minutes and then centrifuged at 8000 rpm for 20 minutes. The maximum portion 
of upper phase (methanol-water phase), containing proteins and non-lipid 
components, was removed by gentle aspiration and the remaining upper phase was 
rinsed out three times with methanol/ water mixture ( 1 : 1 , v/v) without disturbing 
the lower phase. The lower phase (chloroform phase), containing extracted lipids, 
was taken and chloroform was evaporated. The inorganic phosphorus content was 
determined by the method of Fiske and Subbarow (1925) after releasing it from 
phospholipids by heating them in 60% (v/v) perchloric acid at 180°C for 2 hours. 
The phospholipid content was estimated by multiplying the total inorganic 
phophorus content by 25 as suggested by Berg (1969). 
(iii) Determination of (Ca^'-Mg'[)-ATPase activities: (Ca'^^-Mg^^-ATPase 
activities were determined in the hemoglobin-free erythrocyte membranes obtained 
from different species as described earlier (Zaidi et al., 1995). The reaction 
mixture contained 80 mM NaCl, 15 mM KCl, 3 mM MgCl2, 0.1 mM ouabain, 0.2 
mM CaCla, 0.1 mM EGTA, 20 mM Tris-HCl (pH 7.4), 0.5 ml of erythrocyte 
membrane suspension and different concentrations (0-2.5 mM) of ATP in a total 
volume of 2.0 ml. The mixture was incubated for 60 minutes at 37**C. The reaction 
was terminated with 0.5 ml of 1.2 M perchloric acid and the liberated inorganic 
phosphate was estimated by the method of Fiske and Subbarow (1925) against a 
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suitable blank. No Ca'' was used for (Mg* *)-ATPase activities. The (Ca' '-Mg* ')-
ATPase activity was determined by subtracting the (Mg*')-ATPase activity from the 
total [(Ca* *-Mg'')-ATPase + (Mg* *)-ATPase] activity. 
The concentration of Ca ' was measured by O.C.P.C method, using calcium 
measurement kit (Code No. 25952) supplied by Span Diagnostics Ltd., India. 
(iv) Preparation of metal ion loaded erythrocyte membranes: For the 
preparation of metal ion loaded erythrocyte membranes, different concentrations 
of metal salts were added to 1.0 ml of membrane suspension in 50 mM Tris/ HCl 
buffer, pH 7.4 containing 100 mM NaCl and the mixture was incubated for 30 
minutes at 37"C. After removal of the supernatant containing unbound metal ions 
by centrifugation at 15,000 rpm for 20 minutes, membranes were washed with 50 
mM Tris/ HCl buffer, pH 7.4, containing 100 mM NaCl followed by 
centrifugation at 15,000 rpm for 20 minutes. This process was repeated two times. 
Membranes, thus obtained, were resuspended in the same buffer to make the 
volume up to 1.0 ml and used directly for the bilirubin binding experiments. 
(v) Phospholipase C (C. welchii) treatment of erythrocyte membranes: 
Phospholipase C digestion of erythrocyte membranes was carried out according to 
the method of Sato et al. (1987). To 1.0 ml of erythrocyte membrane suspension in 
50 mM Tris/HCl buffer, pH 7.4, containing 100 mM NaCl was added 3.75 ml of 
0.1 M Tris/ HCl buffer, pH 7.4, 50 i^l of 1.0 M CaCb and 200^1 of the enzyme 
solution (5 mg/ ml) and the mixture was incubated for different time periods at 
37°C. After the desired period of incubation, the reaction was stopped by adding 
1.0 ml of 10 mM EDTA. All the contents were centrifiiged at 15,000 rpm for 20 
minutes and the supernatant containing released phosphate was carefiiUy collected 
and subjected to phosphate measurement by the method of Fiske and Subbarow 
(1925). The treated erythrocyte membrane pellet was washed with 50 mM Tris/ 
HCl buffer, pH 7.4, containing 100 mM NaCl and 5.0 mM EDTA followed by 
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centrifugation at 15,000 rpm for 20 minutes at 4°C. This process was repeated two 
times and the last washing was performed with the same buffer but without EDTA. 
The pellet, thus obtained, was resuspended in the same buffer (without EDTA) 
and the volume was made up to 1.0 ml. This membrane preparation was directly 
used for bilirubin binding experiments. 
(vi) Trypsin treatment of erythrocyte membranes: Tryptic digestion of 
erythrocyte membranes was performed by the method of Steck et al. (1971). The 
membrane preparations (1.0 ml) used in this experiment were washed with 2.5 
mM sodium phosphate buffer, pH 8.0. The process was repeated and finally the 
membranes were resuspended in l.O ml of the same buffer. Then, 5.0 mg of solid 
trypsin was added to 1.0 ml of erythrocyte membrane suspension in each tube and 
the mixture was shaken well until the enzyme was completely dissolved. The 
reaction was carried out at room temperature for different time periods i.e., 1 hour, 
2 hours and 3 hours, respectively. Then, the mixture was centriftiged at 15,000 
rpm for 5 minutes and the supernatant containing released glycopeptides was 
collected and subjected to carbohydrate measurement by Orcinol method 
(Svennerholm,1956). The treated erythrocyte membrane pellet was washed with 
cold 50 mM Tris/HCl buffer, pH 7.4, containing 100 mM NaCl, followed by 
centrifugation at 15,000 rpm for 20 minutes. After one more washing, treated 
membranes were resuspended in the same buffer to give a final volume of 1.0 ml. 
This membrane preparation was directly used for bilirubin binding studies. 
(vii) Neuraminidase treatment of erythrocyte membranes: One milliliter of 
erythrocyte membrane suspension, (equivalent to 1.0 ml of erythrocyte suspension 
of 50% hematocrit value), was incubated with 0.5 unit of the enzyme for 1 hour at 
37°C in 50 mM Tris/HCl buffer, pH 7.4. The mixture was centrifiiged at 15,000 
rpm for 5 minutes and the supernatant containing released sialic acid was collected 
and subjected to sialic acid measurement by the method of Warren (1959). The 
neuraminidase-treated membrane pellet was washed with cold 50 mM Tris/HCl 
37 
buffer, pH 7.4 containing 100 mM NaCl, followed by centrifugation at 15,000 rpm 
for 20 minutes. After one more washing step, treated membranes were 
resuspended in the same buffer and the total volume was made to 1.0 ml. These 
membranes were directly used for bilirubin binding experiments. 
(viii) Procedure for bilirubin interaction studies with unmodified/ modified 
erythrocyte membranes: Binding of bilirubin to erythrocyte membranes 
(unmodified/ modified) was studied by incubating 1.0 ml of stock bilirubin 
solution of desied concentration with 1.0 ml of erythrocyte membrane suspension 
(equivalent to 1.0 ml of erythrocyte suspension of 50% hematocrit) and the fmal 
volume was made to 6.0 ml with 50 mM Tris/ HCl buffer, pH 7.4 containing 100 
mM NaCl. After 30 minutes of incubation at 3'fC, the mixture was centrifiiged at 
15,000 rpm for 15 minutes at 4°C and the supernatant containing unbound 
bilirubin was discarded. Membranes were washed several times with the same 
buffer until the last supernatant was devoid of yellow color. After final washing, 
the membrane-bound bilirubin (EMB) was determined by slight modification of 
Fog's method (1958) as described above. For the determination of membrane-
bound bilirubin, bilirubin loaded erythrocyte membranes were subjected to 
following treatments and the data were analysed. 
(a) Direct Fog's reaction. Two milliliters of Fog's reagent 1 and 0.5 ml of reagent 
11 were directly added to 1.0 ml of bilirubin loaded erythrocyte membrane 
(BLEM) suspension. The mixture was shaken well before incubation. If required, 
the reaction was carried out with 1.0 ml of diluted BLEM suspension. After 10 
minutes incubation at room temperature, the mixture was centrifiiged at 4000 rpm 
for 20 minutes. To the pink colored supernatant obtained above, 1.5 ml of Fog's 
reagent III was added and the green colored alkaline azobilirubin was determined 
spectrophotometrically at 600 nm. 
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(b) SDS treatment. In another experiment, BLEMs were dissolved in 1% (w/v) 
sodium dodecyl sulfate (SDS) (to a final volume of 1.5 ml) by incubating the 
content at 60"C for Ih and Fog's reaction was carried out with 1.0 ml of the 
solubilized BLEMs to determine bilirubin concentration. The turbidity caused by 
SDS was removed by centrifugation at 4000 rpm for 20 minutes. The clear green 
colored supernatant was collected and the absorbance was measured at 600 nm. 
The precipitate obtained after centrifugation was white and contained no bilirubin. 
(c) Elution with various media. Membrane-bound bilirubin was also eluted by 
incubating BLEMs with 1.0 ml each of either 3.8 % albumin solution (final 
concentration = 2.5%) or 38mM sodium carbonate solution containing 5 mM 
EDTA, pH 11.0 or with NaCl solution of different ionic strengths for 30 minutes 
at 37^C. The fmal volume of the incubation mixture was made to 1.5 ml with the 
buffer. Then, the mixture was centrifiiged at 8000 rpm for 5 minutes and l.O ml 
of the supernatant containing eluted bilirubin was subjected to Fog's reaction for 
the determination of bilirubin concentration in the eluent. Necessary volume 
corrections were made in determining the bilirubin concentration. The pellet left 
was washed again to remove the eluted bilirubin and then dissolved in 1% (w/v) 
SDS (to a fmal volume of 1.5 ml) and the amount of bilirubin present in the final 
pellet was determined by Fog's method (1958). 
In most of the experiments, membrane-bound bilirubin was determined using SDS 
treatment. 
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RESULTS AND DISCUSSION 
Isolation of serum albumin 
Serum albumins of human, sheep, goat and buffalo were isolated as described in 
the experimental section. About 2 gm protein was obtained from 100 ml of the 
plasma. The isolated preparation showed a fair degree of homogeneity as 
evidenced by the electrophoretic pattern in 7% polyacrylamide gel in which all 
serum albumins gave a single band (Fig. 7). 
Binding of bilirubin to erythrocytes 
Binding of bilirubin to erythrocytes of several mammalian species was studied 
under different conditions as described in the experimental section. The results 
obtained are described below. 
At different B/As (keeping the bilirubin concentration constant while vary ins 
the albumin concentration): Increase in B/As from 0.5 to 3.0 led to an increase 
in the erythrocyte-bound bilirubin (Fig. 8). This increase was smaller up to a B/A 
1: 1 but became more significant (P < 0.0001) at high B/As. Nearly 4-fold increase 
(P < 0.0001) in erythrocyte-bound bilirubin was noticed on increasing the B/A 
from 1.0 to 2.0 in case of human erythrocytes. At three fixed bilirubin 
concentrations, i.e., 41.8 \M, 83.7 fiM and 125.5 ^M (Fig. 8A, B and C), the 
patterns of bilirubin binding to himian erythrocytes were qualitatively similar. 
However, the amount of erythrocyte-bound bilirubin at any B/A in the range of 0.5 
to 3.0 was different at different fixed concentrations of bilirubin, being positively 
correlated with bilirubin concentration. Bilirubin binding pattern obtained with 
human erythrocytes compared well with earlier reports (Bratlid, 1972a; Kaufrnann 
et al, 1967; Hayer et ai, 1989). However, the amount of bound bilirubin was 
found to be smaller as compared to the earlier fmding (Bratlid, 1972a). This 
difference can be attributed to the pH effect, as decrease in pH leads to an 
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Fig 7. Poiyacrs lamide gel electrophoresis of different serum albutnins 
(A) GSA. (B) BuSA, (C ) HSA and (D) SSA 
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Fig 8 Binding of bilirubin to the erythrocytes of goat (•), buffalo (Oj. 
human («)and sheep (0)at different bilirubin/albumin molai 
ratios. Bilirubin concentration was kept constant at (A) 41 8 ^ M 
(B) 83.7 |iM and (C) 125 5 ^M while albumin concentration varied 
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increase in bilirubin binding to human erythrocytes due to increase in cellular 
affinity of bilirubin (Bratlid, 1972b; Sato and Kashiwamata, 1983). This is because 
in an earlier study, binding was studied at pH 7.4, whereas in our experiments, pH 
was kept at 8.0 due to higher solubility of bilirubin at this pH, as compared to pH 
7.4 (Brodersen, 1980). 
A comparison of bilirubin binding to erythrocytes obtained from different species 
suggests significant variation in the amount of bilirubin bound to erythrocytes at 
all B/As. At a given B/A, goat erythrocytes bound the maximum amount of 
bilirubin while sheep erythrocytes bound the lowest amount (Fig. 8). The amounts 
of bilirubin bound by buffalo and human erythrocytes were in between the values 
obtained with goat and sheep erythrocytes; they were higher for buffalo 
erythrocytes as compared to human erythrocytes. 
At different B/As (keeping the albumin concentration constant while varyim the 
bilirubin concentration): The bilirubin binding profiles obtained with different 
erythrocytes at different B/As using fixed albumin concentration (39.5fj,M) and 
different bilirubin concentrations are shown in Fig. 9. These patterns were 
qualitatively similar to those obtained at different B/As when bilirubin 
concentration was kept constant and albumin concentration varied. Increase in B/A 
caused an increase in erythrocyte-bound bilirubin. The amount of bilirubin bound 
to erythrocytes at a given B/A was found to be the same in both the experiments 
using either constant bilirubin concentration or constant albumin concentration 
while varying the other, provided the bilirubin concentration is identical in both. It 
means that bilirubin binding to erythrocytes depends on the free bilirubin 
concentration. 
At constant B/A while varyins both the bilirubin and albumin concentrations: 
At a given constant B/A, the binding of bilirubin to different erythrocytes increas-
ed linearly with increase in bilirubin concentration as shown in Fig. 10 (A-D). 
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Fig. 9. Binding of bilirubin to the erythrocytes of goat (•), buffalo (O), 
human (d) and sheep (O) at different bilirubin/albumin molar ratios. 
Albumin concentration was kept constant at 39.5 ^M while bilirubin 
concentration varied. 
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Fig 10 Binding of bilirubin to erythrocylcs of goat (•), buffalo (O ), human 
(O)and sheep (O) at constant bilirubin/albumin molar ratio Both 
bilirubin and albumin concentrations were varied to obtain a constant 
bilirubin albumin molar ratio of (A) 15 (B) 2.0 (C) 2.5 and (D) 3 0 
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This finding was consistent with the earUer finding on human erythrocytes 
(Kaufinann et al, 1967). However, the value of slope of the linear plots at any 
given B/A was found to be different for different erythrocytes being highest for 
goat erythrocytes, followed by buffalo and human erythrocytes and lowest for 
sheep erythrocytes. Further, with all the species, increased binding was observed 
at higher B/As. Values of the slope obtained from these plots, when plotted against 
B/A, showed an initial rapid increase in all cases, which then became constant at 
higher B/As i.e., 2.5 and 3.0 (Fig. 11). In other words, increase in erythrocyte-
bound bilirubin per unit increase in bilirubin concentration was found to be 
dependent upon B/A up to a value of 2.5 and then became independent above B/A 
2.5, as the value was nearly constant at B/As 2.5 and 3.0. It seems likely that the 
free bilirubin concentration in the bilirubin incubate at different B/As is not 
increasing to the same extent, which can account for the variation in the values of 
the slope obtained. From Fig. 10 and 11, it is clear that receptors for bilirubin 
differ in different erythrocytes either in their affinity or number or in both. In 
addition, binding affinities of different albumins for bilirubin may also be 
different, which can account for the difference in bilirubin binding. 
Fractional bindins of bilirubin to erythrocytes: Percentage difference in 
fractional binding of bilirubin to erythrocytes was calculated using the following 
equation: 
% difference in fractional bilirubin binding = ^ x 100 (7 ) 
where (E-B)2 and (E-B)j are the erythrocyte-boimd bilirubin at higher and lower 
B/As respectively and X is the concentration of bilirubin in the incubate ranging 
from 52.5-125.5 jiM. The values, thus obtained, were plotted against the range of 
B/A and are shown in Fig. 12. As can be seen from the figure, the percentage 
difference in fractional bilirubin binding to human erythrocytes was found highest 
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Fig.l 1. Plots of the slope [taken from Figs. 10 (A - D)] versus bilirubin/ 
albumin molar ratio. Various mammalian species were : goat (•), 
buffalo (O), human (3) and sheep (O). 
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Fig 12 Histogram representing the percentage fractional binding of bilirubin 
to erythrocytes of vanous mammalian species^ i e,goat (•) . buffalo 
1^ 0), human (nD)and sheep (D) at different bihrubm albumin molar 
ratios The bilirubia' albumm molar ratios were from (a) 1 0 - 1 5 (b) 
1 5 - 2 0 (c) 2 0 - 2 5 and (d) 2 5 - 3 0 
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between B/As of 1.5 and 2.0 (P<0.001), whereas at other B/As, the values were 
smaller (P<0.01) and nearly equal to each other. This was also found true for other 
species. A comparison of percentage difference in fractional bilirubin binding at 
B/As of 1.5 to 2.0 shows that goat erythrocytes have the highest percentage 
difference, reaching 16.6 ± 2.4, followed by buffalo (13.4 ± 1.9) and human 
erythrocytes (12.3 ± 3.0) whereas sheep erythrocytes have lowest percentage 
difference as 11.4 ± 0.7. Analysis of these results based on two-tailed t-test reveals 
that goat erythrocytes have statistically significant higher values of percentage 
difference in fractional binding than sheep (P = 0.0001), buffalo (P ^ 0.01), as 
well as human erythrocytes (P ^ 0.07). Significant differences have also been 
found between sheep and buffalo erythrocytes (P = 0.001). However, human 
erythrocytes do not differ statistically with both sheep (P ^ 0.47) and buffalo 
erythrocytes (P = 0.40). These data suggest that a greater amount of bilirubin is 
transferred from plasma to cells in case of goat erythrocytes, followed by buffalo, 
human and sheep erythrocytes. This transfer seems to be more pronounced at B/As 
of 1.5-2.0. At B/A of ^1.5, the free bilirubin concentration available for cellular 
binding is comparable to that obtained during neonatal jaundice (Karp, 1979). 
Relative percentage difference in bound bilirubin by erythrocytes: The relative 
percentage difference in the bilirubin bound to erythrocytes of one species with 
respect to bilirubin bound to erythrocytes of other species was calculated using the 
following equation: 
Relative % difference in bound bilirubin = iE-B}2y^E-B)Y^ j ^ ^ ^g. 
(b-B)Y 
where (E-B)^ is the concentration of bilirubin bound to erythrocytes of one species 
and (E-B)Y is the concentration of bilirubin bound to erythrocytes of other species. 
At all B/As > 1.0, the relative percentage difference in erythrocyte-boimd bilirubin 
between any two species, calculated by using equation (8), was found to be similar 
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(df = 12, 39; F =0.77; P = 0.68). Values of relative percentage difference in the 
bilirubin bound to goat erythrocytes with respect to buffalo, human and sheep 
erythrocytes were found to be 18.8± 3.4 (P = 0.085), 31.8 ± 2.7 ( P = 0.008) and 
44.9 ± 5.2 ( P = 0.0007), respectively. Thus, binding of bilirubin was maximum 
with goat erythrocytes and minimum with sheep erythrocytes. 
Effect of serum albumin on the binding of bilirubin to erythrocytes: The 
difference in relative percentage difference in the bilirubin bound to goat 
erythrocytes with respect to buffalo, human and sheep erythrocytes was not due to 
the difference in the affinities of the respective serum albumins for bilirubin as the 
elution of erythrocyte-bound bilirubin with the appropriate serum albumin gave 
the same amount of bilirubin from human erythrocytes (see Table I). Further, in 
all four species , the binding of bihrubin to erythrocytes was not detected in 
the presence of their respective albumins at a B/A of 0.5 (see Fig. 13 and 
Table II), in which the ratio of the erythrocyte-bound bilirubin in the presence of 
albumin (v) to erythrocyte-bound bilirubin in the absence of albumin (vo) was 
plotted against B/A. Due to the absence of binding of bilirubin to erythrocytes at 
B/A of 0.5 in all species, we can reasonably claim that the difference in bilirubin 
bound to erythrocytes is due to the difference in the affinities of receptors or their 
number or both. Thus, binding seems to be dependent upon the amount of 
available free unconjugated bilirubin. Albumin does not compete with binding of 
bilirubin to erythrocytes but lowers the amount of free unconjugated bilirubin 
available to erythrocytes. 
Bindins of bilirubin to erythrocytes in the absence of albumin: Binding of 
bilirubin to different erythrocytes was studied in absence of serum albumin after 
incubating the cells with increasing concentrations of bilirubin. The results of the 
erythrocyte-bound bilirubin and the bilirubin in the incubate are shown in Fig. 14. 
In all cases, curves correspond to a Michaelian saturation. These are similar to the 
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Table I. Comparison of elution behavior of bilirubin bound to human 
erythrocytes by different concentrations of different serum albumins, 
namely, human, goat, buffalo and sheep serum albumins 
Concentration of 
serum albumin 
used for elution 
(mg/ml) 
1.0 
5.0 
10.0 
15.0 
20.0 
25.0 
30.0 
C 
HSA 
24.0 
57.6 
75.2 
80.0 
88.0 
94.4 
96.0 
HSA- Human serum albumin 
GSA- Goat serum albumin 
Concentration of erythrocyte-bc 
bilirubin (|iM) eluted by 
BuSA GSA 
20.8 
52.8 
76.8 
81.6 
91.2 
86.0 
96.0 
BuSA-
SSA-5 
25.6 
60.8 
76.8 
80.0 
89.6 
94.4 
94.4 
>und 
SSA 
27.2 
60.8 
75.2 
78.4 
91.2 
94.4 
94.4 
• Buffalo serum albumin 
5heep serum albumin 
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Fig. 13. Plots ot the ratio of bilirubin bound to human eiythroc>ies in 
presence (V) as well as in absence (v„) of albumin agamst the 
bilirubiny' albumin molar ratio. 
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Table II. Effect of serum albumin on the erythrocyte-bound bilirubin 
ANOVA 
(df=l,23; F=465.67; P=9.2xl0"'^) 
(df=l,23; F=440.65; P=1.7xl0''') 
(df=l,23; F=566.47; P=l.lxlO-^^) 
(df=l,23; F=392.32; P=6.0xl0-'^) 
(df=3,8; F=0.04 P=0.99) 
Values of slope (m) and intercept (c) were taken from the following equation 
v/vo = m X bilirubin/albumin molar ratio (B/A) + c 
where 'v' is the erythrocyte-bound bilirubin in presence of albumin and 
'vo' is the erythrocyte-bound bilirubin in absence of albumin. 
B/A* intercept on X- axis. 
System m 
(erythrocytes/ 
albumin) 
Human 
Buffalo 
Goat 
Sheep 
0.22 
0.23 
0.28 
0.21 
c 
-0.12 
-0.12 
-0.16 
-0.11 
B/A* 
0.53 
0.53 
0.58 
0.53 
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Fig 14. Binduig of bilirubin b> several mammalian erythrocytes in the absence 
of album,n,i.e,goat (A), buffalo (A), human (O) and sheep (•) 
54 
one obtained earlier using human erythrocytes (Hayer et al, 1989). From the 
figure, it appears that different mammalian erythrocytes have different saturation 
capacities. For the determination of dissociation constants of the bilirubin-receptor 
complex and saturation, the data from Fig. 14 were transformed into double 
reciprocal plots and the values of the slope and intercept were used for the 
calculation of the dissociation constant of the bilirubin-receptor complex and 
saturation (Table III). For clarity, the double reciprocal plot obtained with human 
erythrocytes is shown in Fig. 15. In the case of human erythrocytes, saturation 
corresponded to a binding of 76.9 jimoles of bilirubin per 1000 ml erythrocytes 
and the dissociation constant of bilirubin-receptor complex was found to be 
150x10 moles/ liter. This value of the dissociation constant was 0.9 times less 
than the one reported earlier (Hayer et al, 1989). A comparison of dissociation 
constants of the bilirubin-receptor complex (150x10 moles/liter) with that of the 
-8 
bilirubin-HSA complex (1.5x10 moles/liter) for the primary binding site 
(Brodersen, 1979) suggests that the binding of unconjugated bilirubin to 
erythrocytes, even for high bilirubinemia (150 (imolesAiter) is extremely weak. 
From the Table 111, it can be seen that goat erythrocytes have the highest 
dissociation constant, whereas sheep erythrocytes have the lowest. Buffalo 
erythrocytes bind bilirubin with a dissociation constant similar to human 
erythrocytes. Similarly, saturable binding on the erythrocyte membranes was 
maximum with goat erythrocytes, whereas sheep erythrocytes bound the lowest 
amount of bilirubin. Thus, it appears that the number of saturable bilirubin binding 
sites on goat erythrocytes is the highest of all species studied, whereas the number 
of binding sites on sheep erythrocytes is the lowest. Human and buffalo 
erythrocytes have the same number of binding sites and are in between that of goat 
and sheep erythrocytes. In contrast, the affinity of these sites was highest in sheep 
erythrocytes and lowest in goat erythrocytes. Human and buffalo erythrocytes 
have similar affinities which are between the two. 
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Table III. Interaction parameters of bilirubin with erythrocytes of different 
species 
Species 
Human 
Buffalo 
Goat 
Sheep 
Saturation 
(\i mol of bilirubin/ 
1000 ml erythrocytes) 
76.9 
83.3 
125.9 
62.5 
Dissociation 
constant 
(nmol/1) 
150.0 
155.8 
265.7 
115.6 
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Fig. 15 Double reciprocal plot between inverse of desorbed bilirubin concen-
tration and inverse of bilirubin concentration in the incubate for 
human erythrocytes. 
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Effect of metal ions on the bindins of bilirubin to erythrocytes: Human 
erythrocytes preincubated with different metal ions for 30 minutes at 37°C 
followed by further incubation with bilirubin showed different degree of 
hemolysis. Such type of hemolysis was highly metal ion specific. Out of five metal 
salts used in this study (CaCl2, MgCl2, BaCl2, CuCl2 and MnCl2), three salts i.e., 
CaCl2, CuCl2 and MnCl2 showed hemolysis to varying extent. The percentage 
hemolysis was calculated as A2/ Ai x 100 where Ai is the absorbance at 540 nm of 
hemolysate of erythrocytes with water in 6.0 ml (8.3% hematocrit value) after 1 
hour of incubation and A2 is the absorbance at 540 nm of metal ion-induced 
hemolysate in presence or absence of bilirubin in 6.0 ml (8.3% hematocrit value) 
after 1 hour of incubation. 
Human erythrocytes when incubated with different concentrations of CaCl2 
(0.17-1.67 mM) for 30 minutes were found to be hemolysed in presence of 
bilirubin ( 72 \\M) as shown in Fig. 16a. A marked increase in percentage 
hemolysis ( 58.3 % ) was found at 0.17 mM CaCl2 concentration, beyond 
which it sloped off. The induction of such hemolysis by CaCl2 in the presence 
of bilirubin seems to be a conditional requirement as no hemolysis was observed 
when the erythrocytes were incubated with either CaCl2 or bilirubin alone, even 
at a higher concentration (i.e. , 3.0 mM CaCl2 ; 125.5 jxM bilirubin). As can 
clearly be seen from Fig. 16b when CaCl2 (0.17 - 1.67 mM) and bilirubin (72 i^M) 
were simultaneously added to human erythrocytes , only 14% hemolysis was 
observed at 1.67 mM CaCl2 concentration, compared to 62.5 % when erythrocytes 
were incubated first with 1.67 mM CaCl2 for 30 minutes, followed by addition of 
bilirubin (72 \xM). Moreover, incubation of erythrocytes with bilirubin (72 \iM) 
for 30 minutes at 37°C followed by the addition of 1.67 mM CaCl2 led to only 
11% hemolysis ( Fig. 16c). Similarly, incubation of erythrocytes with bilirubin 
(72 \M) for 30 minutes at 37°C, washing with 50 mM Tris/HCl buffer, pH 7.4 
58 
O 
E 
0.67 1.0 
CaClj ( mM ) 
Fig. 16. Effect of calcium on human eiythrocvtes in the presence of bihrubm 
(a) Erythrocytes fu-st incubated with different concentrations of CaCl: 
(0.17-1.67 mM) for 30 minutes at 37^C followed by further incu-
bation with bilirubin (72 ^M) for 30 minutes at 37'C 
(b) Erythrocytes incubated with different concentrations of CaCl: 
(0.17-1.67 mM) and bilirubin (72 jiM) at the same time for 1 hour 
at 37°C. 
(c) Erythrocytes first incubated with bilirubin (72 jaM) for 30 mmutes 
at 37^C followed by further incubation with different concen-
trations of CaCb (0.17- 1.67 mM) for 30 minutes at 3 r c 
(d) Erythrocytes first incubated with bilirubin (72 jiM) for 30 minutes 
at 3'fC then washed the unbound bilirubin followed by further 
incubation with different concentrations of CaCb (0.17-1 67 mM) 
for 30 minutes at 37^C. 
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containing 100 mM NaCl to remove unbound bilirubin followed by the addition 
of CaCl2 showed only 8% hemolysis (Fig. 16d). Taking the percentage hemolysis 
values (~ 5% ) in the control samples without CaCh, this hemolysis (Fig. 16b-d) 
seems insignificant. These results strongly suggest the pre-requirement of CaCl2 
to interact first with the erythrocytes followed by the interaction of bilirubin 
with the calcium-bound erythrocytes for the induction of hemolysis. Incubation 
of erythrocytes with calcium alone (0.33-2.0 mM) for 30 minutes led to a decrease 
in calcium level in the supernatant (Fig. 17a). This suggests that calcium binds to 
erythrocyte membranes. The addition of bilirubin to this system released some 
calcium from these membranes as calcium level in the supernatant increased in the 
presence of bilirubin (Fig. 17b). However, the increase in the calcium level in the 
supernatant was significantly higher when cells were incubated first with bilirubin 
(72 laM) for 30 minutes followed by the addition of CaCl2 (0.33-2.0 mM) for 30 
minutes (Fig. 17c) compared to when the order was reversed (Fig. I7b). It seems 
that some of the calcium binding sites on erythrocytes are masked by bilirubin. 
The inability of bilirubin-bound erythrocytes to undergo hemolysis in the presence 
of Ca *, unlike the calcium-bound erythrocytes in the presence of bilirubin, 
further supports this theory . This contention is also supported by the fact that 
bilirubin has a high association constant for PC (Nagaoka and Cowger, 1978) 
and its binding to PC prevents the phase separation of PS - PC bilayer 
membranes into a solid phase of PS aggregates bridged by Ca ' chelation 
(Shimshick and McConnell, 1973; Ohnishi and Ito, 1974; Ito et al, 1975). 
Calcium-induced hemolysis of erythrocytes in the presence of bilirubin was found 
to be dependent upon the concentration of bilirubin. This can be clearly seen 
from Fig. 18. Increase in bilirubin concentration up to 100 jxM after preincubation 
of erythrocytes with 1.0 mM CaCl2 for 30 minutes at 37°C led to a linear increase 
in percentage hemolysis. 
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Fig. 17. Plot showing the calcium levels in the supernatant after incubation 
Vkdth human erythrocytes. 
(a) Er\ihroc>tes incubated with different concentrations of CaCl; 
(0.33 - 2.0 mM) for 30 minutes at 3'fC. 
(b) Er>throcytes first incubated with different concentrations of 
CaCl: (0 33-2.0mM) for 30 minutes at 37'C followed by 
further incubation with bilirubin (72 jiM) for 30 minutes at 
3rc. 
(c) Ervihroc\les first incubated with bilirubin ( 72 \i\\ ) for 30 
minutes at 37"C followed by further incubation with different 
concentrations of CaC^ (0.33-2.0 mM) for 30 minutes at 
37"C. 
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Fig. 18. Bilirubin dependence of calcium-induced hemolysis of human 
erythrocytes. Erythrocytes fnst incubated with CaCl2(1.0mM) for 
30 minutes at 37^ C followed by further incubation with different 
concentrations of bilirubin (10-lOO^M) for 30 minutes at 37*^ C. 
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Hemolysis of erythrocytes induced by calcium in the presence of bilirubin was 
found to be dependent upon time of incubation with calcium. As can be seen 
from Fig. 19, the incubation of cells with calcium (ImM) for different time 
periods followed by fiirther incubation with bilirubin ( 72 \xM) for 30 minutes 
yielded a different percentage hemolysis which became constant after 20 minutes. 
These results suggest that the interaction of calcium with human erythrocytes 
reached saturation within 20 minutes. 
Furthermore, the percentage hemolysis was also found to be dependent upon the 
time of incubation of bilirubin with the calcium-loaded erythrocytes, as shown 
in Fig. 20. The percentage hemolysis increased continuously with the increase 
in the time of incubation of bilirubin with calcium-loaded erythrocytes, reaching 
a 95% value after 75 minutes. On the other hand, incubation of cells with 2 mM 
CaCla alone for 75 minutes did not show any significant lysis (Fig. 20). 
It was found that inclusion of EDTA in the incubation mixture along with 
calcium did reduce the percentage hemolysis after the addition of bilirubin, but 
total inhibition was not observed (Fig. 21). The percentage hemolysis decreased 
continuously (from a value of 65% in control) with the increasing concentration 
of EDTA reaching to a value of 35% at an EDTA concentration of 2.0 mM, 
(double the concentration of calcium used). This shows that all the calcium ions 
are not removed by 2.0 mM EDTA. Further, washing of erythrocytes pretreated 
with Ca^ ^ and bilirubin, with 50 mM Tris/HCl buffer, pH 7.4 containing 100 
mM NaCl and different concentrations of EDTA, showed that subsequent 
hemolysis was prevented by removal of cell-bound calcium. As can be seen 
from Fig. 22, 2.0 mM EDTA led to a significant decrease in hemolysis. These 
results probably suggest that the basic reaction which results in the 
hemolysis probably involves the calcium bound to the erythrocyte membrane as 
this calcium can easily be washed out compared to the intracellular calcium. 
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Fig 19 Effect of incubation time on the calciura-induced bilirubin-dependent 
hemolysis of human erythrocytes Er>ihrocytes first mcubated with 
CaCl2 (lOmM) for different time penods (0-30 mmutes) at 37^C 
followed by further incubation with bilmibm (72 )iM) for 30 minutes 
at 37"C 
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Fig 20 Effect of tune after the addition of bilirubin on the calcium-induced 
bilirubin-dependent hemolysis of human erythrocytes Erythrocytes 
first incubated with CaCl2 (2 0 mM) for 30 minutes at 3/C,follo\\ed 
by further incubation with bilirubin (72 }iM) at 3T'C for varying time 
penods (0-75 mmutes) (O-O) shows the effect of mcubation time of 
human erythrocytes with CaCl: (2 0 mM) on the hemolysis in the 
absence of bilirubin 
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Fig. 21. Effect of EDTA on the calcium-induced bilirubin-dependent hemolysis 
of human erythrocytes. Erythrocytes incubated with CaCIa (1.0 mM) 
and different concentrations of EDTA (0-2,0 mM) at the same time for 
30 minutes at 37^ C followed by further incubation with bilirubin 
(72 J^LM) for 30 minutes at 37"C. 
66 
.2 
>« 
"o 
E 
0) 
X 
70 
3 5 -
0 
0 
EDTA (mM) 
Fig. 22. Effect of remo\al of surface-bound calcium on the subsequent hemo-
lysis of human ervthrocytes pretreated with calcium and biluiibin. 
Er>throc>1es first incubated with CaCb (1.0 mM) for 30 minutes at 
37^ 'C followed by further incubation with bilirubin (72 i^M), washing 
with 50 mM Tns HCl buffer, pH 7.4 containing 100 mM NaCl and 
different EDTA concentrations (0-2.0 mM). D control. ^ first wash, 
• second wash 
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To determine the role of activated oxygen species in bilirubin-dependent 
calcium-induced hemolysis, sodium azide and catalase were used in the incubation 
medium. It was found that neither catalase ( 13-120 mg/liter) nor sodium azide 
( 0.17-1.83 mM ) inhibited hemolysis. Further, inclusion of hydrogen peroxide 
( 0.16-1.6 mM ) with human erythrocytes alone also failed to produce any 
significant hemolysis (Fig. 23 ). Therefore, singlet oxygen, H2O2 and OH" are 
not involved in hemolysis. Moreover, the question of generation of any free 
radical by the interaction of calcium with bilirubin did not arise as the incubation 
of calcium with bilirubin for 30 minutes at 37°C followed by addition of human 
erythrocytes did not produce any hemolysis. This is because the calcium 
bilirubinate formed in this reaction did not bind to the cells. 
The effect of other bivalent cations for their possible role of inducing 
hemolysis of human erythrocytes in the presence of bilirubin was also 
investigated. Ba* and Mg' are closely related bivalent cations to Ca ' due 
to their ability to induce membrane aggregation through intramolecular 
chelation of phospholipid molecules (Ito et al.,\915). However, under similar 
conditions of incubation procedure, both Ba * and Mg^ * (0.17-2.0 mM) were 
found to be unable to induce hemolysis of human erythrocytes as compared to 
Ca* (0.17-2.0 mM) in the presence of bilirubin ( 72 i^M) (Figs. 24 d, e and 
Fig. 25 ). Even at higher concentrations (3.3-16.7 mM), both Ba*' and Mg*' 
failed to induce any hemolysis. Although, the effect of both Ba^ * and Mg* 
on biomembrane is reported smaller compared to Ca^\ the failure to induce 
hemolysis even at a higher concentration of these cations, in the presence of 
bilirubin, suggests that either Ba *^  or Mg *^  alone, or Ba^ ^ or Mg * complexed 
with bilirubin (if formed) is unable to alter the permeability of human erythro-
cytes. On the other hand, Mn^^  and Cu *^  -induced hemolysis of himian erythro-
cytes both in the presence and absence of bilirubin, as shown in Figs. 24 b, c 
and Fig. 25. In the absence of bilirubin, Mn"^ ' at a concentration of 1.67 mM 
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Fig. 23. Effect of sodium azide and catalase on calcium-induced bilirubin-
dependent hemolysis of human erythrocytes. Erythrocytes first incu-
bated with CaCl2 (l.OmM) and sodium azide (0.17-1.83 mM) or 
catalase 03-120 rag/1) for 30 minutes at 3 /C followed by further 
incubation with bilirubin (72 nM) for 30 mmutesat 3 f C. Effect of 
H:;02 (0.16- 1.6 mM) on human erythrocytes is also shown. 
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Fig 24. Effect of vanous bivalent cations on human er>throcytes in the 
presence of bilirubin Erythrocytes first incubated with vanous salts 
of bivalent cations (0-2 OmM) for 30 minutes at 37"C followed by 
fiirther incubation with bilirubin (72 i^M) for 30 mmutes at 3/'C fhe 
vanous salts used are CaCU (a), CuClj (b); MnCls (c), BaCl: (d) 
and MgCl: (e) 
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CaCl, CuCI, MnCl, BaCI^  MgCl, 
Fig. 25. Effect of vanous bivalent cations on human erythrocytes in ±e 
absence of bilirubin. Erythrocytes were incubated with different 
salts of bivalent cations (1.67 mM) for 1 hour at 37*^ C 
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produced 20% hemolysis (Fig. 25), whereas in the presence of bilirubin, the 
percentage hemolysis was 22%. From these results it is clear that hemolysis is 
induced by Mn"^ ' alone, unlike bilirubin-dependent calcium-induced hemolysis of 
human erythrocytes. Similarly, in the absence of bilirubin, Cu' (1.67 mM) alone 
can induce about 47% hemolysis (Fig. 25), whereas in the presence of 
bilirubin, about 69 % hemolysis was observed. This is because Cu' * alone or 
complexed with bilirubin can act as a potential oxidative agent (Norman and 
Szentirmay, 1974), thereby causing changes in membrane permeability. It 
can also cross-link various proteins in the membrane. Therefore, hemolysis 
induced by Cu* * is different from that of bilirubin-dependent calcium-induced 
hemolysis of human erythrocytes. 
The possible reason for thisphenomenaof bilirubin-dependent calcium-induced 
hemolysis of human erythrocytes can be explained in the following way. 
Since human erythrocyte membranes have a high ratio of PC to PS (Nagaoka 
and Cowger, 1978), they are, therefore, highly sensitive to calcium to form 
hydrophobic aggregates of phospholipid molecules in erythrocyte membrane. 
Furthermore, the potentiality of bilirubin to remain in hydrophobic medium 
(Brodersen, 1979; Haihm et al., 1992) increases the binding of bilirubin to these 
hydrophobic phospholipid aggregates of membranes. Since calcium-bound human 
erythrocytes are unstable due to transformation of the normal cells to echinocytes 
{Zaidi et al., 1995), the binding of bilirubin to the Ca'-chelated hydrophobic 
phospholipid aggregates of such transformed cells may cause further imbalance 
which results in hemolysis. 
Incubation of two other mammalian erythrocytes, namely, buffalo and sheep with 
different concentrations of CaCla (16.7-1830 ^M) for 30 minutes at 37''C, 
followed by further incubation with 72 \xM bilirubin also resulted in the hemolysis 
of these erythrocytes (Fig 26). A comparison of the hemolytic patterns observed in 
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human, buffalo and sheep erythrocytes shows that these erythrocytes differ 
markedly in hemolysis with increasing CaCh concentration (df =19, 40; F=13.36; 
P= 8.3 X 10"'^ ). In contrast, goat erythrocytes did not show any significant 
hemolysis (P > 0.1), compared to the control value up to 1170 ^M CaCh 
concentration and only 11% hemolysis was observed at the highest CaCl2 
concentration (1830 jiM). Hemolysis at this point was 6-fold (P <0.0001)smaller 
than hemolysis observed in the other three species. These results were highly 
reproducible under similar conditions. In two independent experiments, the SEM 
has been shown in Fig. 26. Dependence of calcium-induced hemolysis of 
mammalian erythrocytes on bilirubin concentiation was also found when the 
concentiation of CaCb was fixed at 330 [iM and bilirubin concentiation varied 
between 0 and 72 i^M in the above experiment. A linear increase in percentage 
hemolysis was observed in different mammalian erythrocytes being maximum for 
human erythrocytes, followed by buffalo and sheep erythrocytes and minimum for 
goat erythrocytes (Fig. 27). The values of slope of linear plots were significantly 
different for human, buffalo and sheep erythrocytes (P < 0.01) whereas the slope 
value obtained with goat erythrocytes was insignificant (P > 0.05 ). It appears that 
goat erythrocytes lack the phenomenon of calcium-induced bilirubin-dependent 
hemolysis. These results were similar to those described above when concentration 
of CaCl2 was varied while fixing the bilirubin concentiation. 
The levels of erythrocyte membrane (Ca*'-Mg'')-ATPase were found to be 
different for different erythrocyte membranes. Maximum activities were noticed in 
human erythrocyte membranes, followed by buffalo erythrocyte membranes 
whereas sheep and goat erythrocyte membranes had lowest activities at all the 
ATP concentiations (0.5 - 2.5 mM) used in this study (Fig. 28). Both goat 
and sheep erythrocyte membranes were indistinguishable ( P = 0.3 ) in their 
(Ca*'-Mg'^)-ATPase activities whereas significant differences were foimd in 
human and goat erythrocyte membranes ( P < 0.0001 ). Further, human and 
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Fig 27 Calcium-induced bilirubin-dependent hemolysis in mammalian 
erythrocytes: human (A), buffalo (•), sheep (O) and goat (A). 
Erythrocytes were first incubated for 30 minutes at 37°C with 330 ^M 
CaCls in 50 mM Tns/HCl buffer, pH 7.4 containing 100 mM NaCl 
followed by further incubation with increasing concentrations of 
bilirubin (0 - 72 |iM) for 30 minutes at 3 T^C. Each point is the mean 
± SEM of two independent experiments. 
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Fig. 28. (Ca*^-Mg*~^-ATPase activities in different mammalian erythrocyte 
membranes at different concentrations of ATP: human (O), buffalo 
(•), sheep (A) and goat (A). Each point is the mean ± SEMoffour 
experiments. 
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buffalo erythrocyte membranes were significantly different (P <0.001) from goat 
and sheep erythrocyte membranes in their (Ca''^-Mg^^)-ATPase activities. These 
results were similar to the one reported earlier (Zaidi et al, 1995). Differences in 
the extent of calcium-induced bilirubin-dependent hemolysis observed in human, 
buffalo and sheep erythrocytes can be correlated well with the (Ca"^ '-Mg"^  ^ )-
ATPase activities of their erythrocyte membranes which were found maximum for 
human erythrocyte membranes and minimum for goat erythrocyte membranes 
(Fig. 28). Our results on goat erythrocytes are in accordance with the earlier 
reports on the lack of calcium-dependent processes in goat erythrocytes (Farooqui 
et al., 1987; Khan and Saleemuddin, 1988; Zaidi, et al, 1995). Besides this, lack of 
calcium-induced bilirubin-dependent hemolysis in goat er>1hrocytes may also 
involve several other factors such as phospholipid composition, shape and size etc. 
Large differences in sphingomyelin (Sph) content [i.e., sheep, 51.0%; goat, 45.9%, 
buffalo, 40.9% and human, 24.7% of the total phospholipid content] among these 
erythrocytes (O'Kelly, 1979; Barenholz and Thompson, 1980) may be one factor, 
since sphingomyelin provides stability to erythrocytes under iso-osmotic 
conditions and reduces the membrane permeability to molecules for which no 
transport systems exist (Deuticke, 1977; Taniguchi et al., 1982). Further, the Sph-
PC ratio (these two choline lipids constitute about half of the total phospholipids 
in the membrane) varies greatly in human and ruminant erythrocytes. This ratio 
(Sph/PC) is about 12 in goat and sheep erythrocytes but only 0.64 in human 
erythrocyte membranes (Barenholz and Thompson, 1980) and 4.26 in buffalo 
erythrocytes (O'Kelly, 1979). This high ratio may cause lower membrane fluidity 
in ruminant erythrocytes compared to human erythrocytes (Smith et al., 1981). 
Marked resistance towards calcium-induced bilirubin-dependent hemolysis in 
sheep and buffalo erythrocytes compared to human erythrocytes correlated well 
with the differences in the sphingomyelin content. In addition, calcium-induced 
phase separation as shown previously in PS-PC bilayers (Shimshick and 
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McConnell, 1973; Ohnishi and Ito, 1974; Ito et al, 1975) may also be responsible 
for the differences in the calcium-induced bilirubin-dependent hemolysis among 
these erythrocytes. The PS/PC ratio is very low in human erythrocytes (0.39) 
compared to 3.33 and 5.59 in sheep and goat erythrocytes, respectively (Barenholz 
and Thompson, 1980) and 1.13 in buffalo erythrocytes (O'Kelly, 1979). Further, 
the triangular/ irregular shape of goat erythrocytes compared to the biconcave 
shape found in human, buffalo and sheep erythrocytes (Farooqui et al, 1987) also 
adds to the unusual behavior shown by goat erythrocytes. Moreover, the 
interaction of band 3 proteins with glycoprotein gpl55 as reported in goat 
erythrocytes (Inaba and Maede, 1988) might contribute to the unusual stability of 
goat erythrocytes under various stresses. Thus, lack of (Ca'-Mg*' )-ATPase 
activity, high sphingomyelin content (Barenholz and Thompson, 1980) and 
triangular/ irregular shape (Farooqui et al, 1987) may all contribute to the 
resistance towards calcium-induced bilirubin-dependent hemolysis exhibited by 
goat erythrocytes. 
In view of the calcium-induced bilirubin-dependent hemolysis of human, buffalo 
and sheep erythrocytes, we tested the effect of Mg' on the interaction of bilirubin 
with different erythrocytes as no significant hemolysis was observed when 
erythrocytes were incubated first with MgCl2 followed by further incubation with 
bilirubin. The binding of bilirubin to erythrocytes of different mammalian species, 
preincubated with increasing concentrations (0-3.33 mM) of MgCb at 37°C for 
30 minutes, was studied after incubating the cells (previously washed to remove 
unbound Mg"^ "^  ions) with fixed concentration of bilirubin (72^M). The results are 
shown in Fig. 29, in which percentage increase in erythrocyte-bound bilirubin is 
plotted against MgCl2 concentration. As is evident from the Fig. 29, increase in the 
concentration of MgCl2 led to an increase in the erythrocyte-bound bilirubin. The 
percentage increase in erythrocytes-bound bilirubin was calculated using the 
following equation. 
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Fig. 29. Effect of MgCb on the binding of bilirubin to tfie erythrocytes of 
different mammalian species: human (•), buffalo (A), sheep (A) and 
goat (O). 
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% increase in erythrocyte-bound bilirubin = [(T - C)/ C] x 100 (9) 
where T is the concentration of bilirubin bound to Mg*-treated erythrocytes and C 
is the concentration of bilirubin bound to untreated erythrocytes. 
A comparison of percentage increase in the erythrocyte-bound bilirubin at various 
MgCli concentrations showed that the percentage increase differ markedly among 
different mammalian species (df = 11, 36; F= 6.28; P = 1.16 x 10'^ ). Maximum 
percentage increase in the bound bilirubin was noticed in human erythrocytes, 
followed by buffalo and sheep erythrocytes while goat erythrocytes showed the 
lowest. Human and buffalo erythrocytes showed similar patterns of the percentage 
increase in bound bilirubin while sheep and goat erythrocytes showed a sharp 
percentage increase in bound bilirubin beyond 2.3 and 2.7 mM MgCl2 
respectively. Mg* ^ has been reported to bind to ATP and phosphate of polar head 
groups of phospholipids present in erythrocyte membranes (de Freitas et al, 1994) 
which results in the shielding of negative charge present on phosphate groups of 
these phospholipids. This shielding of negative charge may be responsible for the 
enhancement of bilirubin binding to these (Mg*-treated) erythrocytes. This has 
also been suggested in an earlier study (Sato et al, 1987). Therefore, the highest 
percentage increase in bound bilirubin observed in human erythrocytes compared 
to buffalo, sheep and goat erythrocytes can be attributed to the differential binding 
of Mg^  ^ to these erythrocytes. 
Binding of bilirubin to erythrocyte membranes 
Quantitative analysis of bilirubin binding to erythrocyte membranes using 
various methods: Table IV shows the comparison of various eluting media for 
their ability to release bilirubin from BLEMs with the amoimt of bilirubin 
released after solubilizing BLEMs in 1% (w/v) SDS and measuring the bilirubin 
by Fog's method. It should be noted that the amount of bilirubin released after the 
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Table IV. Estimation of membrane~bound bilirubin after its extraction from 
erythrocyte membranes using various methods 
Eluting Estimated bilirubin * (jxM) Total estimated 
medium in eluate EMB left after elution bilirubin (^ iM) 
1%SDS 41.9±0.9 41.9 + 0.9 
2.5%aJbumin 13.6±0.8 26.9±0.9 40.5 + 0.5 
0.15-0.45MNaCl 0 41.9 ±0.5 41.9 ±0.5 
38mMNa2C03 + 
5mMEDTA, 32.0 ±0.8 10.1 ±0.9 42.3 ± 0.6 
pHll.O 
Fog's reagents 30.1 ± 0.5 12.4 ± 0.4 42.5± 0.2 
land II 
* Bilirubin was estimated by Fog's method (1958). 
Bilirubin concentration in the incubate was 72nM. 
Each value represents a mean of three observations from three independent 
experiments. 
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solubilization of BLEMs with l%(w/v) SDS represented the total amount of EMB. 
As can be seen from Table IV, at a given bilirubin load in the incubate {12)xM), 
the amount of bilirubin released after SDS solubilization of BLEMs was much 
higher than that eluted with the other media. Use of 2.5% (w/v) albumin, pH 7.4 
solution eluted only 34% of total EMB. These results suggest that 2.5% (w/v) 
albumin solution which is reported to elute about 95% of bound bilirubin from 
intact erythrocytes (Bratlid, 1972), cannot be used as a bilirubin eluting medium 
from erythrocyte membranes. In view of the higher amount of bilirubin bound with 
lysed erythrocyte membranes compared to the sealed membranes (Karp et al., 
1985) and dual nature of bilirubin binding to erythrocyte membranes ( i.e. 
bilirubin dianion to polar heads of phospholipids and bilirubin acid binding to 
lipophilic regions of bilayer) (Cestaro et al., 1983), it seems that albumin removes 
that fraction of EMB which is bound to polar heads. This view is also supported 
by the observation that albumin could not remove aggregated bilirubin acid from 
membrane (Vazquez et al., 1988). 
Use of 38 mM sodium carbonate solution containing 5mM EDTA, pH 11.0, a 
commonly used bilirubin solvent, resulted in the elution of about 77.4% of total 
EMB which was much higher than that eluted with albumin. These results were in 
agreement with the previous reports on the pH dependent binding of bilirubin to 
erythrocyte membranes, i.e. decreased binding of bilirubin to erythrocyte 
membranes with the increase in pH of the incubation medium (Sato and 
Kashiwamata, 1983) and reversibility of bilirubin aggregate at high pH (Vazquez 
et al., 1988). Since 24% of total EMB was still remained bound with the 
membranes as measured by SDS treatment, it can be said that increase in pH 
cannot dislodge all the bound bilirubin from erythrocyte membranes. Therefore, 
use of 38 mM sodium carbonate solution containing 5 mM EDTA, pH 11.0 cannot 
be a successful treatment for the estimation of total EMB. 
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Incubation of BLEMs with solutions of different ionic strengths i.e., 0.15- 0.45M 
NaCl, did not release any amount of bilirubin from the membranes as no bilirubin 
was detected in the eluent. These results suggest that the binding forces between 
bilirubin and membranes cannot be weakened by the increase in ionic strength. 
This was in agreement with an earlier observation that binding between bilirubin 
and membranes is hydrophobic (Kirschner-Zilber et al, 1982). 
Incubation of BLEMs with Fog's reagents I and II (containing sulfanilic acid, 
caffeine and sodium benzoate) also resulted in the removal of bound bilirubin in 
the form of azobilirubin. However, the amount of bilirubin estimated from the 
direct reaction of Fog's reagents with BLEMs was found to be 75% of the total 
EMB. The variation in either the incubation time of Fog's reagents I and II with 
BLEMs from 10 to 120 minutes (Table V) or addition of Fog's reagent III directly 
into the reaction mixture did not result in any significant change in the amount of 
bilirubin estimated. In all the above treatments, the fraction of EMB left 
unattacked by eluting medium was released by SDS treatment and the total sum 
of the amount of bilirubin released by various eluting media and SDS treatment 
was found to be within the range of bilirubin directly estimated after SDS 
solubilization of BLEMs (see Table IV). These results strongly suggest that the 
estimation of total EMB by Fog's method is most reliable when the estimation is 
carried out directly after solubilization of BLEMs with 1% (w/v) SDS. 
In yet another experiment, erythrocyte membranes were incubated with increasing 
concentrations of bilirubin (16.7 - 200nM) and the amount of EMB was estimated 
either by direct reaction of Fog's reagents with BLEMs or with Fog's reaction after 
SDS solubilization of the BLEMs. As can be seen from Fig. 30, in both the cases, 
the amount of EMB estimated increased with the increase in the concentration of 
bilirubin in the incubate. However, within the range of bilirubin concentration 
used in this study, the amount of EMB estimated by direct Fog's reaction with 
intact BLEMs was always less than that of bilirubin estimated by the same method 
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Table V. Effect of time on the direct Fog's reaction with BLEMs in the 
determination of membrane-bound bilirubin 
Time* Estimated EMB** 
(minutes) (pM) 
10 31 2 ±0.8 
30 32.0±0 0 
60 32 4 ± 0 4 
90 33,6±0 0 
120 34 0 ± 0 4 
* Time of incubation of BLEMs with Fog's reagents I and II. 
** Each value represents a mean of two observations from two different 
experiments. 
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Bilirubin in incubate (^M) 
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Fig. 30, Comparison of the amount of EMB estimated by direct Fog's reaction 
with BLEMs (•) and after 1% (w/v) SDS solubilization of BLEMs (O). 
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after the solubilization of BLEMs with l%(w/v) SDS. From these results, there 
seems to be a competition between EMB and sulfate binding proteins and lipids of 
membranes for diazotized sulfanilic acid as diazotized sulfanilic acid is also 
known to bind membrane sulfate binding proteins and lipids (Berg, 1969). Further, 
sodium benzoate and caffeine (accelerators in Fog's reaction) with a known 
potential of displacing bilirubin from bilirubin-albumin complex (Bessard et al, 
1983; Franzini and Cattozzo, 1987), were found to be ineffective in dissociating 
bilirubin from bilirubin-membrane complex. This may account for the difference 
in the estimated bilirubin by two different methods. In addition to the above, 
ineffectiveness of diazotized sulfanihc acid to enter into the bilayer membranes 
(Berg, 1969) might prevent the reaction of diazotized sulfanilic acid with some of 
the bound bilirubin which was reported to be hydrophobically inserted within the 
membrane bilayer (Cestaro et al, 1983). On the other hand, the solubilization of 
BLEMs with SDS favored the estimation of total EMB as all the EMB was 
available for diazotized sulfanilic acid to react. From these results, it appears that 
SDS solubilization of membranes and estimation of EMB by Fog's method can be 
applied successfully in the study of bilirubin binding to erythrocyte membranes. 
Interaction of bilirubin with erythrocyte membranes of different mammalian 
species: Interaction of bilirubin with erythrocyte membranes was studied by 
incubating 1.0 ml of membranes (equivalent to 1.0 ml erythrocyte suspension of 
50% hematocrit value) with increasing concentrations of bilirubin (8.5 - 68.3 fxM) 
and the results are shown in Fig. 31. As can be seen from the figure, in all 
mammalian erythrocyte membranes, the concentration of membrane-bound 
bilirubin increased with the increase in bilirubin concentration in the incubate. A 
comparison of membrane-bound bilirubin among different mammalian species, 
shows that they differ in their bilirubin binding behavior. Maximum binding was 
observed in human erythrocyte membranes, followed by sheep and buffalo 
erythrocyte membranes and lowest binding was seen in goat erythrocyte 
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17.5 35.0 52.5 
BUimbin in incubate ((xM) 
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Fig. 31. Interaction of bilirubin with erythrocyte membranes of different 
mammali (1 species: human ( • ) , sheep (A), buffalo (A) and goat (O). 
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membranes. Human erythrocyte membranes bound significantly higher amount of 
bilirubin (P> 0.001) compared to other mammalian erythrocyte membranes. 
Significant difference in the membrane-bound bilirubin was noticed between sheep 
and buffalo erythroc>1:e membranes (P = 0.01) whereas buffalo and goat 
erythrocyte membranes were marginally different but significant (P = 0.03). 
Neither the amount of membrane proteins nor membrane total phospholipids 
correlated well with the membrane-bound bilirubin (Table VI). For example, both 
human and goat erythrocyte membranes had similar amount of protein but human 
erythrocyte membranes bound more bilirubin than goat erythrocyte membranes. 
Similarly, goat and sheep erythrocyte membranes had similar content of total 
phospholipid, but sheep erythrocyte membranes bound more bilirubin than goat 
erythrocyte membranes. Further, no correlation was found between membrane-
bound bilirubin and total membrane carbohydrate content (Table VI). Lack of any 
correlation between membrane-bound bilirubin and membrane proteins/ 
carbohydrate among erythrocyte membranes of different mammalian species, as 
found in this study, was in agreement with the previous report (Sato and 
Kashiwamata, 1983) which suggests that bilirubin binding sites on membranes are 
not composed of proteins. Although Sato et al. (1987) ruled out the possibility of 
the involvement of polar head groups of phospholipids in bilirubin binding to the 
membranes as suggested earlier by Nagaoka and Cowger (1978) and Brodersen 
(1979), the suggestion of the presence of bilirubin binding sites on both the outer 
and inner surface and iimer part of the membrane (Sato et al, 1987) is not very 
clear in terms of their nature. In order to clarify the role of membrane 
phospholipids in bilirubin binding, the results of membrane-bound bilirubin were 
transformed into membrane-bound bilirubin {\xM)l gm phospholipid and plotted 
against total amount of bilirubin in the incubate. These are shown in Fig. 32. As is 
evident from the figure, the amount of membrane-bound bilirubin varied in various 
erythrocyte membranes even when the amount of phospholipid was same. The 
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Table VI. Chemical composition of erythrocyte membranes of different 
mammahan species (equivalent to 1.0 ml of 50% hematocrit value) 
Species Protein Total Organic* Phospholipid Carbohydrate 
phosphorus phosphorus 
(mg) (pi)(^ig) ( i^g) (mg) (^ ig) 
Human 3.82± 0.32 119.6 ± 14.9 53.2± 1.2 1.33 ± 0.03 242.8 ± 10.7 
Buffalo 3.38±0.17 97.0 ± 8.8 50.4 ±1.6 1.26 ± 0.04 242.0 ± 4.5 
Sheep 3.46±0.09 86.2 ± 9.4 48.0 ±1.2 1.20 ± 0.03 274.8 ± 2.8 
Goat 3.70±0.14 102.9 ±11.5 47.4 ± 2.0 1.18 ±0.05 320.9 ± 8.8 
Each value represent the mean ± S.D. of ten observations with five separate 
membrane preparations. 
* Pi determined in chloroform extracted phospholipids. 
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17.5 35.0 52^ 
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Fig. 32. Interaction of bilirubin with erythrocyte membranes of different 
mammalian species having same phospholipid content: human (•), 
sheep (A), buffalo (A) and goat (O). 
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pattern of bilirubin binding to membranes was similar to the one obtained without 
the transformation of data (Fig. 31). However, using the reported data on 
membrane phospholipid composition of human, buffalo, sheep and goat 
erythrocyte membranes (de Gier and van Deenen, 1961; O'Kelly, 1979 and 
Barenholz and Thompson, 1980), a strong positive correlation (r = 0.98; P> 
0.0001) between the membrane-bound bilirubin and the sum of choline 
phospholipids (PC + Sph) was found. It means that the differences in the 
membrane-bound bilirubin among different mammalian species, as observed in 
this study, were probably due to the differences in their choline phospholipid 
content which was reported to be highest in human ~60.4%, followed by 55.3% in 
sheep, 50.5% in buffalo and 49.4% in goat, of the total phospholipids ( Barenholz 
and Thompson, 1980; O' Kelly, 1979). The calculated value of membrane-bound 
bilirubin/ gm choline phospholipid (using data from Table VI and reported 
percentage content of choline phospholipids) was found to be 47± 0.9 i^M in 
erythrocyte membranes of all four mammalian species when the concentration of 
bilirubin in the incubate was 68.3 f4,M. 
A comparison of the amount of bilirubin bound to erythrocytes with that of bound 
to equivalent membranes at 68.3|aM bilirubin concentration in the incubate under 
similar conditions, showed that membranes bound much higher bilirubin than 
intact erythrocytes. However, the percentage increase in the amount of bilirubin 
bound to membranes from that bound to erythrocytes was found to be different for 
different mammalian species. The percentage increase was 53.8%, 33.0%, 14.6% 
and 10.3 % in human, sheep, buffalo and goat erythrocyte membranes 
respectively. Thus, it appears that large number of bilirubin binding sites were 
present in membranes compared to intact erythrocytes. Similar results have also 
been reported earlier (Karp et al, 1985) describing that the lysed erythrocyte ghost 
bind higher amount of bilirubin than intact (sealed) erythrocyte ghost. They 
suggested tiiat some of the bilirubin binding sites may also be present on the irmer 
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layer of membranes. Since all of the Sph and most of the PC are reported to be 
present on the outer lipid layer of the membranes (Colley et al, 1973; Verkliij et 
al, 1973; Zwaal et al, 1973; 1975; Barenholz and Thompson, 1980) and if 
choline phospholipids are supposed to be the sites for bilirubin binding, the 
bilirubin binding to erythrocytes should be in the following order : human > sheep 
> buffalo > goat. In the isolated membranes, same order was found. However, the 
observed order of the amount of bilirubin boimd to these erythrocytes i.e., goat > 
buffalo > himian > sheep, suggests that the binding of bilirubin to these 
erythrocytes and their membranes was different. Since bilirubin utilizes both the 
surfaces (iimer as well as outer) in the erythrocyte membranes for its binding 
(Karp et al, 1985) as compared to the involvement of outer surface only for 
bilirubin binding in case of erythrocytes, more binding of bilirubin to erythrocyte 
membranes compared to intact erythrocytes is understandable. Variation in the 
lipid distribution in both the surfaces of erythrocyte membranes may be 
responsible for the unequal binding of bilirubin to these erythrocytes and it has 
been shown in an earlier study (Sato et al, 1985) that the iimer surface of 
erythrocyte membrane binds about one-third of the bilirubin bound to the outer 
surface. Taking this into consideration, the amount of bilirubin bound to 
erythrocyte membranes should not be twice of that amount bound to intact 
erythrocytes. Our results on the binding of bilirubin to erythrocytes as well as 
erythrocyte membranes were in accordance with the earlier findings (Karp et al, 
1985; Sato et al, 1987). Moreover, lipid distribution also varies in both the outer 
and inner layers of the membrane from species to species (Zwaal et al 1975; 
Barenholz and Thompson, 1980; Boegheim et al, 1983; Kuypers et al, 1985) 
which may account for the differences in bilirubin binding patterns of erythrocytes 
and erythrocyte membranes observed with four species. 
Effect of metal ions on the binding of bilirubin to erythrocyte membranes: The 
effect of metal ions on the binding of bilirubin to human erythrocyte membranes 
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was studied after incubating the membranes [previously loaded with varying 
concentrations (0 -3.2 mM) of different metal ions as described in experimental 
section] with a fixed concentration of bilirubin (72^iM) for 30 minutes and 
measuring the bound bilirubin by modified Fog's method (1958). The results are 
shown in Fig. 33. Membrane-bound bilirubin increased with the increase in metal 
ion concentration in case of all the four metal ions (Ca'\ Sr'*, Mg'* and Ba*') 
used in this study. The increase was, however, found to be highest with Ca*' 
followed by Sr*', Mg'* and lowest with Ba'* (Fig. 33 A). Further, Ca"-loaded 
membranes showed a marked increase in the bound bilirubin up to 1.2 mM beyond 
which it sloped off On the other hand, binding increased continuously in S r ' , 
Mg ' and Ba* -loaded membranes on increasing the metal ion concentration up to 
3.2 mM. Differential effects of these metal ions on bilirubin binding to human 
erythrocyte membrane can be clearly seen from Fig. 33 B in which the percentage 
increase in the membrane-bound bilirubin from that of control is plotted against 
metal ion concentration. A comparison of the percentage increase in membrane-
bound bilirubin observed with different metal ions shows that at 1.2 mM metal salt 
concentration, the percentage increase in membrane-bound bilirubin was 53.3%, 
18.0%, 9.5% and 4.8% in Ca", Sr \ Mg*' and Ba'' loaded erythrocyte 
membranes respectively. In other words, concentration of metal salts required to 
achieve a defmite increase in the membrane-bound bilirubin (e.g. 27%) was found 
to be different for different metal salts being 3.2 mM, 2.4 mM, 1.6 mM and 0.4 
mM for BaCl2, MgCla, SrCl2 and CaCla respectively. Increased binding of 
bilirubin to erythrocyte membranes in the presence of metal ions can be viewed as 
the shielding effect of metal ions on the negatively charged lipid bilayer 
(Rubalcava et ai, 1969; Sato et al, 1987; Vazquez et al, 1988). However, strength 
of this effect varied from ion to ion being maximum for Ca"^, followed by Sr* * and 
Mg^' and minimum for B a ' . In addition to this shielding effect, metal ions may 
also cause redistribution of phospholipids in the membrane which may be 
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responsible for the increased bilirubin binding to the membranes (Bevers et al, 
1995). The effect has been reported to be maximum with Ca^ * compared to Sr"^ ', 
Mg' * and Ba*' in an earlier study (Ito et al, 1975; Allan and Thomas, 1981). Our 
results were in agreement with the earlier reports (Ito et al., 1975; Allan and 
Thomas, 1981) since maximimi increase was noticed in Ca'*-loaded erythrocyte 
membranes. 
Calciimi ion, being most effective, among all the four metal ions used, in 
increasing bilirubin binding to erythrocyte membranes, its effect on the bilirubin 
binding to erythrocyte membranes of different mammalian species was also 
investigated. Erythrocyte membranes of different mammalian species (previously 
incubated with fixed concentrations of CaCh i.e., 0.5 mM, 1.0 mM and 1.5 mM 
for 30 minutes) were again incubated with increasing concentrations of bilirubin 
(8.5-68.3 |j.M) for 30 minutes and the membrane-bound bilirubin was determined 
as described in the experimental section. The results are shown in Fig 34. As is 
clear from Fig. 34 A, B and C, at all the three CaCla concentrations, membrane-
bound bilirubin increased with the increase in bilirubin concentration in the 
incubate in all the mammalian species studied. However, a different pattern of 
bilirubin binding was observed in Ca* -treated membranes compared to the 
untreated (control) membranes. The order of bilirubin binding in Ca -treated 
membranes was : human > goat > buffalo > sheep against human > sheep > buffalo 
> goat observed with untreated membranes. Further, Ca'-treated goat erythrocyte 
membranes showed anomaly in bilirubin binding behavior. Binding was higher 
than buffalo and sheep erythrocyte membranes at lower concentrations of bilirubin 
which decreased and became lower than buffalo and sheep erythrocyte membranes 
at higher bilirubin concentrations. Higher bilirubin binding to goat erythrocyte 
membranes compared to sheep and buffalo erythrocyte membranes can be 
explained on the basis of high PS content present in goat erythrocyte membranes. 
In view of the known calcium-induced aggregation of PS in model membranes 
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(Ohnishi and Ito, 1974) which make the surface more hydrophobic, it is 
understandable that more bilirubin binds to these surfaces. A comparison of the 
amount of bilirubin bound to Ca'-treated erythrocyte membranes of different 
species with that bound to untreated membranes, suggests that in all the four 
species, treated membranes bound more bilirubin than untreated membranes. This 
increase in the amount of bilirubin bound to these membranes was found to be 
dependent on both Ca* * and bilirubin concentrations. This is shown in Fig 35A, B 
and C. The difference in the amount of bound bilirubin in the presence of Ca'' 
was more in human erythrocyte membranes followed by goat, buffalo and sheep 
erythrocyte membranes. The plot between the difference in membrane-bound 
bilirubin and bilirubin concentration at different fixed Ca*^ * concentrations showed 
a downward curvature in goat erythrocyte membranes which became more 
pronounced at higher Ca" concentrations. Further, at this Ca' * concentration (i.e. 
1.5 mM), human erythrocyte membranes also showed a similar behavior. This was 
probably due to saturable binding of Ca" in goat and human erythrocyte 
membranes. As Ca* * is known to bind a large number of membrane components 
such as acidic phospholipids, spectrin, actin. sialic acid (Moore et al, 1984), PC 
and Sph (Shah and Schulman, 1967), the analysis of bilirubin binding data to 
Ca*'-treated erythrocyte membranes of different mammaUan species was a highly 
difficult task. No correlation between the amount of bilirubin bound to Ca -
treated membranes and the total membrane phospholipid content was found. These 
results may be due to differential shielding of negative charges of different 
mammalian erythrocyte membranes by calcium. 
Interaction of bilirubin with phospholipase C (from C. welchii)-treated 
erythrocyte membranes: The treatment of erythrocyte membranes of different 
mammalian species with phospholipase C for different time periods (i.e. 10, 20 
and 30 minutes) resulted in the release of membrane phosphorus. The amount of 
phosphorus released, increased with the increasing time of enzyme treatment in 
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all the mammalian species. It was highest in human erythroc)^e membranes 
followed by buffalo and sheep erythrocyte membranes and lowest in goat 
erythrocyte membranes (Table VII). Based on the total membrane phosphorus 
content, calculation of the percentage amount of the phosphorus released from 
these membranes after phospholipase C digestion suggests that nearly similar 
percentage amount of the phosphorus released from human, buffalo and sheep 
erythrocyte membranes. This was 35.0%, 54.0% and 63.0% of the total membrane 
phosphorus, after 10 minutes, 20 minutes and 30 minutes treatment respectively, 
of these membranes with phospholipase C (Table VII). However, percentage 
amount of phosphorus released from goat erythrocyte membranes was low (20.1%, 
40.2% and 47.4%) as compared to other species. 
Binding of bilirubin to phospholipase C-treated erythrocyte membranes was 
studied by incubating the treated membranes with increasing concentrations of 
bilirubin (8.5- 68.3 jxM). As can be seen from Fig. 36A, B and C, the membrane-
bound bilirubin increased with the increase in bilirubin concenfration in all the 
four species. However, they differed quantitatively in the amount of membrane-
bound bilirubin at any bilirubin concentration. The order of bilirubin binding to 
these enzyme-freated membranes was : human > buffalo > sheep > goat. Further, 
time of phospholipase C treatment of these membranes also affected the bilirubin 
binding to these membranes. Erythrocyte membranes treated with phospholipase C 
for a longer time period (30 minutes) bound more bilirubin compared to the one 
treated with phospholipase C for a shorter time period (10 minutes). This is more 
clearly shown in Fig. 36A, B and C. As phospholipase C-treated membranes 
bound more bilirubin than unfreated one, the difference in bound bilirubin between 
treated and untreated membranes was plotted against bilirubin concenfration in the 
incubate and the results are shown in Fig. 3 7A, B and C. The pattern of bilirubin 
binding was nearly same as human erythrocyte membranes bound the highest 
amount of bilirubin whereas goat erythrocyte membranes bound the lowest amount 
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Table VII. Effect of phospholipase C (C welchii) treatment on the 
erythrocyte membranes of different mammahan species 
Species Total Membrane phosphorus (Pi) removed after enzyme 
membrane . treatment for 
phosphorus 10 minutes 20 mimites 30 minutes 
(Pi) Amount (%) Amount (%) Amount (%) 
^ (M§) O^ g) (pg) 
Human 119.6± 14.9 42.8± 1.5 35.8 63.4 + 4.6 53.0 74.5 ± 5.7 62.3 
Buffalo 97.0± 8.8 30.8 ± 1.7 31.6 54.8± 2.7 56.5 61.9 ± 4.1 63.8 
Sheep 86.2 ± 9.4 30.1 ±4.2 34.9 45.7± 4.8 53.0 55.4 ±3.1 64.3 
Goat 102.9 ±11.5 20.7 ± 2.6 20.1 41.4± 3.3 40.2 48.8 ±4.1 47.4 
Each value represents the means + S.D. of eight observations. 
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at all the bilirubin concentrations used. The amount of bilirubin bound to buffalo 
and sheep erythrocyte membranes was in between human and goat erythrocyte 
membranes. Since phospholipase C from C. welchii removes membrane 
phosphorus predominantly from PC, PE and Sph, bilirubin binding data were also 
subjected to statistical analysis to find out the correlation between the composition 
of membrane phospholipids and change in bilirubin binding to enzyme-treated 
membranes. A positive correlation ( r = 0.95) was found between the membrane-
bound bilirubin and sum of PC, PE and Sph content which was highest in human 
erythrocyte membranes (1.13 mg) followed by buffalo (1.08 mg) and sheep (0.97 
mg) erythrocyte membranes and lowest in goat (0.91 mg) erythrocyte membranes. 
These results suggest that removal of polar head groups from PC, PE and Sph 
greatly enhanced the bilirubin binding to the membranes. In other words, the 
exposure of non-polai fatty acid diacylglycerols and sphingosine was responsible 
for increased binding of bilirubin to these membranes. This was in accordance 
with an earlier observation (Sato et al., 1987) suggesting that removal of polar head 
groups from PC, PE and PS of human erythrocyte membranes by phospholipase C 
from B. cereus greatly potentiate a large amount of non-specific binding of 
bilirubin to the non-polar fatty acid moiety of diacylglycerols. 
Interaction of bilirubin with trypsin-treated erythrocyte membranes: 
Erythrocyte membranes of different mammalian species when treated with trypsin 
for different time periods (i.e., one hour, two hours and three hours) resulted in 
the loss of membrane proteins and glycopeptides. This was in agreement with the 
previous results of Sato and Kashiwamata (1983) who reported a 65% loss of 
protein content upon trypsin treatment. The amount of released carbohydrate [as 
measured by Orcinol method (Svennerholm, 1956)] increased with the increase in 
time of incubation of enzyme with the membranes, in all the mammalian species. 
Based on the total membrane carbohydrate content, calculation of the percentage 
of carbohydrate content released from these membranes after trypsin treatment 
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suggests that a similar percentage of carbohydrate content was released from the 
erythrocyte membranes of all mammalian species (Table VIII). 
Binding of bilirubin to trypsin-treated erythrocyte membranes was studied by 
incubating the treated membranes with increasing concentrations of bilirubin (8.5-
68.3 \xM). It can be seen from Fig. 38 that the amount of membrane-bound 
bilirubin increased with the increase in bilirubin concentration in all the four 
species. However, they were significantly different from each other in terms of 
membrane-bound bilirubin at higher bilirubin concentrations. The order of these 
membranes with respect to the amount of membrane-bound bilirubin was : human 
> sheep > buffalo > goat. No correlation was found between the amount of 
membrane-bound bilirubin and the amount of carbohydrate released from these 
membranes. Further, treatment of erythrocyte membranes with trypsin for a longer 
time period (i.e., 2 hours and 3 hours) did not result in any substantial increase in 
the amount of membrane-bound bilirubin inspite of the increase in the amount of 
released carbohydrate (see Table VIII). From these results it appears that trypsin 
treatment of the membranes for 1 hour resulted in the disclosure of a large number 
of low affinity sites for bilirubin causing saturation in bilirubin binding and any 
fijrther release of carbohydrate from the membranes did not improve bilirubin 
binding. From the results on the increased binding of bilirubin to erythrocyte 
membranes upon removal of carbohydrate from membrane surface, it can be 
concluded that bilirubin binding sites are not composed of carbohydrate. The 
increase in bilirubin binding to trypsin-treated erythrocyte membranes (as 
observed in this study)(Fig. 39) appears to be due to the degradation of membrane 
proteins by trypsin. It seems justifiable in view of the previous report (Steck et al, 
1971) which suggests extensive degradation of membrane proteins upon trypsin 
treatment. As most of the membrane proteins such as Band III, Na*-K^-ATPase are 
reported to be strongly associated with phospholipids especially with PC, Sph and 
PS (Rodgers and Giaser, 1993), it seems that the degradation of these proteins by 
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Table VIII. Effect of trypsin treatment on the erythrocyte membranes of 
different mammahan species 
Species Total Membrane carbohydrate released after enzyme 
Carbohydrate treatment for 
1 hour 2 horn's 3 hours 
Amount (%) Amount (%) Amount (%) 
(l^ g) (^g) (^g) (l^ g) 
Human 242.8±10.7 113.6111.2 46.9 153.5+8.8 63.2 177.2+ 7.1 73.0 
Buffalo 242.0+4.5 86.5± 2.4 35.7 117.6± 5.0 48.6 161.1±11.8 66.6 
Sheep 274.8± 2.8 117.1± 6.4 42.6 147.1± 2.1 53.5 179.0± 3.7 65.1 
Goat 320.9± 8.8 130.5+7.8 40.7 146.4±4.1 45.6 190.9± 2.6 59.5 
Each value represents the means ± S.D. of eight observations. 
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17.5 35.0 52.5 
Bilirubin in incubate (}iM) 
70.0 
Fig. 38. Interaction of bilirubin with erythrocyte membranes of different 
mammalian species, namely, human (•), buffalo (A), sheep (A) and 
goat (O), treated with trypsin for one hour. 
35.0 52.5 
Bilirubin in incubate (joM) 
Fig. 39. Plot of difference in the amount of bilirubin bound to trypsin-treated 
and untreated erythrocyte membranes of different mammalian species, 
human ( • ), buffalo (A), sheep (A) and goat (O). 
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trypsin may release phosphates from the phospholipids associated with these 
proteins, thereby increasing bilirubin binding to the membranes. Zwaal et al. 
(1975) reported that trypsin treatment of human erythrocyte membranes caused 
extensive degradation of PC along with proteins. Sato and Kashiwamata (1983) 
also suggested the possibility of such phenomena in trypsin-treated membranes. 
The highest extent of bilirubin binding to human erythrocyte membranes compared 
to other species may be due to either differential degradation of membrane 
proteins due to differential location of trypsin cleavable sites (Murayama et al, 
1982) or due to differential protection of protein hydrolysis by trypsin in view of 
the reported protection of membrane jwoteins from extensive hydrolysis provided 
by phospholipids (Yeagle, 1984). The second phenomenon seems to be more 
important as membrane proteins show a higher specificity to particular 
phospholipids (Kramer et a/., 1972) and differential mode of protein-phospholipid 
interaction (Rodgers and Giaser, 1993) which may be responsible for differential 
protection of membrane proteins from trypsin (Yeagle, 1984). 
Interaction of bilirubin with neuraminidase-treated erythrocyte membranes: 
Erythrocyte membranes of different mammalian species were treated with 0.5 
units of neuramiiudase for one hour and the amount of sialic acid released was 
measured by the method of Warren (1959). Sialic acid depleted erythrocyte 
membranes were then incubated with fixed concentration of bilirubin (61.5 i^M) 
and the amount of membrane-bound bilirubin was detemuned. The results are 
shown in Table IX. As can be seen from the table, neuramiiudase treatment 
resulted in the loss of sialic acid. The amount of sialic acid removed from these 
membranes was higher in human erythrocyte membranes followed by buffalo 
erythrocyte membranes whereas sheep and goat erythrocyte membranes showed 
similar loss. A comparison of the amount of membrane-bound bilirubin showed 
that the pattern of bilirubin binding was similar in both untreated as well as freated 
erythrocyte membranes i.e., human > sheep > buffalo > goat. However, the 
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amount of membrane-bound bilirubin was higher (~ 14%) in treated than 
untreated erythrocyte membranes in all mammalian species. A slight increase in 
bilirubin binding to neuraminidase-treated membranes can be ascribed to the loss 
of negatively charged sialic acid residues which otherwise may repel negatively 
charged bilirubin monoanions. These results were in accordance with the earlier 
observation (Sato et ai, 1987) who also showed that neuraminidase treatment did 
not cause significant change in bilirubin binding to membranes. 
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CONCLUSION 
Taken together, these results suggested that goat erythrocytes bound the highest 
amount of bilirubin followed by buffalo and human while sheep erythrocytes 
boimd the lowest amount. On the other hand, studies with the isolated membranes 
suggested that human erythrocyte membranes bound the highest amount of 
bilirubin whereas buffalo, sheep and goat erythrocyte membranes showed different 
mode of bilirubin binding under different conditions (trypsin, phospholipase C, 
neuraminidase and calcium treatments). The order of bilirubin binding to 
uimiodified as well as neuraminidase-treated erythrocyte membranes was : human 
> sheep > buffalo > goat whereas the order was : human > buffalo > sheep > goat 
in phospholipase C and trypsin treated erythrocyte membranes. The calcium 
loaded erythrocyte membranes, however, showed the following order: himian > 
goat > buffalo > sheep. The results of these studies further suggested that both the 
surfaces (inner and outer) of erythrocyte membranes bound bilirubin. The mmiber 
of bilirubin binding sites on both the surfaces were different in different 
erythrocyte membranes. Total number of bilirubin binding sites present on the 
outer and inner surface in unmodified erythrocyte membranes was in the following 
order : human > sheep > buffalo > goat whereas the number of bilirubin binding 
sites on the outer surface of erythrocytes alone appeared to be in the following 
order : goat > buffalo > human > sheep. This study also revealed that membrane 
phospholipids were directly involved in the interaction of bilirubin with the 
membranes. However, membrane proteins played a significant regulatory fimction 
on the binding as degradation of membrane proteins by trypsin exposed a large 
number of bilirubin binding sites. The negatively charged phosphate moiety of 
phospholipids of the membranes appeared to inhibit a large amount of bilirubin 
binding to the membranes as the shielding of negative charges by metal ions or 
removal of negatively charged phosphate groups of phospholipids by 
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phospholipase C greatly enhanced the binding. However, the carbohydrate 
moieties of erythrocyte membranes played a little role in the bilirubin binding 
phenomenon as no correlation was found between the amount of carbohydrate 
released and the increase in the level of bilirubin binding in trypsinized 
erythrocyte membranes. On the other hand, neuraminidase-treated erythrocyte 
membranes showed little increase in the amount of bilirubin binding which may be 
ascribed to the removal of negatively charged sialic acid residues from the 
membrane surface. 
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Binding of bilirubin.to erythrocytes from different 
mammalian species 
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TIK binding of bilirubin to erythrocytes of several mammalian species, Le. hinun, buffalo, goat and 
ihccy was studied, la aB cases, curves beti^een bilirubin desorbed IhMB erythrocytes and bilinMi 
is the incubate folkmed Michaelian saturation kinetics. The diasociatioa constants of the 
bOirubin-rcceptor complex and saturable binduig sites were calculated using double reciprocal plots. 
Goat erythrocytes had dw highest dissociation^ constant (265.7 ^mol/l) and highest saturatioB 
(125.9/I M), whereas sheep erythrocytes had the lowest dissociation constant (I15.6;imol/l) and 
lowest Mturation (623 ^M). Buffalo and human erythrocytes bound bilirubin in a similar fashion, and 
the values of hiteraction parameters were midvvay between those obtained with goat and slMcp 
crytkrocytes. IKfferenccs in die affinity and number of saturable binding sites can be attributed to Ae 
differeat make-up of the erytluocyte membranes of these spedes. 
Key words: Bilirubin; Erythrocytes; Dissociation constant; Saturable binding sites; Mammalian 
spedes. 
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Introduction 
Bihnibin. the end product of hacm catabolism. 
is produced by reticulo-endothelial cells of the 
liver, spleen and bone marrow, and its depo-
sition in the brain during the neonatal period 
causes bilirubin encephalopathy (Odell et al., 
19^). Numerous toxic effects of bilirubin on 
ctthilar functions,, particularly inhibition of sev-
era! membranr bound enzymes, have been re-
ported (Karp, 1979). Erythrocytes also bind 
Hlinibin. and this binding is affected if there is 
a reduction in the capacit> of albumin to bind 
bihrubiii (BratUd, 1972a). Enhanced uptake of 
bilirubin by cryihrocytes has been show-n at low 
plasma pH (Bratlid, 1972b). Because of this, 
bihrubiii uptake by erythrocytes has also been 
used zi a criterion for the risk of bilirubin 
enoephzlopathy (Kaufmann et al., 1967; Bratlid, 
19"2a.b; Malik t/ al., 1986). Several studies ha\c 
been performed to unravel the mechanism of 
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bilirubin entry from pUisma to cells uang 
erythrocytes as a model (Sato and 
Kashiwamata, 1983; Sato et al., 1987). Tljerc is 
no clear evidence about ihr nature of the mem-
brane receptor for bilirubin. Participation of 
membrane proteins as receptors had been ex-
cluded in an earlier stud>. but it v>as sugges:ed 
that membrane proteins may function as an 
effective barrier to the bindmg of bilirubin (Saio 
and Kashiwamata, I983>. Further, it was pro-
posed thai the ncgati\e!\ charged phospbonc 
moiety of phospholipids on the membrane scr-
face may prevent a large amount of bilirubin 
from binding to the membrane (Sato et al.. 
1987). Since the membrane make-up of er>thro-
cytes varies from speaes to species (Lenard. 
1970; Barenholz and Thompson, 1980), we have 
studied the binding of bchrubin to the erythro-
cytes from different specits 
Materials and Methods 
Materials 
Bilirubin, caflfeinc anhydrous, sulpharjjc 
acid, sodium nitrite and sodiuiTA benzoaic »r:c 
507 
SOX S Tdw-ib 1-xi M K Ml 
Tahic 1 Intcr.Klion paramclcrs of bilirubin with enlhro 
i.vtc< of diiTcrenI species 
Bilirubin in the incubaiion mixture. )iM 
Fig. I Binding orbilirubin by several mammalian er>thro-
cytes. 1 e goat (A—A), buffalo (A—A), human (C—C) 
and sheep ( • — # ) 
obtained from S.D. Fine Chemicals. India 
Serum albumins were isolated from the plasma 
of different species, i.e. goat, human, buffalo 
and sheep by the method cf Tayyab and Qasim 
(1990). 
Methods 
Protein concentration was determmed b> the 
method of Lov.r\ et al n951), using bo\ine 
serum albumin as the standard. 
Stock bilirubin solution was prepared b> dis-
solving a few crystals of bilirubin in a known 
volume of 38 mM Na.CO- containing 5 mM 
EDTA (pH 11.0). The solution was stored m the 
A. 
I 10 
10 
()/(bilinibiB] t l O ' t i M ' 
Species 
Human 
Buffalo 
Goat 
Sheep 
Saluraluin 
f<M 
76 9 
B3 3 
125 9 
62.5 
Dis^oaaiu^n 
consiani 
(fimol II 
ISfKi 
155 H 
265-' 
115 6 
Fig ; Double 'fcipriKal plot ^e-ieer inverse ol ^:ei>.'ifv: 
bilirubin con>.enlration and ' r . t -se .^ f bilirubin , ' - ^e r 
iraiion m the incubate icr -..irjn erMhtoc\ie-
dark and used within 1 hr. Bilirubin concen-
tration was determined according to the method 
developed b> Fog (1958). 
Erythroc>tes were collected after ccntnfu-
gation (2000 rpm for 20 min) of the blood ob-
tained from the blood bank/slaughter house and 
washed three times with 0.07 M sodium phos-
phate buffer containing 0.08 M sodium chloride 
(pH 7.4). ErNihrocytes were re-suspended in an 
equal volume of the same buffer to obtain a 
haematocrit value of 50%. 
Bilirubin binding to erythrocytes 
The binding of bilirubin to erythroc>ie5 was 
studied by incubating 1.0 ml erythrocyte suspen-
sion in an equal volume of bilirubin solution 
(45-880/JM) and making up the final volume tc 
6.0 ml with 0.07 M sodium phosphate buflei 
containing 0.08 M sodium chloride (pH 7.#7 
After incubation for 30 min at 37''C, tbie incu-
bation medium was centrifuged at 2(KX) rpm for 
20 min, and the supernatant discarded. The cells 
were washed three times with 5 ml of buffer The 
last supernatant was free from bihrubin dS 
determined b> the method of Fog (1958) Biliru-
bin bound bv erythrocytes was elute<l with 2 ml 
of 3% solution of serum albumin aftsr incubat-
ing for 20 min at 37"C with intermittent shak-
ing. All bilirubin binding experiments were 
performed under yellow light. 
Results and Discussion 
Binding of bilirubin by erythrocytes m ab-
sence of serum albumin was studied after incu-
bating the cells with increasing concentrations 
of bilirubin. After washing the cells three times 
to remove the unbound bilirubin, the bilirubin 
bound to erythrocytes was desorbed with 3'''o 
serum albumin solution. Results on desorbed 
bilirubin from different erythrocytes and the 
bilirubin in the incubate arc shown in Fig. 1 In 
all cases, curves correspond to a Michaeiian 
saturation. These are similar to that obtained 
earlier using human erythrocstes (Ha>er t'f al. 
1990). From the figure, it appears that differen: 
mammalian ervthrocvtcs have differen: satu-
ration capaaties In order to determ ne the 
saturation and dissociation conslant> o: I'ne 
hiUrubtn-reccpior complex, the data fron Fig 1 
Biiiruhr r\lhrtH.>Ii i r i i ' j v ' r MN 
were transrormcii into double reciprcKjl plixs 
For simplicity, the cur\e between the in\ersc of 
the desorbed bihrubin per htre of erythrocytes 
versus the inverse of the bihrubin concentration 
in the incubate for human erythrocytes is show n 
in Fig. 2. The straight line was drav^n by the 
method of least squares Values of the slope and 
inlcrccpt were used for the calculation of the 
dissoaation constant of the bilirubin-reccptor 
complex and saturation. These arc listed in 
Table 1 In the case of human erythrocytes, 
saturation corresponded to a binding of 
76.9//mol bilirubin per 1000 ml erythrocytes. 
The dissociation constant of bilirubin-receptor 
complex was found to be 150 x 10"'moll ' 
This value was 0.9 times less than the one 
reported earlier (Haycr et al., 1990) A 
comparison of dissociation constants of the 
bilirubin-rcceptor complex (150 x 10"' mol 1 ') 
with that of the bilirubin-HSA complex 
(1.5 X 10" * mol 1"') for the primary binding sue 
(Brodersen. 1979) suggests that the binding of 
unconjugated bilirubin to erythrocytes, even for 
high bihrubinemia (150/^mol. 1"'). is extremely 
weak. 
A comparative study of dissociation con-
stants obtained with various erythrocytes 
suggests that goat erythrocytes have the highest 
dissoaation constant, whereas sheep ery»hio-
cytes have the lowest. BafTalo erythrocytes bind 
bilirubin with a dissociation constant similar to 
human erythrocytes. Similarly, saturable bmd-
ing on the erythrocyte membranes was maxi-
mum with goat erythrocytes, whereas sheep 
erythrocytes bound the lowest amount of biliru-
bin 
From these results, it appears that the number 
of saturable bilirubin binding sites on goat 
erythrocytes is the highest of all specie* studieJ, 
whereas the number of sites on sheep erythro-
cytes IS the lowest. Human and buffalo erythro-
cytes ha\e the same number of binding sites, 
and were in between that of goat and sheep 
erythrocytes In contrast, the affinity of these 
sites was highest m sheep erythrocytes and 
lowest in goat erythrocytes Human and buffalo 
erythrocytes have similar affinities which were 
between the two Since the membrane make-up 
of proteins (Lcnard, 1970) and lipids (Barenholz 
and Thompson. 1980) is different in these 
erythrocytes, this might account for the differ-
ence> in the affinity, as well as for the differences 
in the number of saturable binding sites on ihe>e 
crythnxytes These results suggest that the 
biliruMn receptors on the membrane of different 
erythrocytes differ not only in the number 
of receptors, but also in their receptor affin-
ities These differences in affinity may be due to 
the different structures of these receptors. 
Studies are in progress to charactenze these 
rccepiori 
Aikn',<> (ligfmtnii —Facililies provided by Aligsrh Mustiin 
Univcrs w arc gralcfull) acknowledged M K Ah is a 
Junior Research Fellow of Unner i^t> Grants Commission, 
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Binding of Bilirubin to Mammalian Erythrocytes 
Saad Tayyab and Mohammad K. Ali 
INTERDISCIPLINARY BIOTECHNOLOGY UNIT, AUCARH MUSLIM UNIVERSITY, ALICARH-202002, U .P . INDIA 
ABSTRACT. Binding o( bilirubin to erythrocytes of various mammalian species in the presence of their respec-
tive plasma albumins was studied at pH 8.0, ionic strength 0.41 and at 37°C. In human, buffalo, goat, and sheep, 
the amount of erythrocyte-bound bilirubin increased with the increase in both the bilirubin/albumin molar ratio 
(B/A) and the total bilirubin concentration. In all species, the binding patterns were qualitatively similar. How-
ever, at any given B/A, goat erythrocytes bound the highest amount of bilirubin, followed by buffalo and human 
erythrocytes; sheep erythrocytes bound the lowest amount of bilirubin. Increase .in erythrocyte-bound bilirubin 
per unit increase in bilirubin concentration at a constant B/A as obtained from the values of the slope of the 
plot between erythrocyte-bound bilirubin and total bilirubin in the Incubate, was found to be highest for goat 
erythriKytes, followed by buffalo, human, and sheep erythrocytes. At a given bilirubin concentration, percentage 
fractional binding of bilirubin between any two B/As was found to be highest between 1.5 and 2.0, suggesting 
that a greater amount of bilirubin was transferred from plasma to cells between B/As 1.5 and 2.0. Percentage 
fractional binding of bilirubin was highest in goat erythrocytes, followed by buffalo, human, and sheep erythro-
cytes. These differences in the amount of erythrocyte-bound bilirubin were not due to the effect of various plasma 
albumins. These results suggest that the difference in bilirubin binding by different mammalian erythrocytes can 
be attributed to the difference in either the affinity of the erythrocyte receptors or their number or both. COMP 
BiocHEM PHYSIOL 118B;1.97-103, 1997- © 1997 Elsevier Science Inc. 
KEY WORDS, bilirubin, buffalo, en'thriKytes, goat, human, mammalian species, plasma albumin, sheep 
INTRODUCTION 
Binding of bilirubin to erythrocytes was first reported by 
Watson (19). This interaction is of importance not only 
because it acts as a marker for bilirubin hindint; to various 
other ceil types during jaundice (9), but also it helps in un-
derstanding the mechanism of bilirubin entry into cells 
(16). Several groups studied the binding of bilirubin to 
erythrocytes and erythrtKyte ghosts in greater detail ( 2 -
4,6,8-10,14-16), but there is no clear report on the nature 
of membrane receptors for bilirubin. Although participation 
of membrane proteins as receptors has been excluded in an 
earlier study, it is suggested that proteins may function as 
an effective barrier to the binding of bilirubin (16). Further, 
it is possible that negatively charged phosphate groups of 
phospholipid prevent the binding of bilirubin to the mem-
brane (15). Since the membrane make-up of erythrcKytes 
varies between species (1,12), it seems likely that the biliru-
bin-binding properties will differ for different mammalian 
erythrocytes. Therefore, we studied the binding of bilirubin 
to erythrocytes from four mammals—human (Homo sapi-
Address roprini requc'SK to: Sand Tayvah, Interdisciplinary RioH.chnolot;y 
Unit. Aliyarh Mu.slim Univcrsitv, AliKarh-202002, U.P. India. Tel, 0091-
57\-4017lS; Fax 0091-571-401C81. 
Rfcci\cj 6 Fchruary 1996; rcviM'd 1 \ Fohni.irv 1997; accfP'^'J -6 Firhru-
ary 1997. 
ens), goat {Cepra fuVctts), buffalo (Bos indicus), and sheep 
(Ovis aries)—in the presence of their respective plasma al-
bumins. The aim of this study was to analyze the use of 
bilirubin-erythrocyte intetaction as a model for bilirubin 
binding to other cell types. This paper describes the biliru-
bin binding behavior of different mammalian erythrocytes 
at pH 8.0, ionic strength 0.41, and at 37°C under different 
experimental conditions. 
MATERIALS A N D METHODS 
Materials 
Bilirubin, caffeine anhydrous, sulphanilic acid, sixJium ni-
trite, and sodium benzoate were purchased from s.d. Fine 
Chemicals, Bombay, India. Other reagents used were of ana-
lytical grade. 
Human bloixi in 1.32% sodium citrate and 1.47% dex-
trose was supplied by the Blood Bank of J. N. Medical Col-
lege, AMU, Aligarh. T h e bloixJ of buffalo, goat, and sheep 
was collected from the slaughterhouse in 1.32% stxiium ci-
trate at the time of slaughtering, therefore, no clotting took 
place. 
Methods 
Plasma albumins were isolated by the method of Tayyab and 
Qasim (18). 
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Erythrocytes were collected after centrifiigation of the 
bUxxl at 2000 rpm for 20 min and washed three times after 
removing the upper buffy coat with 0.07 M sodium phos-
phate buffer, pH 7.4, containing 0.08 M NaCl (Buffer A). 
Red cells were suspended in an equal volume of the same 
buffer to achieve a 50% hemat(Krit value. 
The concentration of albumin was determined by the 
methixl of Lowry et cd. (13) using bovine serum albumin as 
the standard. 
Bilirubin solution was prepared by dissolving a few ciys-
ftls of bilirubin in the desired volume of 38 mM sodium 
carbonate solution containing 5 mM EDTA, pH 11.0. The 
solution was protected from light to avoid photodegradation 
and experiments with bilirubin were performed in yellow 
liftht. The concentration of bilirubin was determined by 
Fog's method (7). Bilirubin solution was prepared fresh 3nd 
used within 1 hr. 
Erythrocyte'Bilirubin Binding Assay 
Binding of bilirubin to erythrocytes was studied at pH 8.0, 
ionic strength 0.41, and at 37°C according to the methtxl 
of Bratlid (3). To 1.0 ml of albumin solution in buffer A, 
1.0 ml of bilirubin solution was added and the volume was 
increased to 5.0 ml with buffer A. Then 1.0 ml of erythro-
cyte suspension of 50% hematocrit value was added and the 
tubes were incubated for 30 min at 37°C after gentle shak-
ing. After incubation, they were centrifuged at 2000 rpm 
V)r 20 min and the supernatant was removed by gentle de-
cantation. The erythrocytes were washed three times w ith 
buffer A so that the last supernatant was devoid of yellow 
color. Tlie last supernatant was carefully removed by aspira-
tion and 2.5 ml of 25% albumin solution was added to these 
tubes. The erythrocyte-bound bilirubin was eluted by incu-
bation for 30 min at 37°C after shaking the tubes gently. 
The tubes were centrifuged at 2000 rpm for 20 min and 
the supernatant was carefully removed by aspiration. Biliru-
bin concentration in the eluate was determined as above 
(7). 
Bilirubin-binding experiments were.performed at differ-
ent B/As obtained by varying the albumin concentration 
in the range of (a) 14-84 //M, (b) 28-165 //M, and (c) 42- ' 
250 ^M, while keeping the bilirubin concentration con-
stant; i.e., (a) 41.8 /yM, (b) 83.7 fM, and (c) 125.5 pM, 
respectively. In another set of experiments, the bilirubin 
concentration was varied from (a) 6.5 to 38.8 fiM (b) 13.8 
to 78.3 //M and (c) 20.0 to 116.7 //M, while the albumin 
concentration was kept constant; i.e., (a) 13.2 /yM, (b) 26.3 
//M, and (c) 39.5 /iM, respectively to obtain different 
B/As. In another set of experiments, both the bilirubin 
and albumin concentrations were varied to obtain a con-
>itant B/A. 
Percentage difference in fractional binding of bilirubin 
to er\throcYtes was calculated using the following equation: 
% difference in fractional bilirubin binding 
_ ( E - B ) : - (E-B), 
% 
X 100 (1) 
where (E —B): and (E-B)i are the erythnxyte-bound 
bilirubin at higher and lower B/As, respectively and X is 
the concentration of bilirubin in the incubate ranging from 
52.5-125.5//M. 
The relative percentage difference in the bilirubin bound 
to erythrcxytes of one species with respect to bilirubin 
bound to er>'throcytes of other species was calculated using 
the following equation: 
Relative % difference in bound bilirubin 
( E - B ) , X 100 (2) 
where (E—B), is the concentration of bilirubin bound to 
erythrocytes of one species and (E—B), is the concentration 
of bilirubin bound to erythrocytes of other species. 
Statistical analysis of the data included calculations of 
Pearst^n's Prtxiuct moment correlation coefficients and dis-
persion. Correlation coefficients and difference of means 
were tested for significance using two-tailed t tests. Regres-
sion equations were also subjected to analysis of variance 
(ANOVA). 
RESULTS AND DISCUSSION 
Binding of Bilirubin to Erythrocytes 
AT DIFFERENT B/AS^ (KEEPING THE BILIRUBIN CONCEN-
TRATION CONSTANT-^HILE VARYING THE ALBUMIN CON-
CENTRATION). Increase in the B/As from 0.5 to 3.0 led to 
an increase in the erythrocyte-bound bilirubin (Fig. 1). This 
increase was smaller upto a B/A of 1:1 but became more 
significant (P < 0.0001) at high B/As. Nearly 4-fold in-
crease (P < 0.0001) in erythrocyte-bound bilirubin was no-
ticed on increasing the B/A from 1.0 to 2.0 in case of human 
erythrocytes. At the three fixed bilirubin concentrations, 
i.e., 41.8 //M, 83.7 fiM, and 125.5 //M (Fig. 1 A, B, and 
C), the patterns of bilirubin binding to human erythrocytes 
were qualitatively similar. However, the amount of erythro-
cyte-bound bilirubin at any B/A in the range of 0.5 to 3.0 
was different it different fixed concentrations of bilirubin, 
being positively correlated with bilirubin concentration. 
Bilirubin-binding pattern obtained with human erythro-
cytes compared well with earlier reports (3,9,10). However, 
the amount of bound bilirubin was found to be smaller as 
compared to the earlier finding (3). This difference can be 
attributed to the pH effect, as decrease in pH leads to an 
increase in bilirubin binding to human erythrocytes due to 
increase in cellular affinity of bilirubin (4,16). This is be-
cause in an earlier study, binding was studied at pH 7.4, 
whereas in our experiments, pH was kept at 8.0 due to 
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FIG. 1. Binding of bilirubin to the erythrocytes of goat (•) , 
J^  buffalo (©), human (O), and sheep (O) at different bilirubin/ 
albumin molar ratios. Bilirubin concentration was kept con* 
stant at (A) 41.8 //M, (B) 83.7 iM, and (C) 125.5 //M whUe 
albumin concentration varied. 
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FIG. 2. Binding of bilirubin to the erythrocytes of goat (•) , 
buffalo (O), human (a),and sheep (O) at different bilirubin/ 
albumin molar ratios. Albumin concentration was kept con-
stant at 39.5 /iM, while bilirubin concentration varied. 
higher solubility of bilirubin at this pH, as compared to pH 
7.4 (5). 
A comparison of bilirubin binding to erythrocytes ob-
tained from different species suggests significant variation 
in the amount of bilirubin bound to erythrocytes at all B/ 
As. At a given B/A, goat erythrocytes bound the maximum 
amount of bilirubin while sheep erythrocytes bound the 
lowest amount. The amounts of bilirubin bound by buffalo 
and human erythrocytes were in between the values ob-
tained with goat and sheep erythrocytes; they were higher 
for buffalo erythrocytes as compared to human erythrocytes. 
AT DIFFERENT B/AS (KEEPING THE ALBUMIN CONCENTRA-
TION CONSTANT WHILE VARYING THE BILIRUBIN CONCEN-
TRATION). The bilirubin-binding profiles obtained with 
different erythrocytes at different B/As using fixed albumin 
concentration (39.5 //M) and different bilirubin concentra-
tions are shown in Fig. 2. These patterns were qualitatively 
similar to those obtained at different B/As when bilirubin 
concentration was kept constant and albumin concentra-
tion varied. Increase in B/A caused an increase in erythro-
cyte-bound bilirubin. The amount of bilirubin bound to 
erythrocytes at a given B/A was found to be the same in 
both the experiments using either constant bilirubin con-
centration or constant albumin concentration while vary-
ing the other, provided the bilirubin concentration is iden-
tical in both. 
AT CONSTANT B/A WHILE VARYING BOTH THE BILIRUBIN 
AND ALBUMIN CONCENTRATIONS. At a given Constant 
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FIG. 3. Binding of bilirubin to erythrocytes of goat (•) , buffalo (O), human (O), and sheep (O) at constant bilirubin/albumin 
molar ratio. Both bilirubin and albumin concentrations were varied to obtain a constant bilirubin/albumin molar ratio of (A) 
1.5, (B) 2.0, (C) 2.5, and (D) 3.0. 
B/A, the binding of bilirubin to different erythrocytes in-
creased linearly with increase in bilirubin concentration as 
shown in Fig. 3 A-D. This finding was consistant with the 
earlier finding on human erythrocytes (9). However, the 
value of slope of the linear plots at any given B/A was found 
to be different for different erythrocytes, goat erythrocytes 
were highest, followed by buffalo and human erythrocytes, 
and sheep erythrocytes were lowest. Further, with all the 
species, increased binding was observed at higher B/As. 
Values of the slope obtained from these plots, when plotted 
against B/A, showed an initial rapid increase in all cases, 
which then became constant at higher B/As i.e., 2.5 and 
3.0 (Fig. 4). In other words, increase in erythrocyte-bound 
bilirubin per unit increase in bilirubin concentration was 
found to be dependent upon B/A up to a value of 2.5 and 
then became independent above B/A 2.5, as the value was 
nearly constant at B/As 2.5 and 3.0. It seems likely that the 
free bilirubin concentration in the bilirubin incubate at 
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FIG 4 Plots of the slope (taken from Figs 3 (A-DD versus 
bilirubin/albumin molar ratio. Various mammalian species 
were goal ( • ) , buffalo (O), human (O), and sheep <0). 
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FIG 5 Hi<!togram representing the percentage fractional 
binding of bilirubin to erythrocytes of various mamtnalian 
species, i.e., goat ( • ) ; buffalo (K) , human (Bll) and sheep (D) 
at different bilirubin/albumin molar ratios. The bilirubin/ 
albumin molar ratios were from (a) 1.0-1.5, (b) 1.5-2.0, 
(c\ 2.0-2.5, and (d) 2.5-3.0. 
different B/As IS not increa'^inp to the same extent, which can 
account for the variation in the values of the slope obtained 
From Figs 3 and 4, it is clear that receptors for bilirubin differ 
in different erythrocytes either in their affinity or number or 
in both In addition, binding afhnities of different albumins 
for bilirubin may also be different, which can account for the 
difference in bilirubin binding These results were similar to 
the rine obtained earlier on the binding of bilirubin to various 
erythrocytes in the absence of albumin (17) 
Fractional Binding of Bilirubin to Erythrocytes 
The values of percentage difference in fractional bilirubin 
binding were calculated using Equation (1) as described m 
Materials and Methods and plotted against the range of B/ 
A as shown in Fig 5 The percentage difference in fractional 
bilirubin binding to human erythrocytes was found highest 
between B/As of I 5 and 2 0 (P < 0 001), whereas at o ther 
B/As, the values were smaller (P < 0 01) and nearly equal 
to each other This was also found true for other species A 
comparison of percentage difference in fractional bilirubin 
binding at B/As of 1 5-2 0 shows that goat erythrocytes 
have the highest percentage difference, reaching 16 6 ± 
2 4, followed by buffalo (13 4 ± 19) and human erythro-
cytes (12 3 ± 3 0) , whereas sheep erythrocytes have lowest 
percentage difference as 11 4 ± 0 7 Analysis of these results 
based on two-tailed t test reveals that goat ery throcy tes have 
statistically significant higher values of percentage differ-
ence in fractional binding than sheep (P = 0 0001) , buffalo 
(P = 0 01) , as well as human erythrocytes (P = 0 07) Sig-
nificant differences have also been found between sheep and 
buffalo erythrocytes (P = 0 COl) However, h u m a n erythro-
cytes do not differ statistically with both sheep (P = 0 47) 
and buffalo erythrocytes (P = 0 40) These data suggest that 
a greater amount of bilirubin is transferred from plasma to 
cells m case of goat erythrocytes, followed b^ buffalo, 
human, and sheep erythrocytes This transfer seems to be 
TABLE 1. Comparison of elation behavior of bilirubin 
bound to human erythrocytes by different concentrat ions 
of different plasma albumins, namely, human, goat, buffalo, 
and sheep plasma albumins 
Concentration of 
plasma albumin 
used for elution 
(mg/ml) 
10 
50 
100 
150 
20 0 
250 
300 
Concentration of erythrocyte-
bound bilirubin (//M) eluted by 
HPA 
24 0 
57 6 
75 2 
80 0 
88 0 
94 4 
96 0 
BuPA 
20 8 
52 8 
76 8 
816 
912 
86 0 
96 0 
GPA SPA 
25 6 27 2 
60 8 60 8 
76 8 75 2 
80 0 78 4 
89 6 912 
94 4 94 4 
94 4 94 4 
HPA = human phima albumin BuPA = buffalo pla^m.i albumin, GPA 
= g,oat plasma altwAmm, SPA = dxecp plasma albumm 
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FIG. 6 Plot of the ratio of bilirubin bound to human erythro-
cytes in presence (v) as well as in absence (v„) of albumin 
against the bilirubin/albumin molar ratio. 
more pronounced at B/As of 1 5-2 0 At B/A of 3^1 5, the 
free bilirubin concentration available for cellular binding is 
comparable to that obtained during neonatal jaundice (11) 
Relative Percentage Dijiferertce 
in Bound BiUrubin by Erythrocytes 
At all 8 /As > 1 . 0 , the relative percentage difference m 
er>'throcyte-bound bilirubin between any two species, calcu-
lated by using Equation (2) as described m Materials and 
Methods, was found to be similar (df = 12, 39, F = 0 77; 
P = 0 68) Values of relative percentage difference in the 
bilirubin bound to goat erythrocytes with respect to buffalo, 
human, and sheep erythrocytes were found to be 18 8 ± 3.4 
(P = 00S5), 3 1 8 ± 2 7 (P = 0 0 0 8 ) and 44 9 ± 5 2 (P = 
0 0007), respectively Thu>, binding of bihrubin \va<; maxi-
mum with goat erythrocytes and minimum with sheep 
erythrocytes 
Ejjcti of Plasma Albumin 
on the Binding of Bilirubin to Erythrocytes 
T h e difference in relative percentage difference >n the bili-
rubin bound to goat er> thrix:ytes with respect to buffalo, 
human, and sheep erythrocytes was not due to the differ-
ence in the affinities of the respective plasma albumins for 
bilirubin as the elution of er> throcyte-bound bilirubin with 
the appropriate plasma albumins gave the same amount of 
bilirubin from human erythrocytes (see Table 1) Further, 
In all four species, the binding of bilirubin to erythrocytes 
was not detected m the presence of their respective albu-
mins at a B/A of 0 5 (see Fig 6 and Table 2), in which the 
ratio of the erythrtKyte-Kiund bilirubin in the presence of 
albumin ( \ ) to erythrocyte-Kiund bilirubin m the absence 
of albumin (v ) was plotted against B/A EXie to the absence 
of binding of bilirubin to erythrocytes at B/A of 0 5 in all 
species, we can reasonabl> claim that the difference in bili-
rubin bound to erythrocytes is due to the difference m the 
affinities of receptors or their number or bo th Thus, binding 
seems to be dependent upon the amount of available free 
unconjugated bilirubin Albumin does not compete with 
binding of bilirubin to er>throc>tes but lowers the amount 
of free unconjugated bilirubin available to erythrocytes 
From these results it can be seen that erythrocytes of 
several mammalian specie"; differ significantly in their 
bilirubin-binding characteristics Al though such studies are 
useful m characterizing the bilirubin receptors on these 
membranes, bilirubin-er>throcyte interaction cannot be 
used as a model to study the interaction of bilirubin toother 
cell types, especially neonatal brain cells 
Facilities provided by Ahgarh Muslim Una erstty are gratefully acknowl-
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TABLE 2. Effect of plasma albumin on the erythrocyte-bound bilirubin 
System 
(erythrocytcs/albumin) m M.R.* ANOVA 
Human 
Buffalo 
Goat 
Sheep 
( d / = 3,8. F = 0 04, P = 099) 
0 22 
0 23 
0 28 
021 
- 0 12 
- 0 12 
- 0 16 
- O i l 
0 53 
0 53 
0 58 
0 53 
{df = 1,23, F = 465 67. P = 9 2 X 10 ") 
(df = 1 23, F = 440 65, P = 1 7 X 10 "•) 
(d/= 1,23, F = 566 47, P = 1 1 X 10 ") 
(d/= 1,23, F = 392 32. P = 6 0 X 10'") 
Values of slope (m) and intercepi (c) were taken from the followmg equation, v/x,. = m X Biliruhin/alliumm molar ratio (M R ) + c where \ is the 
enthroc>tc K'unJ bihrubm >n presence of albumm and vo is the erythrocyte-bound bilirubin in absence of albumin 
•MR intercept on X-axis 
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Abstract 
Huinan erythrocytes, preincubated with dilTcrcnt concentrations of calcium chloride (0.17-1.67 mM) showed hemolysis 
after addition of bilirubin (72 ptM). Hemolysis was observed only when cells were incubated first with calcium followed by 
bilirubin and not vice versa. This hemolysis was found to be dependent upon several factors such as concentration of 
bilirubin, time of incubation of erythrocytes with calcium and time of incubation of bilirubin with the calcium-loaded 
erythrocytes. Inclusion of EDTA in the incubation medium reduced the percentage hemolysis to a significant extent. 
Involvement of activated oxygen species in hemolytic process seems to be unlikely as inclusion ol sodium azide and 
catalase did not prevent hemolysis. A comparison of other bivalent cations such as Ba"*, Mg"*. Mn"' and Cu"* with 
Ca'* for their ability to hemolyse cells in presence of bilirubin shows that Ba"* and Mg"* are ineffective, whereas both 
Mn'"^ and Cu"* induce hemolysis both in the absence as well as in the presence of bilirubin. However, their mechanism of 
hemolysis is different from that of calcium-induced hemolysis. Formation of calcium-induced hydrophobic aggregates of 
phospholipid molecules in erythrocyte membrane may open the new binding sites for bilirubin on these membranes which 
may perturb the membrane conformation. 
Keywords- Huinan erythrocyte; Bilirubin; Calcium; Hemolysis 
1. Introduction 
Calcium is known to play impoilanl role in many 
cellular functiotis. The ability of calcium to aggregate 
phospholipids of membranes, especially those con-
taining high phosphatidylserine (PS) and phospha-
tidic acid (PA) is well documented [1-3]. These 
phospholipids respond characteristically to calcium 
and are aggregated by calcium through intramolec-
ular chelation. This calcium-induced aggregation re-
duces the lateral diffusion of lipid molecules and 
retards the motion of alkyl chains which leads to the 
reduction in the transverse movement of molecules 
Concspondinj: auihnr Fax: 4 91 .S7I4()I()«I 
and ions across the aggregates [3]. Further, activities 
of proteins associated with lipid especially with PS is 
also affected. This type of effect has also been re-
ported with Ba^*, Sr'^* and Mg^"^ but its magnitude 
is smaller than that of calcium [3]. The aggregation is 
reported to be dependent upon the percentage PS 
content of biomembranes. Further, calcium also 
changes the shape and size of erythrocytes which is 
species-dependent. For example, human erythrocytes 
are more prone to calcium and are transformed into 
echinocytes. whereas goat erythrocytes do not [4]. in 
addition, calcium also affects various uptake pro-
ce.s.ses. Increased bilirubin binding has been reported 
by human erythrocyte ghosts in the presence of I 
mM CaCI, [.S], In (he picscnce of hiliiubin (mono or 
(XK)5-27.-<6/97/$l7.(X)Cop)right © 1997 Elsevier .Science B.V. All rights reserved. 
Pit 50005-2736(97)00020-5 
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diiinion). the calcium-induced phospholipid aggrega-
tion might be effected. In this report wc present our 
data on the calcium-induced changes in human ery-
throcytes in the presence of bilirubin. 
2. Materials and methods 
Bilirubin, cafleine anhydrous, sulphanilic acid, 
sodium bcn/oatc. .sodium nitrite, .sodium a/ide and 
cupric chloride were purchased from SD's Fine 
Chemicals, India. Calcium chloride, magnesium chlo-
ride, barium chloride and manganous chloride were 
obtained from Qualigens Fine Chemicals, India. Cata-
iase was purchased from Sigma Chemical Company, 
USA. Other reagents were of analytical grade. Hu-
man blood was obtained from the Blood Bank of J.N. 
Medical College, Aligarh Muslim University, Ali-
garh. 
Erythrocytes were isolated by centrifugation of 
collected blood at 1000 Xj? for 20 min. The cells 
were then washed three times with 50 mM Tris-HCl 
buffer (pH 7.4) containing KM) mM NaCI, alter re-
moving the butfy coat by centrifugation at tOOO X g 
for 20 min. The final packed cell volume uas diluted 
with the same buffer in a ratio of 1:1 to get 50% 
hematocrit value of human erythrocytes. 
Bilirubin solution was prepared by dissolving few 
crystals of bilirubin in 38 mM sodium carbonate 
solution containing 0.15 M NaCl (pH 11.0) (adjusted 
with 0.1 N HCI). The concentration of bilirubin 
solution was determined by Fog's method [6]. The 
bilirubin solution was protected from light and used 
within 30 min. All the experiments weie carried out 
under yellow light. 
The solutions of calcium chloride, baiium chlo-
ride, magnesium chloride, cupric chloride and 
manganous chloride were prepared in 50 mM Tris-
HCl buffer (pH 7.4) containing 100 mM NaCl. 
The concentration of Ca'^ * was measured by 
O.C.P.C. method, using calcium measurement kit 
(Code No. 25952) supplied by Span Diagnostics Ltd., 
India. 
The procedure of incubation was followed as de-
scribed by Bratlid [7], except that instead of 0.5 ml, 
I.O ml of bilirubin solution was taken. The incubation 
was carried out in 50 mM Tris-HCl bufler (pH 7.4) 
containing 100 mM NaCl at 37°C and the final 
volume of the incubation mixture was 6.0 ml. The 
final hematocrit value of human erythrtK'ytes was 
8.3% and the final pH and ionic strength of the 
incubation medium was 8.1 and 0.17 respectively. 
Although the calculated solubility of bilirubin at pH 
8.1 is less (about 91 nM) [8], the aggregation of 
bilirubin is checked with the hydrophobic inclusion 
of bilirubin into membranes which seems to be much 
higher at pH 8.0 [9]. In all experiments, the cells 
were incubated first with various salt solutions, i.e., 
calcium chloride, barium chloride, magnesium chlo-
ride, manganous chloride and cupric chloride of de-
sired concentration for 30 min at 37°C and then a 
constant amount of bilirubin (72 /xM) (otherwise 
stated) was added. The percentage hemolysis was 
calculated by the following formula: 
O.D., 
Percentage hemolysis = X 100 
where O.D., is the O.D. at 540 nm of hemolysate of 
human erythrocytes with distilled water in 6.0 ml 
(8.3% hematocrit value) alter 1 h of incubation and 
O.D.I is the O.D. at 540 nm of bivalent ion-induced 
hemolysate in presence or absence of bilirubin in 6.0 
ml (8.3% hematocrit value) after 1 h of incubation. 
3. Results and discussion 
Human erythrocytes when incubated with different 
concentrations of calcium chloride (CaClj) (0.17-
1.67 mM) for 30 min were found to be hemolysed in 
presence of bilirubin (72 ^M) as shown in Fig. la. A 
marked increase in percentage hemolysis (58.3%) 
was found at 0.17 mM CaCl, concentration, beyond 
which it sloped off. The induction of such hemolysis 
by CaCU in the pre.sence of bilirubin seems to be a 
conditional requirement as no hemolysis was ob-
served when the erythrocytes were incubated with 
either CaCl, or bilirubin alone, even at a higher 
concentration (i.e., 3.0 mM CaCK; 125.5 /xM biliru-
bin) (data not shown). As can clearly be seen from 
Fig. lb. when CaCl, (0.17-1.67 mM) and bilirubin 
(72 fxM) were simultaneously added to human ery-
throcytes, only 14% hemolysis was observed at 1.67 
mM CaCU concentration, compared to 62.5% when 
erythrocytes were incubated first with 1.67 mM CaClj 
I2(. M A Al, S lii\ \(,h / HUH hum, ,i ft Hwph\ \ii a At Id I.U(> (IW7) 124- IM) 
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Fig I Effect of cnlctum on human eryttirotyles in llie presence 
of bilirubin (a) Erythrocytes first incubated vMth different con-
teniMlions of CaC'l, (0 17-1 67 inM) for 0^ mm al MX fol-
lowed by luilher iiKubalion with bilirubin (72 ^iM) for 0^ mm at 
'17°C (b) Erythrocytes incubated with different conccntiations of 
CaClj (() 17-1 67 niM) and bilirubin (72 /nM) at the same time 
for I h at ''7°C (c) Erythrocytes first incubated with bilirubin (72 
fiM) lor 10 mm at 17°C followed by further incubation with 
dillcrcnt concentrations of CaCI, (f) 17 I 67 niM) lor '^ 0 mm al 
"M (• (d) I rythrocytcs first incubated with hiliiiiliiii (72 /iM) lor 
•^ 0 nun at ^^7 C then washed the unbound biliruhm lollowed by 
further incubation with different concentrations of CaCU (0 17-
1 67 mM) tor "^O min at 37'=C 
tor 30 inin, followed by addition of bilirubin (72 
/xM) Moreover, incubation of erythrocytes with 
bilirubin (72 /xM) for 30 min at 37°C followed by 
the addition of 1.67 mM CaCl, led to only 11% 
hemolysis (Fig. Ic) Similarly, incubation of erythro-
cytes with bilirubin (72 /xM) for 30 min at 37°C, 
washing with 50 mM Tris-HCI buffer (pH 7.4) con-
taining 1(H) mM NaCI to remove unbound bilirubin 
followed by the addition of CaCI, showed only 8% 
hemolysis (Fig Id). Taking the percentage hemolysis 
values (5%) in the control samples without CaCl,, 
this hemolysis (Fig. Ib-d) seems insignificant. These 
results strongly suggest the pre-requirement of CaCI, 
to interact first with the erythrocytes followed by the 
interaction of bilirubin with (he calcium-bound ery-
throcytes for the induction of hemolysis. Incubation 
of erythrocytes with calcium alone (0.33-2 0 mM) 
for 30 min led to a decrease in calcium level in the 
supernatant (see Fig. 2a). This suggests that calcium 
binds to erythrocyte membranes. The addition of 
bilirubin to this system released some calcium from 
these membranes as calcium level in the supernatant 
increased in the presence of bilirubin (Fig. 2b). How-
ever, the increase in the calcium level in the super-
natant was significantly higher when cells were incu-
bated first with bilirubin (72 ^M) for 30 min fol-
lowed by the addition of CaClj (0.33-2.0 mM) for 
30 min (Fig. 2c) compared to when the order was 
reversed (Fig. 2b). It seems that some of the calcium 
binding sites on crythrcKytcs arc masked by bilirubin. 
The inability of hilirubin-bound erythrocytes to un-
dergo hemolysis in the presence of Ca^" ,^ unlike the 
calcium-bound erythrocytes in the presence of biliru-
bin, further supports this theory. This contention is 
also supported by the fact that bilirubin has a high 
association constant for phosphatidylcholine (PC) [10] 
and its binding to PC prevents the phase separation of 
PS-PC bilayer membranes into a solid phase of PS 
aggregates bridged by Ca"* chelation [1-3]. 
Calcium-induced hemolysis of erythrocytes in the 
presence of bilirubin was found to be dependent upon 
the concentration of bilirubin. This can be clearly 
seen from lig 3. Increase in bilirubin concentration 
U l.t I.S 
Cikhini \m hKvbair (mM) 
!.• 
Fig 2 Plot showing the calcium levels in the supernatant after 
incubatuin with human erythrocytes (a) ErythnM.ylcs incutiatcd 
with dillerent concentrations of CaCI, (0 7>^-l 0 mM) for 30 mm 
at 37°C (b) Erythrocytes first incubated with different concentra-
tions ot CaCU (0 33-2 0 mM) for 30 mm at 37°C followed by 
furthet incubation with bilirubin (72 /nM) for 30 mm at 37°C. (c) 
Erythrocytes first incubated with bilirubin (72 fiM) for 30 mm at 
37°C followed by lurther incubation with different concentrations 
of C J C U (0 33-2 0 inM) lor W mm at 37T 
M K Ah. S T<>\\ah/Hi,» luwU<i el Hiopln \i< <i A( W Ii26 (IW7) 124-130 127 
Bilirubin In incubate ( MM ) 
Fig. 3. Biliiubin dependence of culcium-induced hemolysis of 
humun crylhrocyies, Eryihrocylcs firsl incubated uilli C'aCI, (1.0 
mM) for 30 min al 37°C followed by further incubation with 
diflercnt concentrations of bilirubin (lO-KK) /AM) lor .30 min al 
37°C. 
IS M 4S 
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Fig. 5. EtI'ect of lime after the addition of bilirubin on the 
calcium-induced bilirubin-dependent hemolysis of human 
erythrocytes. Erythrocytes first incubated with CaCK (2.0 mM) 
lor 30 min at 37°C, followed by further incubation with bilirubin 
(72 ixM) at 37°C for varying time periods (0-75 min). (0-0) 
shows the el feci of incubation lime ol human erythrcKyies with 
CaClj (2.0 mM) on the hemolysis in the absence of bilirubin. 
up to 100 fiM after preincubation of erythrocytes 
with 1.0 mM CaCl2 for 30 min at 37°C led to a linear 
increase in pcrccntajic hcmoly.sis. 
Hemolysis ol erythrocytes induced by calcium in 
the presence of bilirubin was found to be dependent 
upon time of incubation with calcium. As can be seen 
from Fig. 4, the incubation of cells with calcium (I 
inM) for different time periods followed by further 
incubation with bilirubin (72 /xM) for 30 min yielded 
a different percentage hemolysis which became con-
stant after 20 min. These results suggest that the 
Ttint(intn) 
Fig. 4. Effect of incubation time on the calcium-induced biliru-
bin-dependent hemolysis of human erythrocytes. Erythrocytes 
first incubated with CaCI, (1.0 niM) lor dilferem time periods 
(0-30 min) at 37°C followed by further incubation with bilirubin 
(72 ^M) for,,30 min at 37°C. 
interaction of calcium with human erythrocytes 
reached saturation within 20 min. 
I'uilhcmtotc. the pcrccntat!C hemolysis was also 
lound to be dependent upon the time of incubation of 
bilirubin with the calcium-loaded erythrocytes, as 
shown in Fig. 5. The percentage hemolysis increased 
continuously with the increase in the time of incuba-
tion of bilirubin with calcium-loaded erythrocytes, 
reaching a 95% value after 75 min. On the other 
hand, incubation of cells with 2 mM CaCI, alone for 
75 min did not show any significant lysis (see Fig. 5). 
It was found that inclusion of EDTA in the incuba-
tion mixture along with calcium did reduce the per-
centage hemolysis after the addition of bilirubin, but 
total inhibition was not observed (see Fig. 6). Tlie 
percentage hemolysis decreased continuously (from a 
value of 65% in control) with the increasing concen-
tration of EDTA reaching to a value of 35% at an 
EDTA concentration of 2.0 mM, (double the concen-
tration of calcium used). This shows that all the 
calcium ions are not removed by 2 mM EDTA. 
Further, washing of erythrocytes pretreated with Ca~* 
and bilirubin, with 50 mM Tris-HCI buffer (pH 7.4), 
containing 100 mM NaCI and different concentra-
tions of EDTA, showed that sub.sequent hemolysis 
was prevented by removal of cell-bound calcium. As 
can be seen from Fig. 7, 2.0 mM EDTA led to a 
significant decrease in hemolysis. The.se results prob-
ably suggest that the basic reaction which results in 
I:K M.K Ml. S Tawiih/liKHliiiiiKii II Hioplivsnii A<i(i IJ2f)(IW7) 124-130 
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Fig. 6. Effect of EDTA on the calcium-induced hilirubin-depen-
dcm hemolysis of human erythnK-ylcs. Erythlocylcs incubated 
with CaCli (1.0 niM) and dillercnt concentrations ol EDTA 
(0-2.0 mM) at the same time for 30 min at 37°C followed by 
further incubation with bilirubin (72 ^M) lor 30 min at 37°C. 
the hemolysis pnihahly involves Ihc ciilciiiiii hoiuul 
lo the crylhrocytc membrane as this calcium can 
easily be washed out compared to the intracellular 
calcium. 
To determine the role of activated oxygen species 
in bilirubin-dependent calcium-induced hemolysis, 
sodium azide and cutalase were u.sed in the incuba-
70 
1. 
EL 
e 1 1 
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Fig. 7. Effect of removal of surface-bound calcium on the 
subsequent hemolysis of human erythrocytes pretrealcd with 
calcium and bilirubin. Erythrocytes first intubated with CaCI-, 
(1.0 mM) for .30 min at 37°C followed by further incubation with 
bilirubin (72 /xM). washing with 50 mM Tris-HCl buffer (pH 
7.4) containing l(K) mM NaCI and dillercnt EDTA concentra-
tions (0-2.0 niM). Shaded columns, control: hatched colunins. 
first wash; filled columns, second wash. 
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Fig. t>. Effect of sodium azide and catalase on calcium-induced 
bilirubin-dependent hemolysis of human erythrocytes. Erythro-
cytes first incubated with CaCl, (1.0 mM) and sodium azide 
(0.17-1.83 mM) or catalase (13-120 mg/l) for 30 min at 37°C 
followed by further incubation with bilirubin (72 ^M) for 30 min 
al 37°C. Elfecl of H , 0 , (0.16-1.6 mM) on human erythrwyles 
is also shown. 
tion medium. It was found that neither catalase (13-
120 mg/l) nor siKliuin a/idc (0.17-I.K3 inM) inhib-
ited hemolysis, l-urthcr, inclusion of hydrogen perox-
ide (0.16-1.6 mM) with human erythrocytes alone 
also failed to produce any significant hemolysis (see 
Fig. 8). Therefore, singlet oxygen, H2O2 and OH" 
are not involved in hemolysis. Moreover, the ques-
tion of generation of any free radicul by the interac-
tion of calcium with bilirubin did not arise as the 
incubation of calcium with bilirubin for 30 min al 
37°C followed by addition of human erythrocytes did 
not produce any hemolysis. This is because the cal-
cium bilirubinate formed in this reaction did not bind 
to the cells. 
The effect of other bivalent cations for their possi-
ble role of inducing hemolysis of human erythrocytes 
in the presence of bilirubin was also investigated. 
Ba""^  and Mg^ "^  are closely related bivalent cations 
to Ca""^  due to their ability to induce membrane 
aggregation through intramolecular chelation of phos-
pholipid molecules [3]. However, under similar con-
ditions of incubation procedure, both Ba^* and Mg-"^ 
(0.17-2.0 mM) were found to be unable to induce 
hemolysis of human erythrocytes as compared to 
Ca-* (0.17-2.0 mM) in the presence of bilirubin (72 
fiM) (see Fig. 9d.e and Fig. 10). Even at higher 
concentrations (3.3-16.7 mM), both Ba"* and Mg'"^ 
failed to induce any hemolysis (data omitted for 
Af.^  Ml. S. 7<(x\<i/i/'<"'<'"""<" 'I lli«i>li\M<(i A< «( I.U6(IW7) 124-1M) 129 
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Fiji. 9. Effecl of various hiviilenl cations on human erylhrocyles 
in the pre<ience of bilirubin. ErythnKyles first incubated with 
various salts of bivalent cations (0-2.0 mM) lor !?() niin at .^ 7°C 
followed by further incubatioi with bilirubin (72 ixM) lor 30 min 
at T'TC. The various sails used are: CaCI, (a): CuCI_, (b); MnCI, 
(c): BaCI, (d) and MgCI, (c). 
brevity). Although the effect of both Ba-^ and Mg-^ 
on biomembrane is reported smaller compared to 
Ca'^, the failure lo induce hemolysis even al a higher 
concentration of these cations, in the presence of 
bilirubin, suggests that either Ba"* or Mg"^ alone, 
or Ba"* or Mg"* complexed with bilirubin (if 
formed) is unable to alter the permeability of human 
erythrocytes. On the other hand, Mn'* and Cu'"^ 
induced hemolysis of human erythrocytes both in the 
presence and absence of bilirubin, as shown in Fig. 
9b.c and Fig. 10. In the absence of bilirubin. Mn'"^ at 
a concentration of 1.67 mM produced 20% hemolysis 
(Fig. 10). whereas in the presence of bilirubin, the 
s i . 
M -
I I 
n 
CaCl, C«a, M.CI, BaO, MfCI, 
Fig. 10. Eflect of various bivalent cations on human cr)throcytes 
in the absence' ol bilirubin. ErylbrtKytcs v^ crc incubated with 
different salts of bivalent cations (1.67 mM) for I h al VC 
percentage hemolysis was 22%. From these results it 
is clear that hemolysis is induced by Mn'"^ alone, 
unlike bilirubin-dependent calcium-induced hemoly-
sis of human erythrocytes. Similarly, in the absence 
of bilirubin, Cu^ "^  (1.67 mM) alone can induce about 
47% hemolysis (Fig. 10), whereas in the presence of 
bilirubin, about 69% hemolysis was ob.served. This is 
because Cu** alone or complexed with bilirubin can 
act as a polcniial oxidative agent [11], thereby cau.s-
ing changes in membrane permeability, it can also 
cross-link various proteins in the membrane. There-
fore, hemolysis induced by Cu^ "^  is different from 
that of bilirubin-dependent calcium-induced hemoly-
sis of human erythr(Kytes. 
The possible reason for this phenomena of biliru-
bin-dependent calcium-induced hemolysis of human 
erythrocytes can be explained in the following way. 
Since human erythrocyte membranes have a high 
ratio of phosphatidylcholine and phosphatidylserine 
[12], they are. therefore, highly sensitive to calcium 
to form hydrophobic aggregates of phospholipid 
molecules in erythrt)cyle ntcnihranc. Furthermore, the 
potentiality of bilirubin to remain in hydrophobic 
medium [8] increases the binding of bilirubin to these 
hydrophobic phospholipid aggregates of membranes. 
Since calcium-bound human erythrocytes are unsta-
ble due to transformation of the normal cells to 
echinocytes [4], the binding of bilirubin to the Ca*"^ -
chelated hydrophobic phospholipid aggregates of such 
transformed cells may cause further imbalance which 
results in hemolysis. 
Although calcium-induced hemolysis of erythro-
cytes has been reported in the presence of other 
ligands such as toxin [13] and complement compo-
nents [14], the mechanism of calcium-induced biliru-
bin-dependent hemolysis may or may not be similar 
to the mechanism of calcium-induced hemolysis in 
the presence of other ligands and thus requires further 
investigation. 
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Abstract 
Washed erythrocytes from human, buffalo, sheep and goat preincubated with different concentrations of calcium chloride 
(16.7-1830 ;iM) showed significantly different rates of hemolysis (up to 62%) after addition of bilirubin (72 iiM). Goat 
erythrocytes displayed marked resistance to hemolysis with only 11% hemolysis observed at the highest calcium concentration. 
Similar trend in hemolysis was also observed when the concentration of CaClj was fixed (330 nM) and bilirubin concentration 
varied (0-72 nM). (Ca^"^-Mg^'^)-ATPase levels were found significantly lower in goat and sheep erythrocyte membranes 
compared to human and buffalo erythrocyte membranes. This was correlated well with the observed hemolysis in vaidous 
mammalian erythrocytes. © 1998 Elsevier Science Inc. All rights reserved. 
Keywords: Bilirubin; Buffalo; Calcium; (CA^+-M^^"^)-ATPase; Erythrocytes; Goat; Hemolysis; Human; Mammalian species; 
Sheep / 
1. Introduction 
Calcium, an essential constituent of biological sys-
tems and many biochemical reactions, has been re-
ported to cause several changes in biological 
membranes and in their related properties [13]. Among 
these are: phase separation of phosphatidylserine-
phosphatidylcholine (PS-PC) bilayer [10,13,16], shape 
changes [21], cell fusion [6], hemolysis by various sub-
stances [1,15,19], etc. Recently, we have shown calcium-
induced bilirubin-dependent hemolysis in human 
erythrocytes [1]. Several differences have been reported 
among the different mammalian erythrocytes, such as 
lipid and protein composition [2,9,12], (Ca^^-Mg^"^)-
ATPase activity [20], calcium-induced cell fusion [6], 
rigidity to Ca^^-induced alterations [5], calcium-in-
duced ^transglutaminase-stimulated ^membrane 
crosslinking, as well as membrane protein degradation 
•Corresponding author. Tel.: +91 571 401718; fax: +91 571 
401081. ! 
[11] and differential morphological alterations against 
ATP depletion and calcium-induced stresses [21]. We 
therefore decided to assess calcium-induced bilirubin-
dependent hemolysis in ruminant erythrocytes which 
are markedly different from human erythrocytes in 
various calcium-induced processes. In this report, we 
present data on the calcium-induced bilirubin-depen-
dent hemolysis of different mammalian erythrocytes. 
2. Materials and methods 
Freshly collected blood was used. Human {Homo 
sapiens) blood was obtained from the Blood Bank of 
J.N. Medical College, Aligarh Muslim University, Ali-
garh. The blood of buffalo {Bos indicus), goat {Cepra 
hircus) and sheep {Ovis aries) was collected from the 
slaughterhouse in 1.32% sodium citrate. Ouabain, 
phenylmethylsulfonylfluoride (PMSF) and ethylenegly-
coI-0-0'-bis-(2-aminoethyl) N,N,N',N'-teTaacetic acid 
(EGTA) were purchased from Sigma. Bilirubin and 
0742-8413/98/S19.00 © 1998 Elsevier Science Inc. All rights reserved. 
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adenosine triphosphate (ATP) were obtained from 
Sisco Research Laboratories, India. Other reagents 
used were of analytical grade. 
Erythrocytes obtained by centrifugation of blood at 
1000 X g for 20 min were washed three times with 50 
mM Tris-HCl buffer (pH 7.4) containing 100 mM 
NaCl, after removing the buffy coat. The final packed 
cell volume was diluted with the same buffer to achieve 
a hematocrit value of 50%. The washed erythrocytes 
were hemolysed with 20-fold excess of cold lysis buffer 
containing 10 mM Tris-HCl (pH 7.4), 0.1 mM EDTA 
and 0.01 mM PMSF. The suspensions were centrifuged 
at 12000 X g for 30 min and the membrane pellets were 
washed several times with lysis buffer until the prepara-
tion was free of hemoglobin. The membranes were 
resuspended to a final concentration of 4 mg of protein/ 
ml of 80 mM Tris-HCl buffer (pH 7.4) and used 
immediately for further experiments. Calcium chloride 
solution was prepared in 50 mM Tris-HCl buffer (pH 
7.4) containing 100 mM NaCl. 
Bilirubin crystals were dissolved in 38 mM sodium 
carbonate solution containing 0.15 M NaCl (pH 11.0) 
(adjusted with 0.1 N HCl), and its concentration was 
determined by Fog's method [8]. The solution was 
protected from light and used within 30 min. All exper-
iments were carried out under yellow light. 
Samples were incubated as described by Bratlid [3], 
except that 1.0 ml of bilirubin solution was used instead 
of 0.5 ml. The incubation was carried out in 50 mM 
Tris-HCl buffer (pH 7.4) containing 100 mM NaCl at 
37°C, and the final incubation mixture volume was 6.0 
ml. Cells were pre-incubated with different concentra-
tions of calcium chloride for 30 min at 37°C followed 
by further incubation with 72 fiM bilirubin for 30 min 
at 37°C. Percentage hemolysis was calculated as A2I 
Ay X 100, where A^ is the absorbance at 540 nm of 
hemolysate of erythrocytes with water in 6.0 ml (8.3% 
hematocrit) after 1 h of incubation and A-^ is the 
absorbance at 540 nm of calcium-induced hemolysate 
in presence or absence of bilirubin in 6.0 ml (8.3% 
hematocrit) after 1 h of incubation. Each experiment 
was performed in duplicate with the blood samples 
coming from an animal only and in different indepen-
dent experiments, the blood samples were drawn from 
different animals of the same species. 
(Ca^'^-Mg^"^)-ATPase activities were determined in 
the hemoglobin-free erythrocyte membranes obtained 
from different species as described earlier [21]. The 
reaction mixture contained 80 mM NaCl, 15 mM KCl, 
3 mM MgClz, 0.1 mM ouabain, 0.2 mM CaClj, 0.1 
mM EGTA, 20 mM Tris-HCl (pH 7.4), 0.5 ml of 
erythrocyte membrane suspension and different concen-
trations (0-2.5 mM) of ATP in a total volume of 2.0 
ml. The mixture was incubated for 60 min at 37°C. The 
reaction was terminated with 0.5 ml of 1.2 M perchloric 
acid and the liberated inorganic phosphate was esti-
mated by the method of Fiske and Subbarow [7] 
against a suitable blank. No Ca^+ wasjused for (Mg^"^ 
)-ATPase activities. The (Ca^'^-Mg^'*')fATPase activity 
was determined by subtracting the (Mg^'^)-ATPase ac-
tivity from the total ((Ca^ + -Mg^ + )-ATPase-|-(Mg^-*' 
)-ATPase) activity. 
3. Results 
Incubation of mammalian erythrocytes with different 
concentrations of CaCl2 (16.7-1830 //M) for 30 min at 
37°C followed by further incubation with 72 /zM biliru-
bin resulted in the hemolysis of these erythrocytes (see 
Fig. 1). Incubation of these erythrocytes with CaCl2 or 
bilirubin alone did not produce any hemolysis (data not 
shown). Human, buffalo and sheep erythrocytes 
showed a similar pattern of hemolysis which became 
constant at higher CaCl2 concentrations {t\ 500 /^M). 
In contrast, goat erythrocytes did not show any signifi-
cant hemolysis (P > 0.1), compared to the control value 
up to 1170 //M CaClj concentration and only 11% 
hemolysis was observed at the highest CaClj concentra-
tion (1830 ;^M). Hemolysis at this point was 6-fold 
( P < 0.0001) smaller than hemolysis observed in the 
other three species. These results were highly repro-
ducible under similar conditions. For two independent 
experiments, the S.E.M. is shown in Fig. 1. 
Dependence of calcium-induced hemolysis of mam-
malian erythrocytes on bilirubin concentration was also 
found when the concentration of CaClj was fixed at 330 
//M.and bilirubin concentration varied between 0 and 
72 //M in the above experiment. A linear increase in 
percentage hemolysis was observed in different mam-
malian erythrocytes, being maximun for human ery-
throcytes, followed by buffalo and sheep erythrocytes, 
and minimum for goat erythrocytes (Fig. 2). These 
results were similar to those described above when 
concentration of CaClj was varied while fixing the 
bilirubin concentration. 
The levels of erythrocyte membrane (Ca^"^-Mg^"*')-
ATPase were found to be different for different ery-
throcyte membranes. Maximum activities were noticed 
in human erythrocyte membranes, followed by buffalo 
erythrocyte membranes, whereas sheep and goat ery-
throcyte membranes had lowest activities at all the ATP 
concentrations (0.5-2.5 mM) used in this study (Fig. 
3). Both goat and sheep erythrocyte membranes were 
indistinguishable (/' = 0.3) in their (Ca^ + -Mg^ + )-AT-
Pase activities, whereas significant differences were 
found in human and goat erythrocyte membranes {P < 
0.0001). Further, human and buffalo erythrocyte mem-
branes were significantly different (/•< 0.001) from 
goat and sheep erythrocyte membranes in their (Ca^ "^  -
Mg^ "^  )-ATPase activities. These results were similar to 
the one reported eadier [21]. 
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4. Discussion 
Human, buffalo and sheep erythrocytes differ 
markedly in hemolysis with increasing CaClj concen-
Tration (df='l9,40j F = 13.36; /> = 8.3 x 10"'^). For 
example, the concentration of CaClj required to 
achieve 30% hemolysis in human, buffalo and sheep 
erythrocytes was found to be 105, 135 and 465 /;M, 
respectively (see Fig. 1). Further, buffalo and sheep 
erythrocytes showed a poor response at lower CaCl2 
^oricentrat ions^^ only 5.5 and 2.5%, respixtively^ ^^ 
hemolysis was observed in these erythrocyte;, at 67 
/iM CaCl2 concentration which seems to be insignifi-
cant (P>0.05) compared to the control values. In 
contrast, human erythrocytes showed 18.0% hemoly-
sis at this CaCl2 concentration. A similar trend in 
hemolysis was also observed when the concentration 
of CaClj was fixed and bilirubin concentration 
varied. However, the increase in hemolysis was linear 
on increasing bilirubin concentration. The values of 
slope of linear plots were significantly different for 
human, buffalo and sheep erythrocytes {P<0.0\), 
whereas the slope value obtained with goat erythro-
cytes was insignificant (P > 0.05). It appears that 
goat erythrocytes lack the phenomenon of calcium-
induced bilirubin-dependent hemolysis. This is in ac-
cordance with the earlier reports on the lack of 
calcium-dependent processes in goat erythrocytes 
[6,11,21]. Differences in the extent of calcium-induced 
bilirubin-dependent hemolysis observed in human, 
buffalo and sheep erythrocytes can be correlated well 
with the (Ca^ + -Mg^'^)-ATPase activities of their 
erythrocyte membranes, which were found maximum 
for human erythrocyte membranes and iTiinimum_ for_ 
jsba^~erytRrocyte Inembranes (Fig. 3). Lack of this 
phenomenon in goat erythrocytes may involve several 
other factors, such as phospholipid composition, 
shape and size, etc. Large differences in sphin-
gomyelin (Sph) content (i.e. sheep, 51.0%, goat, 
45.9%, buffalo, 40.9%, and human, 24.7% of the to-
tal phospholipid content) among these erythrocytes 
[2,14] may be one factor, since sphingomyelin pro-
vides stability to erythrocytes under isoosmotic con-
ditions and reduces the membrane permeability to 
molecules for which no transport systems exist [4,18]. 
Further, the sphingomyelin-phosphatidylcholine (PC) 
ratio—these two choline lipids constitute about half 
of the total phospholipids in the membrane—varies 
greatly in human and ruminant erythrocytes. This ra-
tio (Sph/PC) is about 12 in goat and sheep erythro-
cytes but only 0.64 in human erythrocyte membranes 
[2] and 4.26 in buffalo erythrocytes [14]. This high 
ratio may cause lower membrane fluidity in ruminant 
erythrocytes compared to human erythrocytes [17]. 
Marked resistance towards calcium-induced bilirubin-
dependent hemolysis in sheep and buffalo erythro-
cytes compared to human erythrocytes correlated 
well with the differences in the sphingomyelin con-
tent. In addition, calcium-induced phase separation 
as shown previously in phosphatidylserine (PS)-PC 
bilayers [10,13,16], may also be responsible for the 
differences in the calcium-induced bilirubin-dependent 
I 
5? 
150 7.00 330 500 2000 
CaClj in incubate (jiM) 
Fig. 1. Calcium-induced bilirubin- ' iependent hemolysis in mammal ian erythrocytes: h u m a n ( A ) ; buffalo ( • ) ; sheep ( O ) ; and goat ( V ) . 
Erythrocytes were first incubated for 30 min at 37°C with different concentrat ions of CaCl j (16 .7 -1830 / /M) in 50 m M T r i s - H C l buffer (pH 7.4) 
containing 100 m M NaCl followed by further incubation with 72 / (M bilirubin-for 30 min a t 37°C. Percentage hemolysis was calculated as 
described in Section 2. Each point is the mean + S.E.M. of two independent experiments in duplicate. 
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Fig. 2. Calcium-induced bilirubin-dependent hemolysis id mammalian erythrocytes: human (A); buffalo {•); sheep (O); and goat (Jf). 
Erythrocytes were first incubated for 30 min at 37°C with 330 ixtA CaClj in 50 mM Tris-HCl buffer (pH 7.4) containing 100 mM NaCl followed 
by further incubation with increasing concentrations of bilirubin (0-72^/1 M) for 30 min at 37°C. Percentage hemolysis was calculated as described 
in Section 2. Each point is the mean ± S.E.M, of two Independent expcrimcnls. 
Fig. 3. (Ca_f +~Mgjt +)-ATPase activities in different mammalian erythrocyte membranes at different concentrations of ATP. Human (O); 
buffal o (j); sheep ((A);*and goat f2). Each point is the mean + S.E 
A ^—. — ^ • 
hemolysis among these erythrocytes. The PS/PC ratio is 
very low in human erythrocytes (0.39) compared to 3.33 
and 5.59 in sheep and goat erythrocytes, respectively 
[2], and 1.13 in buffalo erythrocytes [14]. Further, the 
triangular/irregular shape of goat erythrocytes com-
pared to the biconcave shape found in human, buffalo 
and sheep erythrocytes [6] also adds to the unusual 
behavior shown by goat erythrocytes. Moreover, the 
interactiori of band .t%ge proteins with glycoprotein 
gpl55, as reported in goat erythrocytes [9], might con-
tribute to the unusual stability of goat erythrocytes 
under various stresses. Thus, lack of (Ca^"^-Mg^•^)-
^TPase activity, high sphingomyelin content [2] and 
.riangular/vrregular shape [6] may all contribute to the 
resistance towards calcium-induced bilirubin-dependent 
hemolysis exhibited by goat erythrocytes. 
M. of four experiments. 
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